Substituted oxyiminomethylphenyl uracils and salts thereof, and use thereof as herbicidal active substances

Abstract

The present invention relates to oxyiminomethylphenyl uracils of general formula (I) with 4-difluoroalkyl substitution on the uracil and salts thereof, wherein the radicals in general formula (I), (I) correspond to the definitions given in the description, and to the use thereof as herbicides, in particular for controlling weeds and / or weed grasses in crops of useful plants, and / or as plant growth regulators for influencing the growth of crops of useful plants.

Description

[0001] Bayer AG Substituted oxyiminomethylphenyluracils and their salts and their use as herbicidal active ingredients Description The invention relates to the technical field of crop protection agents, in particular to herbicides for the selective control of weeds and grass weeds in crops. Specifically, this invention relates to substituted oxyiminomethylphenyluracils with 4-difluoroalkyl substitution on the uracil and their salts, processes for their preparation, and their use as herbicides, in particular for controlling weeds and / or grass weeds in crops and / or as plant growth regulators for influencing the growth of crops.Previously known plant protection products for the selective control of weeds in crops or active substances for controlling undesirable plant growth sometimes have disadvantages in their use, either because they (a) have no or insufficient herbicidal activity against certain weeds, (b) have an insufficiently narrow spectrum of weeds that can be controlled with one active substance, (c) have insufficient selectivity in crops, and / or (d) have a toxicologically unfavorable profile. Furthermore, some active substances that can be used as plant growth regulators in some crops lead to undesirably reduced crop yields in others or are incompatible with the crop or only compatible within a narrow application rate range.Some of the known active ingredients cannot be produced economically on an industrial scale due to difficult-to-access precursors and reagents, or they have insufficient chemical stability. For other active ingredients, the effect depends too heavily on environmental conditions, such as weather and soil conditions. The herbicidal effect of these known compounds, especially at low application rates, and their tolerance to crops remain in need of improvement. It is known from various publications that certain substituted N-linked aryluracils can be used as herbicidal active ingredients (cf. EP408382, EP473551, EP648749, US4943309, US5084084, US5127935, WO91 / 00278, WO95 / 29168, WO95 / 30661, WO96 / 35679, WO97 / 01541, WO98 / 25909, WO2001 / 39597). However, the known aryluracils have several gaps in their activity, particularly against monocotyledonous weeds.A number of herbicidal active ingredient combinations based on N-linked aryluracils have also been disclosed (cf. DE4437197, EP714602, WO96 / 07323, WO96 / 08151, JP11189506). However, the properties of these active ingredient combinations are not entirely satisfactory. It is also known that certain N-aryluracils with optionally further substituted lactic acid groups can also be used as herbicidal active ingredients (cf. JP2000 / 302764, JP2001 / 172265, US6403534, EP408382A1). It is also known that N-aryluracils with specific, optionally further substituted, thiolactic acid groups also exhibit herbicidal effects (cf. WO2010 / 038953, KR20110110420, WO2020 / 013500). Selected substituted tetrahydrofuryl esters of N-aryluracils with optionally further substituted thiolactic acid groups are described in JP09188676.Also known are substituted N-benzoic acid uracils that carry chlorine substituents in the benzoic acid moiety (cf. WO91 / 000278, DE19741411, WO95 / 32952, US6207830, WO88 / 10254, EP0831091). Furthermore, highly substituted 3-amino-1-(3-carboxy-4-cyanophenyl)uracils with various carboxylate side chains have been described (cf. WO98 / 25909). Highly substituted N-benzoic acid uracils with an aminosulfonylaminocarbonylalkoxy side chain are also known (cf. WO2004 / 009561). It is also known that certain substituted N-benzoic acid thiobarbiturates can be used as herbicidal active ingredients (cf. WO2021 / 259224). Certain oxyiminomethylphenyluracils are described as herbicidal active ingredients (cf. EP 4089078). Difluoroalkyl-substituted uracils are also described as herbicidal active ingredients (cf. WO1988010254; WO2023285222).Surprisingly, it has now been found that certain substituted oxyiminomethylphenyluracils with 4-difluoroalkyl substitution on the uracil or their salts are highly suitable as herbicides and can be used particularly advantageously as active ingredients for controlling monocotyledonous and dicotyledonous weeds in crops. The present invention thus relates to substituted oxyiminomethylphenyluracils of the general formula (I) or their salts (I). where W stands for the group

[0002] W -1 W-2 stands R 1 represents hydrogen, halogen, or (C1-C4)-alkoxy, R 2 represents halogen, cyano, nitro, C(O)NH2, C(S)NH2, (C1-C8)-haloalkyl, or (C2-C8)-alkynyl, R 3 and R 4 independently of each other represent hydrogen, (C1-C8)-alkyl, R 13 O-(C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C2-C8)-alkenyl, aryl-(C1-C8)-alkyl, heteroaryl-(C1-C8)-alkyl, or heterocyclyl-(C1-C8)-alkyl, or R3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 10-membered carbocyclic ring, which optionally carries further substituents, R 5 represents hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, R 13 O-(C1-C8)-alkyl, (C2-C8)-alkenyl, aryl-(C1-C8)-alkyl, heteroaryl-(C1-C8)-alkyl, heterocyclyl-(C1-C8)-alkyl, (C3-C8)-cycloalkyl, aryl, heteroaryl, or heterocyclyl, R 6 represents (C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C2-C8)-alkenyl, aryl-(C1-C8)-alkyl, or (C3-C8)-cycloalkyl-(C1-C8)-alkyl, R 7 represents hydrogen, fluorine, chlorine or methyl, Q represents hydroxy or a radical of the following formulas 0 R 5 stands, R 8 for hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, aryl, aryl-(C1-C8)-alkyl, heteroaryl, 30 (C2-C8)-alkynyl, (C2-C8)-alkenyl, C(O)R 13 , C(O)OR 13 , or (C1-C8)-alkoxy-(C1-C8)-alkyl, R 9für Wasserstoff oder (C1-C8)-Alkyl steht, R 10 für Wasserstoff, Halogen, Cyano, NO2, (C1-C8)-Alkyl, (C1-C8)-Haloalkyl, (C3-C8)-Cycloalkyl, (C3-C8)-Cycloalkyl-(C1-C8)-alkyl, (C3-C8)-Halocycloalkyl, (C3-C8)-Halocycloalkyl-(C1-C8)- alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, Aryl, Aryl-(C1-C8)-alkyl, Heteroaryl, Heteroaryl- (C1-C8)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C8)-alkyl, R 11 R 12 N-(C1-C8)-alkyl, R 13 O-(C1-C8)- alkyl, Cyano-(C1-C8)-alkyl, (C1-C8)-Alkylcarbonyloxy-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl- carbonyloxy-(C1-C8)-alkyl, Arylcarbonyloxy-(C1-C8)-alkyl, Heteroarylcarbonyloxy-(C1-C8)- alkyl, Heterocyclylcarbonyloxy-(C1-C8)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S- (C1-C8)-alkyl, R 14 (O)S-(C1-C8)-alkyl, R 14O2S-(C1-C8)-alkyl, tris-[(C1-C8)-alkyl]silyl-(C1-C8)-alkyl, bis-[(C1-C8)-alkyl](aryl)silyl(C1-C8)-alkyl, [(C1-C8)-alkyl]-bis-(aryl)silyl-(C1-C8)-alkyl, Tris-[(C1-C8)-Alkyl]silyl, Bis-hydroxyboryl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkoxy]boryl-(C1-C8)-alkyl, Tetramethyl-1,3,2-Dioxaborolan-2-yl, Tetramethyl-1,3,2-Dioxaborolan-2-yl-(C1-C8)- alkyl, nitro-(C1-C8)alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C8)-alkyl, R 11 R 12 N(O)C-(C1-C8)-alkyl, or bis-(C1-C8)-alkoxy-(C1-C8)-alkyl, or R 8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12gleich oder verschieden sind und unabhängig voneinander für Wasserstoff, (C1-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C1-C8)-Cyanoalkyl, (C1-C10)-Haloalkyl, (C2-C8)-Haloalkenyl, (C3-C8)-Haloalkinyl, (C3-C10)-Cycloalkyl, (C3-C10)-Halocycloalkyl, (C4-C10)-Cycloalkenyl, (C4-C10)-Halocycloalkenyl, (C1-C8)-Alkoxy-(C1-C8)-alkyl, (C1-C8)-Haloalkoxy-(C1-C8)-alkyl, (C1-C8)-Alkylthio-(C1-C8)-alkyl, (C1-C8)-Haloalkylthio-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)- haloalkyl, Aryl, Aryl-(C1-C8)-alkyl, Heteroaryl, Heteroaryl-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl- (C1-C8)-alkyl, (C4-C10)-Cycloalkenyl-(C1-C8)-alkyl, COR 13 , SO2R 14 , Heterocyclyl, (C1-C8)- Alkoxycarbonyl, Bis-[(C1-C8)-alkyl]aminocarbonyl-(C1-C8)-alkyl, (C1-C8)-Alkyl-amino- carbonyl-(C1-C8)-alkyl, Aryl-(C1-C8)-alkyl-aminocarbonyl-(C1-C8)-alkyl, Aryl-(C1-C8)- alkoxycarbonyl, Heteroaryl-(C1-C8)-alkoxycarbonyl, (C2-C8)-Alkenyloxycarbonyl, (C2-C8)- Alkinyloxycarbonyl, oder Heterocyclyl-(C1-C8)-alkyl stehen, oder R 11and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13 for hydrogen, (C1-C8)-alkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (C1-C8)-cyanoalkyl, (C1-C10)-haloalkyl, (C2-C8)-haloalkenyl, (C3-C8)-haloalkynyl, (C3-C10)-cycloalkyl, (C3-C10)-halocycloalkyl, (C4-C10)-cycloalkenyl, (C4-C10)-halocycloalkenyl, (C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-haloalkoxy-(C1-C8)-alkyl, (C1-C8)-alkoxy-(C1-C8)-haloalkyl, (C1-C8)-alkoxy- (C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkyl, aryl, aryl-(C1-C8)-alkyl, aryl-(C1-C8)-alkoxy-(C1-C8)-alkyl, heteroaryl, Heteroaryl-(C1-C8)-alkyl, (C3-C8)-cycloalkyl-(C1-C8)-alkyl, (C4-C 10)-Cycloalkenyl-(C1-C8)-alkyl, Bis-[(C1-C8)- alkyl]aminocarbonyl-(C1-C8)-alkyl, (C1-C8)-Alkyl-aminocarbonyl-(C1-C8)-alkyl, Aryl-(C1-C8)- alkyl-aminocarbonyl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkyl]amino-(C2-C6)-alkyl, (C1-C8)-Alkyl- amino-(C2-C6)-alkyl, Aryl-(C1-C8)-alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C8)-alkyl, R 14 (O)S- (C1-C8)-alkyl, R 14 O2S-(C1-C8)-alkyl, Hydroxycarbonyl-(C1-C8)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C8)-alkyl, Tris-[(C1-C8)-Alkyl]silyl-(C1-C8)-alkyl, Bis-[(C1-C8)- Alkyl](aryl)silyl(C1-C8)-alkyl, [(C1-C8)-Alkyl]-bis-(aryl)silyl-(C1-C8)-alkyl, (C1-C8)- Alkylcarbonyloxy-(C1-C8)-alkyl, (C3-C8)-Cycloalkylcarbonyloxy-(C1-C8)-alkyl, Arylcarbonyloxy-(C1-C8)-alkyl, Heteroarylcarbonyloxy-(C1-C8)-alkyl, Heterocyclylcarbonyloxy-(C1-C8)-alkyl, Aryloxy-(C1-C8)-alkyl, Heteroaryloxy-(C1-C8)-alkyl, oder (C1-C8)-Alkoxycarbonyl steht, R 14 für Wasserstoff, (C1-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C1-C8)-Cyanoalkyl, (C1-C 10)- Haloalkyl, (C2-C8)-Haloalkenyl, (C3-C8)-Haloalkinyl, (C3-C 10 )-Cycloalkyl, (C3-C 10 )- Halocycloalkyl, (C4-C 10 )-Cycloalkenyl, (C4-C 10 )-Halocycloalkenyl, (C1-C8)-Alkoxy-(C1-C8)- alkyl, (C1-C8)-Alkoxy-(C1-C8)-haloalkyl, Aryl, Aryl-(C1-C8)-alkyl, Heteroaryl, Heteroaryl- (C1-C8)-alkyl, Heterocyclyl-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl-(C1-C8)-alkyl, (C4-C10)- Cycloalkenyl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkyl]amino, (C1-C8)-Alkyl-amino, Aryl-(C1-C8)- amino, Aryl-(C1-C6)-alkyl-amino, Aryl-[(C1-C8)-alkyl]amino; (C3-C8)-Cycloalkyl-amino, (C3- C8)-Cycloalkyl-[(C1-C8)-alkyl]amino; N-Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, oder N- Morpholinyl steht und R 15 und R 16 unabhängig voneinander für (C1-C8)-Alkyl, (C3-C8)-Cycloalkyl, Aryl, Heteroaryl, oder Heterocyclyl stehen, oder 35 R 15 und R 16with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 7-membered carbocycle. It has surprisingly been found that the compounds of the general formula (I) according to the invention, on the one hand, achieve good herbicidal activity, but on the other hand, also have good, environmentally friendly degradation properties and are thus less harmful to the environment. The compounds of the general formula (I) can form salts by addition of a suitable inorganic or organic acid, such as, for example, mineral acids such as HCl, HBr, H2SO4, H3PO4 or HNO3, or organic acids, e.g., carboxylic acids such as formic acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid, or sulfonic acids such as, for example, p-toluenesulfonic acid, to a basic group, such as, for example, amino, alkylamino, dialkylamino, piperidino, morpholino or pyridino. These salts then contain the conjugate base of the acid as an anion.Suitable substituents that are present in deprotonated form, such as sulfonic acids, certain sulfonic acid amides, or carboxylic acids, can form internal salts with protonatable groups, such as amino groups. Salt formation can also occur through the action of a base on compounds of general formula (I). Suitable bases include, for example, organic amines, such as trialkylamines, morpholine, piperidine, and pyridine, as well as ammonium, alkali, or alkaline earth metal hydroxides, carbonates, and bicarbonates, in particular sodium and potassium hydroxide, sodium and potassium carbonate, and sodium and potassium bicarbonate.These salts are compounds in which the acidic hydrogen is replaced by a cation suitable for agriculture, for example metal salts, in particular alkali metal salts or alkaline earth metal salts, in particular sodium and potassium salts, or also ammonium salts, salts with organic amines or quaternary ammonium salts, for example with cations of the formula [NR. a R b R c R d ] + , where R a to R d each independently of one another represents an organic radical, in particular alkyl, aryl, aralkyl or alkylaryl. Also suitable are alkylsulfonium and alkylsulfoxonium salts, such as (C1-C4)-trialkylsulfonium and (C1-C4)-trialkylsulfoxonium salts. In the following, the compounds of the formula (I) and their salts used in the invention are referred to as "compounds of the general formula (I)". Preferred subject matter of the invention are compounds of the general formula (I) in which W represents the group W-1 W-2 stands R 1 represents hydrogen, fluorine, chlorine, or bromine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, trifluoromethyl, ethynyl, or propyn-1-yl, R 3 and R 4 independently of each other represent hydrogen, (C1-C6)-alkyl, R 13 O-(C1-C6)alkyl, (C3-C6)cycloalkyl, (C2-C6)alkenyl, aryl(C1-C6)alkyl, heteroaryl(C1-C6)alkyl, or heterocyclyl(C1-C6)alkyl, or R 3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 10-membered carbocyclic ring, R 5 for hydrogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, R 13 O-(C1-C6)-alkyl, aryl-(C1-C6)-alkyl, heteroaryl-(C1-C6)-alkyl, heterocyclyl-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, aryl, heteroaryl, or heterocyclyl, R 6für (C1-C6)-Alkyl, (C3-C6)-Cycloalkyl, (C2-C6)-Alkenyl, Aryl-(C1-C6)-alkyl, oder (C3-C6)- Cycloalkyl-(C1- C6)-alkyl steht, R 7 für Wasserstoff oder Methyl steht, Q für Hydroxy oder einen Rest der nachfolgenden Formeln steht, R 8 für Wasserstoff, (C1-C6)-Alkyl, (C1-C6)-Haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, (C2-C6)-Alkinyl, (C2-C6)-Alkenyl, C(O)R 13 , C(O)OR 13 , oder (C1-C6)-Alkoxy-(C1-C6)-alkyl steht, R 9 für Wasserstoff oder (C1-C6)-Alkyl steht, R 10 für Wasserstoff, Halogen, Cyano, NO2, (C1-C7)-Alkyl, (C1-C7)-Haloalkyl, (C3-C7)-Cycloalkyl, (C3-C7)-Cycloalkyl-(C1-C7)-alkyl, (C3-C7)-Halocycloalkyl, (C3-C7)-Halocycloalkyl-(C1-C7)- alkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, Aryl, Aryl-(C1-C7)-alkyl, Heteroaryl, Heteroaryl- (C1-C7)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C7)-alkyl, R 11 R 12 N-(C1-C7)-alkyl, R 13O-(C1-C7)- alkyl, Cyano-(C1-C7)-alkyl, (C1-C7)-Alkylcarbonyloxy-(C1-C7)-alkyl, (C3-C7)- Cycloalkylcarbonyloxy-(C1-C7)-alkyl, Arylcarbonyloxy-(C1-C7)-alkyl, Heteroarylcarbonyloxy- (C1-C7)-alkyl, Heterocyclylcarbonyloxy-(C1-C7)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S-(C1-C7)-alkyl, R 14 (O)S-(C1-C7)-alkyl, R 14 O2S-(C1-C7)-alkyl, Tris-[(C1-C7)-Alkyl]silyl- (C1-C7)-alkyl, Bis-[(C1-C7)-Alkyl](aryl)silyl(C1-C7)-alkyl, [(C1-C7)-Alkyl]-bis-(aryl)silyl- (C1-C7)-alkyl, Tris-[(C1-C7)-Alkyl]silyl, Bis-hydroxyboryl-(C1-C7)-alkyl, Bis-[(C1-C7)- alkoxy]boryl-(C1-C7)-alkyl, Tetramethyl-1,3,2-Dioxaborolan-2-yl, Tetramethyl-1,3,2- Dioxaborolan-2-yl-(C1-C7)-alkyl, Nitro-(C1-C7)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C7)-alkyl, R 11 R 12 N(O)C-(C1-C7)-alkyl, oder Bis-(C1-C7)-alkoxy-(C1-C7)-alkyl steht, oder R8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12 are the same or different and independently represent hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-cyanoalkyl, (C1-C6)-haloalkyl, (C2-C6)-haloalkenyl, (C3-C6)-haloalkynyl, (C3-C6)-cycloalkyl, (C3-C6)-halocycloalkyl, (C4-C6)-cycloalkenyl, (C4-C6)-halocycloalkenyl, (C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-haloalkoxy-(C1-C6)-alkyl, (C1-C6)-alkylthio-(C1-C6)-alkyl, (C1-C6)-haloalkylthio-(C1-C6)-alkyl, (C1-C6)-alkoxy-(C1-C6)-haloalkyl, aryl, aryl-(C1-C6)-alkyl, heteroaryl, heteroaryl-(C1-C6)-alkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, (C4-C6)-cycloalkenyl-(C1-C6)-alkyl, C(O)R 13 , SO2R 14, heterocyclyl, (C1-C6)-alkoxycarbonyl, bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)-alkyl, (C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxycarbonyl, heteroaryl-(C1-C6)-alkoxycarbonyl, (C2-C6)-alkenyloxycarbonyl, (C2-C6)-alkynyloxycarbonyl, or heterocyclyl-(C1-C6)-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)-35 Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)- Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, (C1-C6)-Alkoxy-(C1-C6)- alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)- Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, Aryl, Aryl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxy-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl- (C1-C6)-alkyl, (C4-C6)-Cycloalkenyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)- alkyl, (C1-C6)-Alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C7)-alkyl-aminocarbonyl-(C1-C6)- alkyl, Bis-[(C1-C6)-alkyl]amino-(C2-C6)-alkyl, (C1-C6)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1-C6)- alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C6)-alkyl, R 14(O)S-(C1-C6)-alkyl, R 14 O2S-(C1-C6)-alkyl, Hydroxycarbonyl-(C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)-alkyl, Tris-[(C1-C6)- Alkyl]silyl-(C1-C6)-alkyl, Bis-[(C1-C6)-Alkyl](aryl)silyl(C1-C6)-alkyl, [(C1-C6)-Alkyl]-bis- (aryl)silyl-(C1-C6)-alkyl, (C1-C6)-Alkylcarbonyloxy-(C1-C6)-alkyl, (C3-C6)- Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy- (C1-C6)-alkyl, Heterocyclylcarbonyloxy-(C1-C6)-alkyl, Aryloxy-(C1-C6)-alkyl, Heteroaryloxy- (C1-C6)-alkyl, oder (C1-C6)-Alkoxycarbonyl steht, R 14für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)- Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)- Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)- alkyl, Heterocyclyl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C4-C6)-Cycloalkenyl- (C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]amino, (C1-C6)-Alkyl-amino, Aryl-(C1-C6)-amino, Aryl-(C1- C6)-alkyl-amino, Aryl-[(C1-C6)-alkyl]amino; (C3-C6)-Cycloalkyl-amino, (C3-C6)-Cycloalkyl- [(C1-C6)-alkyl]amino; N-Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, oder N-Morpholinyl steht, und R 15 und R 16 unabhängig voneinander für (C1-C6)-Alkyl, (C3-C6)-Cycloalkyl, Aryl, Heteroaryl, oder Heterocyclyl stehen, oder R 15 und R 16with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 7-membered carbocycle. Particularly preferred subject of the invention are compounds of the general formula (I), in which 35 W represents the group

[0003] stands R 1 represents hydrogen, fluorine, or chlorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, or trifluoromethyl, R 3 and R 4 independently of one another represent hydrogen, (C1-C4)-alkyl, or (C1-C4)-haloalkyl, or R 3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 7-membered carbocyclic ring, R 5 represents hydrogen, (C1-C4)-alkyl, or (C1-C4)-haloalkyl, R 6 represents methyl, ethyl, or prop-1-yl, R 7 represents hydrogen, Q represents hydroxy or a radical of the following formulas 0 R 5 steht, R 8 für Wasserstoff, (C1-C5)-Alkyl, (C1-C5)-Haloalkyl, Aryl, Aryl-(C1-C5)-alkyl, Heteroaryl, (C2-C5)-Alkinyl, (C2-C5)-Alkenyl, C(O)R 13 , C(O)OR 13 , oder (C1-C5)-Alkoxy-(C1-C5)-alkyl steht, R 9 für Wasserstoff oder (C1-C5)-Alkyl steht, R 10 für Wasserstoff, Halogen, Cyano, NO2, (C1-C6)-Alkyl, (C1-C6)-Haloalkyl, (C3-C6)-Cycloalkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C3-C6)-Halocycloalkyl, (C3-C6)-Halocycloalkyl-(C1-C6)-30 alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl- (C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)-alkyl, R 11 R 12 N-(C1-C6)-alkyl, R 13 O-(C1-C6)- alkyl, Cyano-(C1-C6)-alkyl, (C1-C6)-Alkylcarbonyloxy-(C1-C6)-alkyl, (C3-C6)- Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy- (C1-C6)-alkyl, Heterocyclylcarbonyloxy-(C1-C6)-alkyl, OR 13 , NR 11 R 12 , SR 14, S(O)R 14 , SO2R 14 , R 14 S-(C1-C6)-alkyl, R 14 (O)S-(C1-C6)-alkyl, R 14 O2S-(C1-C6)-alkyl, tris-[(C1-C6)-alkyl]silyl-(C1-C6)-alkyl, bis-[(C1-C6)-alkyl](aryl)silyl(C1-C6)-alkyl, [(C1-C6)-alkyl]-bis-(aryl)silyl-(C1-C6)-alkyl, Tris-[(C1-C6)-alkyl]silyl, bis-hydroxyboryl-(C1-C6)-alkyl, bis-[(C1-C6)-alkoxy]boryl-(C1-C6)-alkyl, tetramethyl-1,3,2-dioxaborolan-2-yl, tetramethyl-1,3,2- Dioxaborolan-2-yl-(C1-C6)-alkyl, nitro-(C1-C6)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C6)-alkyl, R 11 R 12 N(O)C-(C1-C6)-alkyl, or bis-(C1-C6)-alkoxy-(C1-C6)-alkyl, or R 8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11und R 12 gleich oder verschieden sind und unabhängig voneinander für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)-Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C 10 )-Cycloalkyl, (C3-C6)-Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkylthio-(C1-C6)-alkyl, (C1-C6)-Haloalkylthio-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)- haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl- (C1-C6)-alkyl, (C4-C10)-Cycloalkenyl-(C1-C6)-alkyl, C(O)R 13 , SO2R 14, heterocyclyl, (C1-C6)-alkoxycarbonyl, bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)-alkyl, (C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxycarbonyl, heteroaryl-(C1-C6)-alkoxycarbonyl, (C2-C6)-alkenyloxycarbonyl, (C2-C6)-alkynyloxycarbonyl, or heterocyclyl-(C1-C6)-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C10)- Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)- 35 Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, (C1-C6)-Alkoxy-(C1-C6)- alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)- Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, Aryl, Aryl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxy-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl- (C1-C6)-alkyl, (C4-C6)-Cycloalkenyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)- alkyl, (C1-C6)-Alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)- alkyl, Bis-[(C1-C6)-alkyl]amino-(C2-C6)-alkyl, (C1-C6)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1-C6)- alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C6)-alkyl, R 14(O)S-(C1-C6)-alkyl, R 14 O2S-(C1-C6)-alkyl, Hydroxycarbonyl-(C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)-alkyl, Tris-[(C1-C6)- Alkyl]silyl-(C1-C6)-alkyl, Bis-[(C1-C6)-Alkyl](aryl)silyl(C1-C6)-alkyl, [(C1-C6)-Alkyl]-bis- (aryl)silyl-(C1-C6)-alkyl, (C1-C6)-Alkylcarbonyloxy-(C1-C6)-alkyl, (C3-C6)- Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy- (C1-C6)-alkyl, Heterocyclylcarbonyloxy-(C1-C6)-alkyl, Aryloxy-(C1-C6)-alkyl, Heteroaryloxy- (C1-C6)-alkyl, oder (C1-C6)-Alkoxycarbonyl steht, R 14 für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)- Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C 10)-Cycloalkyl, (C3-C6)- Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)- alkyl, Heterocyclyl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C4-C6)-Cycloalkenyl- (C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]amino, (C1-C6)-Alkyl-amino, Aryl-(C1-C6)-amino, Aryl-(C1- C6)-alkyl-amino, Aryl-[(C1-C6)-alkyl]amino; (C3-C6)-Cycloalkyl-amino, (C3-C6)-Cycloalkyl- [(C1-C6)-alkyl]amino; N-Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, oder N-Morpholinyl steht und R 15 und R 16 unabhängig voneinander für (C1-C6)-Alkyl, (C3-C6)-Cycloalkyl, Aryl, Heteroaryl, oder Heterocyclyl stehen, oder R 15 und R 16with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 6-membered carbocycle. Compounds of the general formula (I) are particularly preferred in the invention, in which 35 W represents the group W -1 W-2 stands R 1 represents hydrogen or fluorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, or C(S)NH2, R 3 and R 4 independently of one another represent hydrogen, methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methyl-prop-1-yl, 1,1-dimethyleth-1-yl, or trifluoromethyl, or R 3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 7-membered carbocyclic ring, R 5 represents hydrogen, methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methyl-prop-1-yl, 1,1-dimethyleth-1-yl, or trifluoromethyl, R 6represents methyl or ethyl, R 7 stands for hydrogen, and Q stands for one of the following specifically named groups Q-1 to Q-500:

[0004] O O O O O C)

[0005] 0 jc

[0006] ) ) Particularly preferred subject matter of the invention are compounds of the general formula (I), wherein W represents the group W -1 W-2 stands R 1 represents hydrogen or fluorine, R 2 represents fluorine, chlorine, bromine, cyano, or nitro, R 3 and R 4independently of one another represent hydrogen, methyl, ethyl, or prop-1-yl, or R 3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 6-membered carbocyclic ring, R 5 represents hydrogen, methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methyl-prop-1-yl, 1,1-dimethyleth-1-yl, or trifluoromethyl, R 6 represents methyl or ethyl, R 7 represents hydrogen, and Q represents one of the above-mentioned groups Q-1 to Q-500. A very special preferred subject of the invention are compounds of the general formula (I), wherein W represents the group W -1 W-2 stands R 1 represents hydrogen or fluorine, R 2 represents fluorine, chlorine, bromine, cyano, or nitro, R 3 and R 4 independently represent hydrogen, methyl, or ethyl R 5represents hydrogen, methyl, ethyl, prop-1-yl, or trifluoromethyl, R 6 represents methyl or ethyl, R 7 represents hydrogen, and Q represents one of the above-mentioned groups Q-1 to Q-500. Particularly preferred subject matter of the invention are compounds of the general formula (I), wherein W represents the group stands R 1 represents fluorine, R 2 stands for chlorine, R 3 and R 4 independently represent hydrogen or methyl, R 5 stands for hydrogen, R 6 stands for methyl, R 7represents hydrogen, and Q represents one of the groups Q-1, Q-286, Q-371, Q-441, Q-442, or Q-481 specifically mentioned above. The radical definitions listed above, either general or in preferred ranges, apply both to the end products of the formula (I) and, correspondingly, to the starting materials or intermediates required for their preparation. These radical definitions can be combined with one another as desired, i.e., even within the stated preferred ranges. With regard to the compounds according to the invention, the designations used above and below are explained. These are familiar to the person skilled in the art and have, in particular, the meanings explained below: Unless defined otherwise, the general rule for the designation of chemical groups is that the connection to the skeleton or the rest of the molecule occurs via the last-mentioned structural element of the chemical group in question, i.e.for example in the case of (C2-C8)-alkenyloxy via the oxygen atom, and in the case of heterocyclyl-(C1-C8)-alkyl or R. 13 O(O)C-(C1-C8)-alkyl via the C atom of the alkyl group. In a compound chemical group such as heterocyclyl-(C1-C8)-alkyl or R 13 O(O)C-(C1-C8)-alkyl, the term “alkyl” therefore also refers to an alkylene group. For the functional groups C(=O)R 13 , C(=O)OR 13 , C(=O)NR 11 R 12 , NR 11 R 12 , OR 13 , S(O)mR 14The bond to the framework or the remainder of the molecule is established via the first-mentioned structural element of the respective chemical group. According to the invention, "alkylsulfonyl" - alone or as part of a chemical group - stands for straight-chain or branched alkylsulfonyl, preferably with 1 to 8, or with 1 to 6 carbon atoms, e.g.(aber nicht beschränkt auf) (C1-C6)-Alkylsulfonyl wie Methylsulfonyl, Ethyl- sulfonyl, Propylsulfonyl, 1-Methylethylsulfonyl, Butylsulfonyl, 1-Methylpropylsulfonyl, 2-Methyl- propylsulfonyl, 1,1-Dimethylethylsulfonyl, Pentylsulfonyl, 1-Methylbutylsulfonyl, 2-Methylbutyl- sulfonyl, 3-Methylbutylsulfonyl, 1,1-Dimethylpropylsulfonyl, 1,2-Dimethylpropylsulfonyl, 2,2-Di- methylpropylsulfonyl, 1-Ethylpropylsulfonyl, Hexylsulfonyl, 1-Methylpentylsulfonyl, 2-Methyl- pentylsulfonyl, 3-Methylpentylsulfonyl, 4-Methylpentylsulfonyl, 1,1-Dimethylbutylsulfonyl, 1,2-Di- methylbutylsulfonyl, 1,3-Dimethylbutylsulfonyl, 2,2-Dimethylbutylsulfonyl, 2,3-Dimethylbutylsulfonyl, 3,3-Dimethylbutylsulfonyl, 1-Ethylbutylsulfonyl, 2-Ethylbutylsulfonyl, 1,1,2-Trimethylpropylsulfonyl, 1,2,2-Trimethylpropylsulfonyl, 1-Ethyl-1-methylpropylsulfonyl und 1-Ethyl-2-methylpropylsulfonyl.According to the invention, "heteroarylsulfonyl" represents optionally substituted pyridylsulfonyl, pyrimidinylsulfonyl, pyrazinylsulfonyl, or optionally substituted polycyclic heteroarylsulfonyl, here in particular optionally substituted quinolinylsulfonyl, for example substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, alkyl, haloalkyl, haloalkoxy, amino, alkylamino, alkylcarbonylamino, dialkylamino, or alkoxy groups. According to the invention, "alkylthio" - alone or as part of a chemical group - represents straight-chain or branched S-alkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as (C1-C10), (C1-C6), or (C1-C4)-alkylthio, e.g.(aber nicht beschränkt auf) (C1- C6)-Alkylthio wie Methylthio, Ethylthio, Propylthio, 1-Methylethylthio, Butylthio, 1-Methylpropylthio, 2-Methylpropylthio, 1,1-Dimethylethylthio, Pentylthio, 1-Methylbutylthio, 2-Methylbutylthio, 3- Methylbutylthio, 1,1-Dimethylpropylthio, 1,2-Dimethylpropylthio, 2,2-Dimethylpropylthio, 1- Ethylpropylthio, Hexylthio, 1-Methylpentylthio, 2-Methylpentylthio, 3-Methylpentylthio, 4-Methyl- pentylthio, 1,1-Dimethylbutylthio, 1,2-Dimethylbutylthio, 1,3-Dimethylbutylthio, 2,2-Dimethylbutyl- thio, 2,3-Dimethylbutylthio, 3,3-Dimethylbutylthio, 1-Ethylbutylthio, 2-Ethylbutylthio, 1,1,2-Tri-35 methylpropylthio, 1,2,2-Trimethylpropylthio, 1-Ethyl-1-methylpropylthio und 1-Ethyl-2-methyl- propylthio.According to the invention, "alkenylthio" means an alkenyl radical bonded via a sulfur atom, alkynylthio means an alkynyl radical bonded via a sulfur atom, cycloalkylthio means a cycloalkyl radical bonded via a sulfur atom, and cycloalkenylthio means a cycloalkenyl radical bonded via a sulfur atom. "Alkylsulfinyl (alkyl-S(=O)-)", unless defined otherwise elsewhere, according to the invention stands for alkyl radicals bonded to the skeleton via -S(=O)-, such as (C1-C 10)-, (C1-C6)- oder (C1-C4)- Alkylsulfinyl, z. B. (aber nicht beschränkt auf) (C1-C6)-Alkylsulfinyl wie Methylsulfinyl, Ethylsulfinyl, Propylsulfinyl, 1-Methylethylsulfinyl, Butylsulfinyl, 1-Methylpropylsulfinyl, 2-Methylpropylsulfinyl, 1,1-Dimethylethylsulfinyl, Pentylsulfinyl, 1-Methylbutylsulfinyl, 2-Methylbutylsulfinyl, 3- Methylbutylsulfinyl, 1,1-Dimethylpropylsulfinyl, 1,2-Dimethylpropylsulfinyl, 2,2-Di- methylpropylsulfinyl, 1-Ethylpropylsulfinyl, Hexylsulfinyl, 1-Methylpentylsulfinyl, 2-Methylpentyl- sulfinyl, 3-Methylpentylsulfinyl, 4-Methylpentylsulfinyl, 1,1-Dimethylbutylsulfinyl, 1,2-Dimethyl- butylsulfinyl, 1,3-Dimethylbutylsulfinyl, 2,2-Dimethylbutylsulfinyl, 2,3-Dimethylbutylsulfinyl, 3,3- Dimethylbutylsulfinyl, 1-Ethylbutylsulfinyl, 2-Ethylbutylsulfinyl, 1,1,2-Trimethylpropylsulfinyl, 1,2,2- Trimethylpropylsulfinyl, 1-Ethyl-1-methylpropylsulfinyl und 1-Ethyl-2-methylpropylsulfinyl.Analogously, “alkenylsulfinyl” and “alkynylsulfinyl” are defined according to the invention as alkenyl or alkynyl radicals which are bonded to the skeleton via -S(=O)-, such as (C2-C. 10 )-, (C2-C6)- or (C2-C4)- alkenylsulfinyl or (C3-C 10)-, (C3-C6)- or (C3-C4)-alkynylsulfinyl. Analogously, “alkenylsulfonyl” and “alkynylsulfonyl” are defined according to the invention as alkenyl or alkynyl radicals that are bonded to the skeleton via -S(=O)2-, such as (C2-C10)-, (C2-C6)- or (C2-C4)-alkenylsulfonyl or (C3-C10)-, (C3-C6)- or (C3-C4)-alkynylsulfonyl. “Alkoxy” means an alkyl radical bonded via an oxygen atom, e.g.(but not limited to) (C1-C6)-alkoxy such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-Trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy. Alkenyloxy means an alkenyl radical bonded via an oxygen atom. Alkynyloxy means an alkynyl radical bonded via an oxygen atom, such as (C2-C10)-, (C2-C6)-, or (C2-C4)-alkenoxy or (C3-C10)-, (C3-C6)-, or (C3-C4)-alkynoxy.“Cycloalkyloxy” means a cycloalkyl radical bonded via an oxygen atom, and cycloalkenyloxy means a cycloalkenyl radical bonded via an oxygen atom. “Alkylcarbonyl” (alkyl-C(=O)-), unless defined otherwise elsewhere, represents, according to the invention, alkyl radicals bonded to the skeleton via -C(=O)-, such as (C1-C10)-, (C1-C6)-, or (C1-C4)-alkylcarbonyl. The number of C atoms refers to the alkyl radical in the alkylcarbonyl group. Analogously, “alkenylcarbonyl” and “alkynylcarbonyl,” unless defined otherwise elsewhere, represent, according to the invention, alkenyl and alkynyl radicals, respectively, bonded to the skeleton via -C(=O)-, such as (C2-C. 10 )-, (C2-C6)- or (C2-C4)-alkenylcarbonyl or (C2-C 10), (C2-C6) or (C2-C4) alkynylcarbonyl. The number of C atoms refers to the alkenyl or alkynyl radical in the alkenyl or alkynylcarbonyl group. “Alkoxycarbonyl (alkyl-OC(=O)-)”, unless defined otherwise elsewhere: Alkyl radicals that are bonded to the skeleton via -OC(=O)-, such as (C1-C 10 )-, (C1-C6)- or (C1-C4)-alkoxycarbonyl. The number of C atoms refers to the alkyl radical in the alkoxycarbonyl group. Analogously, "alkenyloxycarbonyl" and "alkynyloxycarbonyl", unless defined otherwise elsewhere, represent alkenyl or alkynyl radicals, respectively, which are bonded to the skeleton via -OC(=O)-, such as (C2-C 10 )-, (C2-C6)- or (C2-C4)-alkenyloxycarbonyl or (C3-C 10)-, (C3-C6)- or (C3-C4)-alkynyloxycarbonyl. The number of C atoms refers to the alkenyl or alkynyl radical in the alkene or alkynyloxycarbonyl group. The term “alkylcarbonyloxy” (alkyl-C(=O)-O-) stands for alkyl radicals that are bonded to the skeleton with the oxygen via a carbonyloxy group (-C(=O)-O-), such as (C1-C10)-, (C1-C6)- or (C1-C4)-alkylcarbonyloxy. The number of C atoms refers to the alkyl radical in the alkylcarbonyloxy group. Analogously, “alkenylcarbonyloxy” and “alkynylcarbonyloxy” are defined according to the invention as alkenyl or alkynyl radicals that are bonded to the skeleton via (-C(=O)-O-) with the oxygen, such as (C2-C10)-, (C2-C6)- or (C2-C4)-alkenylcarbonyloxy or (C2-C10)-, (C2-C6)- or (C2-C4)-alkynylcarbonyloxy. The number of C atoms refers to the alkenyl or alkynyl radical in the alkenyl or alkynylcarbonyloxy group. 35 In short forms such as C(O)R13 , C(O)OR 13 , OC(O)NR 11 R 12 , or C(O)NR 11 R 12 The abbreviation O in parentheses stands for an oxygen atom bonded to the adjacent carbon atom via a double bond. In abbreviations such as OC(S)OR 13 , OC(S)SR 14 , OC(S)NR 11 R 12, the abbreviation S in parentheses stands for a sulfur atom bonded to the adjacent carbon atom via a double bond. The term “aryl” means an optionally substituted mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring C atoms, for example phenyl, naphthyl, anthryl, phenanthrenyl, and the like, preferably phenyl. The term “optionally substituted aryl” also includes multicyclic systems such as tetrahydronaphthyl, indenyl, indanyl, fluorenyl, biphenylyl, where the bonding site is on the aromatic system. From a systematic point of view, “aryl” is generally also included in the term “optionally substituted phenyl”. Preferred aryl substituents here are, for example, hydrogen, halogen, alkyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, halocycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, alkoxyalkyl,Alkylthio, Haloalkylthio, Haloalkyl, Alkoxy, Haloalkoxy, Cycloalkoxy, Cycloalkylalkoxy, Aryloxy, Heteroraryloxy, Alkoxyalkoxy, Alkinylalkoxy, Alkenyloxy, Bis-alkylaminoalkoxy, Tris- [alkyl]silyl, Bis-[alkyl]arylsilyl, Bis-[alkyl]alkylsilyl, Tris-[alkyl]silylalkinyl, Arylalkinyl, Heteroarylalkinyl, Alkylalkinyl, Cycloalkylalkinyl, Haloalkylalkinyl, Heterocyclyl-N-alkoxy, Nitro, Cyano, Amino, Alkylamino, Bis-alkylamino, Alkylcarbonylamino, Cycloalkylcarbonylamino, Arylcarbonylamino, Alkoxycarbonylamino, Alkoxycarbonylalkylamino, Arylalkoxycarbonylalkylamino, Hydroxycarbonyl, Alkoxycarbonyl, Aminocarbonyl, Alkylaminocarbonyl, Cycloalkylaminocarbonyl, Bis-Alkylaminocarbonyl, Heteroarylalkoxy, Arylalkoxy Ein heterocyclischer Rest (Heterocyclyl) enthält mindestens einen heterocyclischen Ring (=carbocyclischer Ring, in dem mindestens ein C-Atom durch ein Heteroatom ersetzt ist, vorzugsweise durch ein Heteroatom aus der Gruppe N, O, S, P) der gesättigt, ungesättigt,is partially saturated or heteroaromatic and may be unsubstituted or substituted, where the bonding site is located on a ring atom. If the heterocyclyl radical or the heterocyclic ring is optionally substituted, it may be fused with other carbocyclic or heterocyclic rings. In the case of optionally substituted heterocyclyl, polycyclic systems are also included, such as, for example, 8-azabicyclo[3.2.1]octanyl, 8-azabicyclo[2.2.2]octanyl or 1-azabicyclo[2.2.1]heptyl. In the case of optionally substituted heterocyclyl, spirocyclic systems are also included, such as, for example, 1-oxa-5-aza-spiro[2.3]hexyl. Unless otherwise defined, the heterocyclic ring preferably contains 3 to 9 ring atoms, in particular 3 to 6 ring atoms, and one or more, preferably 1 to 4, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, O, and S,however, two oxygen atoms should not be directly adjacent, such as, for example, with a heteroatom from the group N, O and S 1- or 2- or 3-pyrrolidinyl, 3,4-dihydro-2H-pyrrol-2- or 3-yl, 2,3-dihydro-1H-pyrrol- 1- or 2- or 3- or 4- or 5-yl; 2,5-dihydro-1H-pyrrol-1- or 2- or 3-yl, 1- or 2- or 3- or 4-piperidinyl; 2,3,4,5-tetrahydropyridin-2- or 3- or 4- or 5-yl or 6-yl; 1,2,3,6-tetrahydropyridin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2,3,4-Tetrahydropyridin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,4-Dihydropyridin-1- or 2- or 3- or 4-yl; 2,3-Dihydropyridin- 2- or 3- or 4- or 5- or 6-yl; 2,5-Dihydropyridin-2- or 3- or 4- or 5- or 6-yl, 1- or 2- or 3- or 4-azepanyl; 2,3,4,5-Tetrahydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1H-azepin-1- or 2- or 3- or 4-yl; 3,4,5,6-Tetrahydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydro-1H-azepin-1- or 2- or 3- or 4-yl; 2,5-Dihydro-1H-azepin- 1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-Dihydro-1H-azepin-1- or -2- or 3- or 4- yl; 2,3-Dihydro-1H-azepin-1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 3,4-Dihydro-2H-azepin- 2- or 3- or 4- or 5- or 6- or 7-yl; 3,6-Dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 5,6-Dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydro-3H-azepin- 2- or 3- or 4- or 5- or 6- or 7-yl; 1H-azepin-1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 3H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl, 2- or 3-oxolanyl (= 2- or 3-tetrahydrofuranyl); 2,3-dihydrofuran-2- or 3- or 4- or 5-yl; 2,5-dihydrofuran-2- or 3-yl,2- or 3- or 4-oxanyl (= 2- or 3- or 4-tetrahydropyranyl); 3,4-dihydro-2H-pyran-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-pyran-2- or 3- or 4- or 5- or 6-yl; 2H-pyran-2- or 3- or 4- or 5- or 6-yl; 4H-pyran-2- or 3- or 4-yl, 2- or 3- or 4-oxepanyl; 2,3,4,5-tetrahydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydrooxepin-2- or 3- or 4-yl; 2,3-Dihydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydrooxepin-2- or 3- or 4-yl; 2,5-Dihydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; Oxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2- or 3-Tetrahydrothiophenyl; 2,3-Dihydrothiophene-2- or 3- or 4- or 5-yl; 2,5-Dihydrothiophen-2- or 3-yl; tetrahydro-2H-thiopyran-2- or 3- or 4-yl; 3,4-Dihydro-2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 4H-thiopyran-2- or 3- or 4-yl. Preferred 3-membered and 4-membered ring heterocycles are, for example, 1- or 2-aziridinyl, oxiranyl, thiiranyl, 1- or 2- or 3-azetidinyl, 2- or 3-oxetanyl, 2- or 3-thietanyl, and 1,3-dioxetan-2-yl. Further examples of “heterocyclyl” are a partially or fully hydrogenated heterocyclic radical having two heteroatoms from the group consisting of N, O, and S, such as, for example, 1- or 2- or 3- or 4-pyrazolidinyl; 4,5-Dihydro-3H-pyrazol- 3- or 4- or 5-yl; 4,5-Dihydro-1H-pyrazol-1- or 3- or 4- or 5-yl; 2,3-Dihydro-1H-pyrazol-1- or 2- or 3- or 4- or 5-yl; 1- or 2- or 3- or 4- imidazolidinyl; 2,3-Dihydro-1H-imidazol-1- or 2- or 3- or 4-yl; 2,5-Dihydro-1H-imidazol-1- or 2- or 4- or 5-yl; 4,5-Dihydro-1H-imidazol-1- or 2- or 4- or 5-yl; Hexahydropyridazin-1- or 2- or 3- or 4-yl; 1,2,3,4-Tetrahydropyridazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2,3,6-Tetrahydropyridazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,4,5,6-Tetrahydropyridazin-1- or 3- or 4- or 5- or 6-yl; 3,4,5,6-Tetrahydropyridazin-3- or 4- or 5-yl; 4,5-Dihydropyridazin-3- or 4-yl; 3,4-Dihydropyridazin-3- or 4- or 5- or 6-yl; 3,6-Dihydropyridazin-3- or 4-yl; 1,6-Dihydropyriazin-1- or 3- or 4- or 5- or 6-yl; Hexahydropyrimidin-1- or 2- or 3- or 4-yl; 1,4,5,6-Tetrahydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2,5,6-Tetrahydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2,3,4-Tetrahydropyrimidin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,6-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 2,5-Dihydropyrimidin- 2- or 4- or 5-yl; 4,5-Dihydropyrimidin- 4- or 5- or 6-yl; 1,4-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1- or 2- or 3-Piperazinyl; 1,2,3,6-Tetrahydropyrazin-1- or 2- or 3- or 5- or 6-yl; 1,2,3,4-Tetrahydropyrazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2-Dihydropyrazin-1- or 2- or 3- or 5- or 6-yl; 1,4-Dihydropyrazin-1- or 2- or 3-yl; 2,3-Dihydropyrazin-2- or 3- or 5- or 6-yl; 2,5-Dihydropyrazin-2- or 3-yl; 1,3-Dioxolan-2- or 4- or 5-yl; 1,3-Dioxol-2- or 4-yl; 1,3-Dioxan-2- or 4- or 5-yl; 4H-1,3-dioxin-2- or 4- or 5- or 6-yl; 1,4-dioxan-2- or 3- or 5- or 6-yl; 2,3-dihydro-1,4-dioxin-2- or 3- or 5- or 6-yl; 1,4-dioxin-2- or 3-yl; 1,2-dithiolan-3- or 4-yl; 3H-1,2-dithiol-3- or 4- or 5-yl; 1,3-dithiolan-2- or 4-yl; 1,3-dithiol- 2- or 4-yl; 1,2-dithian-3- or 4-yl; 3,4-dihydro-1,2-dithiin-3- or 4- or 5- or 6-yl; 3,6-Dihydro- 1,2-dithiin-3- or 4-yl; 1,2-dithiin-3- or 4-yl; 1,3-dithian-2- or 4- or 5-yl; 4H-1,3-dithiin-2- or 4- or 5- or 6-yl; isoxazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydroisoxazol-2- or 3- or 4- or 5-yl; 2,5-Dihydroisoxazol-2- or 3- or 4- or 5-yl; 4,5-Dihydroisoxazol-3- or 4- or 5-yl; 1,3-Oxazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydro-1,3-oxazol-2- or 3- or 4- or 5-yl; 2,5-Dihydro-1,3-oxazol-2- or 4- or 5-yl; 4,5-Dihydro-1,3-oxazol-2- or 4- or 5-yl; 1,2-Oxazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-4H-1,2-oxazin-3- or 4- or 5- or 6-yl; 2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 6H-1,2-oxazin-3- or 4- or 5- or 6-yl; 4H-1,2-oxazin-3- or 4- or 5- or 6-yl; 1,3-Oxazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,3-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,3-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,3-oxazin-2- or 4- or 5- or 6-yl; 5,6-dihydro-4H-1,3-oxazin-2- or 4- or 5- or 6-yl; 2H-1,3-oxazin-2- or 4- or 5- or 6-yl; 6H-1,3-oxazin-2- or 4- or 5- or 6-yl; 4H-1,3-oxazin-2- or 4- or 5- or 6-yl; morpholin-2- or 3- or 4-yl; 3,4-dihydro-2H-1,4-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1,4-oxazin-2- or 3- or 5- or 6-yl; 2H-1,4-oxazin-2- or 3- or 5- or 6-yl; 4H-1,4-oxazin-2- or 3-yl; 1,2-oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-Dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 1,3-Oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,5-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-Dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 2,7-Dihydro-1,3-oxazepin- 2- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 1,4-oxazepan-2- or 3- or 5- or 6- or 7-yl; 2,3,4,5-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1,4-oxazepin- 2- or 3- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 2,5-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 2,7-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 4,5-Dihydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,7-Dihydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; isothiazolidin-2- or 3- or 4- or 5-yl; 2,3-dihydroisothiazol-2- or 3- or 4- or 5-yl; 2,5-dihydroisothiazol-2- or 3- or 4- or 5-yl; 4,5-dihydroisothiazol-3- or 4- or 5-yl; 1,3-thiazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydro-1,3-thiazol-2- or 3- or 4- or 5-yl; 2,5-Dihydro-1,3-thiazol-2- or 4- or 5-yl; 4,5-Dihydro-1,3-thiazol-2- or 4- or 5-yl; 1,3-Thiazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,3-thiazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,3-thiazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,3-thiazin-2- or 4- or 5- or 6-yl; 5,6-Dihydro-4H-1,3-thiazin-2- or 4- or 5- or 6-yl; 2H-1,3-thiazin-2- or 4- or 5- or 6-yl; 6H-1,3-thiazin-2- or 4- or 5- or 6-yl; 4H-1,3-Thiazin-2- or 4- or 5- or 6-yl. Further examples of “heterocyclyl” are a partially or fully hydrogenated heterocyclic radical with 3 heteroatoms from the group N, O and S, such as, for example, 1,4,2-dioxazolidin-2- or 3- or 5-yl; 1,4,2-dioxazol-3- or 5-yl; 1,4,2-dioxazinan-2- or -3- or 5- or 6-yl; 5,6-dihydro-1,4,2-dioxazin-3- or 5- or 6-yl; 1,4,2-dioxazin-3- or 5- or 6-yl; 1,4,2-dioxazepan-2- or 3- or 5- or 6- or 7-yl; 6,7-Dihydro-5H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl; 2,3-Dihydro-7H-1,4,2-dioxazepin-2- or 3- or 5- or 6- or 7-yl; 2,3-Dihydro-5H-1,4,2-dioxazepin-2- or 3- or 5- or 6- or 7-yl; 5H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl; 7H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl. Structural examples of optionally further substituted heterocycles are also listed below: \1, ) ) ) ) j

[0007] A . . K1 _ _

[0008] Die oben aufgeführten Heterocyclen sind bevorzugt beispielsweise durch Wasserstoff, Halogen, Alkyl, Haloalkyl, Hydroxy, Alkoxy, Cycloalkoxy, Aryloxy, Alkoxyalkyl, Alkoxyalkoxy, Cycloalkyl, Halocycloalkyl, Aryl, Arylalkyl, Heteroaryl, Heterocyclyl, Alkenyl, Alkylcarbonyl, Cycloalkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, Alkoxycarbonyl, Hydroxycarbonyl, Cycloalkoxycarbonyl, Cycloalkylalkoxycarbonyl, Alkoxycarbonylalkyl, Arylalkoxycarbonyl, Arylalkoxycarbonylalkyl, Alkinyl, Alkinylalkyl, Alkylalkinyl, Tris-alkylsilylalkinyl, Nitro, Amino, Cyano, Haloalkoxy, Haloalkylthio, Alkylthio, Hydrothio, Hydroxyalkyl, Oxo, Heteroarylalkoxy, Arylalkoxy, Heterocyclylalkoxy, Heterocyclylalkylthio, Heterocyclyloxy, Heterocyclylthio, Heteroaryloxy, Bis- alkylamino, Alkylamino, Cycloalkylamino, Hydroxycarbonylalkylamino, Alkoxycarbonylalkylamino, Arylalkoxycarbonylalkylamino, Alkoxycarbonylalkyl(alkyl)amino, Aminocarbonyl, Alkylaminocarbonyl, Bis-alkylaminocarbonyl, Cycloalkylaminocarbonyl,Hydroxycarbonylalkylaminocarbonyl, alkoxycarbonylalkylaminocarbonyl, arylalkoxycarbonylalkylaminocarbonyl. If a basic structure is substituted "by one or more residues" from a list of residues (= group) or a generically defined group of residues, this includes simultaneous substitution by several identical and / or structurally different residues. If it is a partially or fully saturated nitrogen heterocycle, it can be linked to the rest of the molecule via both carbon and nitrogen. The substituents listed below are possible substituents for a substituted heterocyclic residue.Additionally, oxo and thioxo are also included. The oxo group as a substituent on a ring C atom then means, for example, a carbonyl group in the heterocyclic ring. This preferably also includes lactones and lactams. The oxo group can also occur on the hetero ring atoms, which can exist in different oxidation states, e.g., N and S, and then forms, for example, the divalent groups N(O), S(O) (also abbreviated to SO) and S(O)2 (also abbreviated to SO2) in the heterocyclic ring. In the case of -N(O)- and -S(O)- groups, both enantiomers are included. According to the invention, the term "heteroaryl" stands for heteroaromatic compounds, i.e., fully unsaturated aromatic heterocyclic compounds, preferably 5- to 7-membered rings with 1 to 4, preferably 1 or 2 identical or different heteroatoms, preferably O,S oder N. Erfindungsgemäße Heteroaryle sind beispielsweise 1H-Pyrrol-1-yl; 1H-Pyrrol-2-yl; 1H-Pyrrol- 3-yl; Furan-2-yl; Furan-3-yl; Thien-2-yl; Thien-3-yl, 1H-Imidazol-1-yl; 1H-Imidazol-2-yl; 1H-Imidazol- 4-yl; 1H-Imidazol-5-yl; 1H-Pyrazol-1-yl; 1H-Pyrazol-3-yl; 1H-Pyrazol-4-yl; 1H-Pyrazol-5-yl, 1H-1,2,3- Triazol-1-yl, 1H-1,2,3-Triazol-4-yl, 1H-1,2,3-Triazol-5-yl, 2H-1,2,3-Triazol-2-yl, 2H-1,2,3-Triazol-4-yl, 1H-1,2,4-Triazol-1-yl, 1H-1,2,4-Triazol-3-yl, 4H-1,2,4-Triazol-4-yl, 1,2,4-Oxadiazol-3-yl, 1,2,4- Oxadiazol-5-yl, 1,3,4-Oxadiazol-2-yl, 1,2,3-Oxadiazol-4-yl, 1,2,3-Oxadiazol-5-yl, 1,2,5-Oxadiazol-3-yl, Azepinyl, Pyridin-2-yl, Pyridin-3-yl, Pyridin-4-yl, Pyrazin-2-yl, Pyrazin-3-yl, Pyrimidin-2-yl, Pyrimidin-4-yl, Pyrimidin-5-yl, Pyridazin-3-yl, Pyridazin-4-yl, 1,3,5-Triazin-2-yl, 1,2,4-Triazin-3-yl, 1,2,4-Triazin-5-yl, 1,2,4-Triazin-6-yl, 1,2,3-Triazin-4-yl, 1,2,3-Triazin-5-yl, 1,2,4-, 1,3,2-, 1,3,6- und 1,2,6-Oxazinyl, Isoxazol-3-yl, Isoxazol-4-yl, Isoxazol-5-yl, 1,3-Oxazol-2-yl,1,3-oxazol-4-yl, 1,3-oxazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,3-thiazol-2-yl, 1,3-thiazol-4-yl, 1,3-thiazol-5-yl, oxepinyl, thiepinyl, 1,2,4-triazolonyl and 1,2,4-diazepinyl, 2H-1,2,3,4-tetrazol-5-yl, 1H-1,2,3,4-tetrazol-5-yl, 1,2,3,4-oxatriazol-5-yl, 1,2,3,4-thiatriazol-5-yl, 1,2,3,5-oxatriazol-4-yl, 1,2,3,5-Thiatriazol-4-yl. The heteroaryl groups according to the invention can further be substituted by one or more identical or different radicals. If two adjacent carbon atoms are part of another aromatic ring, these are fused heteroaromatic systems, such as benzofused or multiply fused heteroaromatics. Preferred examples are quinolines (e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl); isoquinolines (e.g., isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl,Isochinolin-8-yl); Chinoxalin; Chinazolin; Cinnolin; 1,5-Naphthyridin; 1,6-Naphthyridin; 1,7-Naphthyridin; 1,8-Naphthyridin; 2,6- Naphthyridin; 2,7-Naphthyridin; Phthalazin; Pyridopyrazine; Pyridopyrimidine; Pyridopyridazine; Pteridine; Pyrimidopyrimidine. Beispiele für Heteroaryl sind auch 5- oder 6-gliedrige benzokondensierte Ringe aus der Gruppe 1H-Indol-1-yl, 1H-Indol-2-yl, 1H-Indol-3-yl, 1H-Indol-4-yl, 1H-Indol-5-yl, 1H- Indol-6-yl, 1H-Indol-7-yl, 1-Benzofuran-2-yl, 1-Benzofuran-3-yl, 1-Benzofuran-4-yl, 1-Benzofuran-5- yl, 1-Benzofuran-6-yl, 1-Benzofuran-7-yl, 1-Benzothiophen-2-yl, 1-Benzothiophen-3-yl, 1- Benzothiophen-4-yl, 1-Benzothiophen-5-yl, 1-Benzothiophen-6-yl, 1-Benzothiophen-7-yl, 1H-Indazol- 1-yl, 1H-Indazol-3-yl, 1H-Indazol-4-yl, 1H-Indazol-5-yl, 1H-Indazol-6-yl, 1H-Indazol-7-yl, 2H-Indazol-35 2-yl, 2H-Indazol-3-yl, 2H-Indazol-4-yl, 2H-Indazol-5-yl, 2H-Indazol-6-yl, 2H-Indazol-7-yl, 2H-Iso- indol-2-yl, 2H-Isoindol-1-yl, 2H-Isoindol-3-yl, 2H-Isoindol-4-yl,2H-isoindol-5-yl, 2H-isoindol-6-yl; 2H-Isoindol-7-yl, 1H-Benzimidazol-1-yl, 1H-Benzimidazol-2-yl, 1H-Benzimidazol-4-yl, 1H-Benzimidazol-5-yl, 1H-Benzimidazol-6-yl, 1H-Benzimidazol-7-yl, 1,3-Benzoxazol-2-yl, 1,3-Benzoxazol-4-yl yl, 1,3-Benzoxazol-5-yl, 1,3-Benzoxazol-6-yl, 1,3-Benzoxazol-7-yl, 1,3-Benzthiazol-2-yl, 1,3-Benzthiazol-4-yl, 1,3-Benzthiazol-5-yl, 1,3-Benzthiazol-6-yl, 1,3-Benzthiazol-7-yl, 1,2-benzisoxazol-3-yl, 1,2-Benzisoxazol-4-yl, 1,2-Benzisoxazol-5-yl, 1,2-Benzisoxazol-6-yl, 1,2-Benzisoxazol-7-yl, 1,2-Benzisothiazol-3-yl, 1,2-Benzisothiazol-4-yl, 1,2-Benzisothiazol-5-yl, 1,2-Benzisothiazol-6-yl, 1,2-Benzisothiazol-7-yl. The term "halogen" means, for example, fluorine, chlorine, bromine, or iodine. If the term is used for a radical, then "halogen" means, for example, a fluorine, chlorine, bromine, or iodine atom. According to the invention, "alkyl" means a straight-chain or branched, open-chain, saturated hydrocarbon radical.which is optionally mono- or polysubstituted and, in the latter case, is referred to as "substituted alkyl." Preferred substituents are halogen atoms, alkoxy, haloalkoxy, cyano, alkylthio, haloalkylthio, amino, or nitro groups; particular preference is given to methoxy, methyl, fluoroalkyl, cyano, nitro, fluorine, chlorine, bromine, or iodine. The prefix "bis" also includes the combination of different alkyl radicals, e.g., methyl(ethyl) or ethyl(methyl). "Haloalkyl," "-alkenyl," and "-alkynyl" mean alkyl, alkenyl, or alkynyl that is partially or fully substituted by identical or different halogen atoms, e.g., monohaloalkyl (= monohaloalkyl) such as, e.g., CH2CH2Cl, CH2CH2Br, CHClCH3, CH2Cl, CH2F; perhaloalkyl such as, e.g., CCl, 3, CClF 2, CFCl2, CF2CClF 2,CF2CClFCF3; Polyhaloalkyl such as CH2CHFCl, CF2CClFH, CF2CBrFH, CH2CF3; The term perhaloalkyl also includes the term perfluoroalkyl. “Partially fluorinated alkyl” means a straight-chain or branched, saturated hydrocarbon that is mono- or polysubstituted by fluorine, where the corresponding fluorine atoms can be located as substituents on one or more different carbon atoms of the straight-chain or branched hydrocarbon chain, such as CHFCH3, CH2CH2F, CH2CH2CF3, CHF2, CH2F, CHFCF2CF3. “Partially fluorinated haloalkyl” means a straight-chain or branched, saturated hydrocarbon that is substituted by various halogen atoms with at least one fluorine atom, where all other halogen atoms that may be present are selected from the group consisting of fluorine, chlorine, or bromine.Iodine. The corresponding halogen atoms can be located as substituents on one or more different carbon atoms of the straight-chain or branched hydrocarbon chain. Partially fluorinated haloalkyl also includes the complete substitution of the straight-chain or branched chain by halogen with the participation of at least one fluorine atom. "Haloalkoxy" is, for example, OCF3, OCHF2, OCH2F, OCF2CF3, OCH2CF3, and OCH2CH2Cl; the same applies to haloalkenyl and other halogen-substituted radicals. The term "(C1-C4)-alkyl," used here as an example, is a shorthand notation for straight-chain or branched alkyl with one to four carbon atoms, corresponding to the range specified for carbon atoms, i.e., includes the radicals methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl, or tert-butyl. General alkyl radicals with a larger specified range of C atoms, e.g. "(C1-C6)-alkyl",Accordingly, they also include straight-chain or branched alkyl radicals with a larger number of carbon atoms, ie, according to the example, also alkyl radicals with 5 and 6 carbon atoms. Unless specifically stated, lower carbon skeletons, e.g., with 1 to 6 carbon atoms, or with 2 to 6 carbon atoms in the case of unsaturated groups, are preferred for hydrocarbon radicals such as alkyl, alkenyl, and alkynyl radicals, even in compound radicals. Alkyl radicals, including compound radicals such as alkoxy, haloalkyl, etc., mean, for example, methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i-hexyl and 1,3-dimethylbutyl, heptyls, such as n-heptyl, 1-methylhexyl and 1,4-dimethylpentyl; alkenyl and alkynyl radicals have the meaning of the possible unsaturated radicals corresponding to the alkyl radicals,containing at least one double bond or triple bond. Preferred are radicals with one double bond or triple bond. The term "alkenyl" includes, in particular, straight-chain or branched open-chain hydrocarbon radicals with more than one double bond, such as 1,3-butadienyl and 1,4-pentadienyl, but also allenyl or cumulenyl radicals with one or more cumulated double bonds, such as, for example, allenyl (1,2-propadienyl), 1,2-butadienyl, and 1,2,3-pentatrienyl. Alkenyl means, for example, vinyl, which may optionally be substituted by further alkyl radicals, e.g. (but not limited to) (C2-C6)-alkenyl such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl,1-Methyl-3-butenyl, 2-Methyl-3- butenyl, 3-Methyl-3-butenyl, 1,1-Dimethyl-2-propenyl, 1,2-Dimethyl-1-propenyl, 1,2-Dimethyl-2- propenyl, 1-Ethyl-1-propenyl, 1-Ethyl-2-propenyl, 1-Hexenyl, 2-Hexenyl, 3-Hexenyl, 4-Hexenyl, 5-35 Hexenyl, 1-Methyl-1-pentenyl, 2-Methyl-1-pentenyl, 3-Methyl-1-pentenyl, 4-Methyl-1-pentenyl, 1- Methyl-2-pentenyl, 2-Methyl-2-pentenyl, 3-Methyl-2-pentenyl, 4-Methyl-2-pentenyl, 1-Methyl-3- pentenyl, 2-Methyl-3-pentenyl, 3-Methyl-3-pentenyl, 4-Methyl-3-pentenyl, 1-Methyl-4-pentenyl, 2- Methyl-4-pentenyl, 3-Methyl-4-pentenyl, 4-Methyl-4-pentenyl, 1,1-Dimethyl-2-butenyl, 1,1-Dimethyl- 3-butenyl, 1,2-Dimethyl-1-butenyl, 1,2-Dimethyl-2-butenyl, 1,2-Dimethyl-3-butenyl, 1,3-Dimethyl-1- butenyl, 1,3-Dimethyl-2-butenyl, 1,3-Dimethyl-3-butenyl, 2,2-Dimethyl-3-butenyl, 2,3-Dimethyl-1- butenyl, 2,3-Dimethyl-2-butenyl, 2,3-Dimethyl-3-butenyl, 3,3-Dimethyl-1-butenyl, 3,3-Dimethyl-2- butenyl, 1-Ethyl-1-butenyl, 1-Ethyl-2-butenyl, 1-Ethyl-3-butenyl, 2-Ethyl-1-butenyl,2-Ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl, and 1-ethyl-2-methyl-2-propenyl. The term "alkynyl" particularly includes straight-chain or branched open-chain hydrocarbon radicals with more than one triple bond or with one or more triple bonds and one or more double bonds, such as 1,3-butatrienyl or 3-penten-1-yn-1-yl. (C2-C6)-alkynyl means, for example, ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-Methyl-3-pentynyl, 1-Methyl-4-pentynyl, 2-Methyl-3-pentynyl, 2-Methyl-4-pentynyl, 3-Methyl-1-pentynyl, 3-Methyl-4-pentynyl, 4-Methyl-1-pentynyl, 4-Methyl-2-pentynyl,1,1-Dimethyl-2-butynyl, 1,1-Dimethyl-3-butynyl, 1,2-Dimethyl-3-butynyl, 2,2-Dimethyl-3-butynyl, 3,3-Dimethyl-1-butynyl, 1-Ethyl-2-butynyl, 1-Ethyl-3-butynyl, 2-Ethyl-3-butynyl and 1-Ethyl-1-methyl-2-propynyl. The term "cycloalkyl" means a carbocyclic, saturated ring system with preferably 3-8 ring carbon atoms, e.g., cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl, which is optionally further substituted, preferably by hydrogen, alkyl, alkoxy, oxo, cyano, nitro, alkylthio, haloalkylthio, halogen, alkenyl, alkynyl, haloalkyl, amino, alkylamino, bisalkylamino, alkoxycarbonyl, hydroxycarbonyl, arylalkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, cycloalkylaminocarbonyl. In the case of optionally substituted cycloalkyl, cyclic systems with substituents are included, including substituents with a double bond on the cycloalkyl radical, e.g., an alkylidene group such as methylidene.are included. In the case of optionally substituted cycloalkyl, polycyclic aliphatic systems are also included, such as bicyclo[1.1.0]butan-1-yl, bicyclo[1.1.0]butan-2-yl, bicyclo[2.1.0]pentan-1-yl, bicyclo[1.1.1]pentan-1-yl, bicyclo[2.1.0]pentan-2-yl, bicyclo[2.1.0]pentan-5-yl, bicyclo[2.1.1]hexyl, bicyclo[2.2.1]hept-2-yl, bicyclo[2.2.2]octan-2-yl, bicyclo[3.2.1]octan-2-yl, bicyclo[3.2.2]nonan-2-yl, adamantan-1-yl and adamantan-2-yl, but also systems such as. B. 1,1'-Bi(cyclopropyl)-1-yl, 1,1'-Bi(cyclopropyl)-2-yl. The term "(C3-C7)-cycloalkyl" is a shorthand for cycloalkyl with three to 7 carbon atoms, corresponding to the range for C atoms. In the case of substituted cycloalkyl, spirocyclic aliphatic systems are also included, such as spiro[2.2]pent-1-yl, spiro[2.3]hex-1-yl, spiro[2.3]hex-4-yl, 3-spiro[2.3]hex-5-yl, spiro[3.3]hept-1-yl, spiro[3.3]hept-2-yl. "Cycloalkenyl" means a carbocyclic,Non-aromatic, partially unsaturated ring system with preferably 4-8 C atoms, e.g. 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1,3-cyclohexadienyl or 1,4-cyclohexadienyl, which also includes substituents with a double bond on the cycloalkenyl radical, e.g. an alkylidene group such as methylidene. In the case of optionally substituted cycloalkenyl, the explanations for substituted cycloalkyl apply accordingly. The term "alkylidene", e.g. also in the form (C1-C, 10 )-Alkylidene, means the residue of a straight-chain or branched open-chain hydrocarbon residue that is bonded via a double bond. Naturally, only positions on the parent structure where two H atoms can be replaced by the double bond are possible as bonding sites for alkylidene; examples of residues are, for example, =CH2, =CH-CH3, =C(CH3)-CH3, =C(CH3)-C2H5, or =C(C2H5)-C2H 5.Cycloalkylidene means a carbocyclic radical bonded by a double bond. "Cycloalkylalkyloxy" means a cycloalkylalkyl radical bonded by an oxygen atom, and "arylalkyloxy" means an arylalkyl radical bonded by an oxygen atom. "Alkoxyalkyl" means an alkoxy radical bonded by an alkyl group, and "alkoxyalkoxy" means an alkoxyalkyl radical bonded by an oxygen atom, e.g., (but not limited to) methoxymethoxy, methoxyethoxy, ethoxyethoxy, and methoxy-n-propyloxy. "Alkylthioalkyl" means an alkylthio radical bonded by an alkyl group, and "alkylthioalkylthio" means an alkylthioalkyl radical bonded by an oxygen atom. "Arylalkoxyalkyl" means an aryloxy radical bonded by an alkyl group, and "heteroaryloxyalkyl" means a heteroaryloxy radical bonded by an alkyl group."Haloalkoxyalkyl" means a linked haloalkoxy group, and "haloalkylthioalkyl" means a haloalkylthio group linked via an alkyl group. 35 "Arylalkyl" means an aryl group linked via an alkyl group, "heteroarylalkyl" means a heteroaryl group linked via an alkyl group, and "heterocyclylalkyl" means a heterocyclyl group linked via an alkyl group. "Cycloalkylalkyl" means a cycloalkyl group linked via an alkyl group, e.g., (but not limited to) cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclopropyleth-1-yl, 2-cyclopropyleth-1-yl, 1-cyclopropylprop-1-yl, 3-cyclopropylprop-1-yl. “Arylalkenyl” means an aryl radical bonded via an alkenyl group, “heteroarylalkenyl” means a heteroaryl radical bonded via an alkenyl group, and “heterocyclylalkenyl” means a heterocyclyl radical bonded via an alkenyl group."Arylalkynyl" stands for an aryl radical bonded via an alkynyl group, "heteroarylalkynyl" stands for a heteroaryl radical bonded via an alkynyl group, and "heterocyclylalkynyl" stands for a heterocyclyl radical bonded via an alkynyl group. According to the invention, "haloalkylthio"—alone or as part of a chemical group—stands for straight-chain or branched S-haloalkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as (C1-C8)-, (C1-C6)-, or (C1-C4)-haloalkylthio, e.g. (but not limited to) trifluoromethylthio, pentafluoroethylthio, difluoromethyl, 2,2-difluoroeth-1-ylthio, 2,2,2-difluoroeth-1-ylthio, 3,3,3-prop-1-ylthio. “Halocycloalkyl” and “halocycloalkenyl” mean cycloalkyl or cycloalkenyl partially or fully substituted by identical or different halogen atoms, such as F, Cl and Br, or by haloalkyl, such as trifluoromethyl or difluoromethyl, e.g.1-Fluorocycloprop-1-yl, 2-Fluorocycloprop-1-yl, 2,2-Difluorocycloprop-1-yl, 1-Fluorocyclobut-1-yl, 1-Trifluoromethylcycloprop-1-yl, 2-Trifluoromethylcycloprop-1-yl, 1-Chlorocycloprop-1-yl, 2-Chlorocycloprop-1-yl, 2,2-Dichlorocycloprop-1-yl, 3,3-Difluorocyclobutyl, According to the invention, "trialkylsilyl" - alone or as part of a chemical group - stands for straight-chain or branched Si-alkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as tri-[(C1-C8)-, (C1-C6)- or (C1-C4)-alkyl]silyl, e.g. (but not limited to) trimethylsilyl, triethylsilyl, Tri-(n-propyl)silyl, tri-(iso-propyl)silyl, tri-(n-butyl)silyl, tri-(1-methylprop-1-yl)silyl, tri-(2-methylprop-1-yl)silyl, tri(1,1-dimethyleth-1-yl)silyl, tri(2,2-dimethyleth-1-yl)silyl. "Trialkylsilylalkynyl" refers to a trialkylsilyl radical bonded via an alkynyl group.35 If the compounds can form tautomers by hydrogen shift which would not be structurally covered by formula (I), these tautomers are nevertheless encompassed by the definition of the compounds of formula (I) according to the invention, unless a specific tautomer is the subject of consideration. For example, many carbonyl compounds can exist in both the keto form and the enol form, both forms being encompassed by the definition of the compound of formula (I). The compounds of general formula (I) can exist as stereoisomers depending on the nature and linkage of the substituents. The possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, Z- and E-isomers, are all encompassed by formula (I). If, for example, one or more alkenyl groups are present, diastereomers (Z- and E-isomers) can occur.For example, if one or more asymmetric carbon atoms are present, enantiomers and diastereomers can occur. Stereoisomers can be obtained from the mixtures obtained during production using conventional separation methods. Chromatographic separation can be carried out both on an analytical scale to determine the enantiomeric excess or diastereomeric excess, and on a preparative scale to produce test samples for biological testing. Stereoisomers can also be selectively produced by using stereoselective reactions using optically active starting materials and / or auxiliaries. The invention thus also relates to all stereoisomers encompassed by the general formula (I) but not specified with their specific stereoform, as well as mixtures thereof. If the compounds are obtained as solids, purification can also be carried out by recrystallization or digestion.If individual compounds (I) cannot be satisfactorily obtained by the methods described below, they can be prepared by derivatization of other compounds (I). Suitable methods for the isolation, purification, and stereoisomer separation of compounds of the formula (I) are methods that are generally known to the person skilled in the art from analogous cases, e.g., by physical processes such as crystallization, chromatography, especially column chromatography and HPLC (high-pressure liquid chromatography), distillation, optionally under reduced pressure, extraction, and other processes. Any remaining mixtures can generally be separated by chromatographic separation, e.g., on chiral solid phases. For preparative quantities or on an industrial scale, processes such as crystallization, e.g.,diastereomeric salts, which can be obtained from the diastereomer mixtures with optically active acids and, if acidic groups are present, with optically active bases. 35 Synthesis of substituted oxyiminomethylphenyluracils with 4-difluoroalkyl substitution on the uracil of the general formula (I):.

[0009] The substituted oxyiminomethylphenyluracils according to the invention with 4-difluoroalkyl substitution on the uracil of general formula (I) can be prepared using known methods. The synthetic routes used and investigated are based on commercially available or readily prepared synthetic building blocks. The groups W, Q, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 and R 16of the general formula (I) have the meanings defined above in the following schemes, unless exemplary but non-limiting definitions are given. The synthesis of the compounds of the general formula Ia, Ib or Ic proceeds as described below by way of example in Scheme 1, where R 1 here, by way of example but not limitation, is fluorine, R 6 by way of example, but not limitation, is methyl, R 7 by way of example, but not limitation, is hydrogen and R 3 , R 4 and R 5 by way of example, but not limitation, are equal to hydrogen. S (Ib) (Ic) Scheme 1 Starting from the literature-known benzaldehydes, the nitrated benzaldehydes (II) are obtained using potassium nitrate in the presence of sulfuric acid or, alternatively, using nitrating acid (cf. Medicinal Chemistry Letters (2016), 7(12), 1077-1081 or J. Agric. Food Chem. 2019, 67, 45, 12382-12392). Subsequent reaction of the nitrated benzaldehyde (II) with hydroxylamine hydrochloride in the presence of sodium acetate in aqueous ethanol yields the corresponding hydroxylimine (III), which is converted into the silyl-protected hydroxylimine (IV) by reaction with suitable trialkylsilyl chlorides, represented here by way of example but not limitation as tert-butyldimethylsilyl chloride. The silylation is carried out using a suitable base (e.g. triethylamine or Hünig base) in a suitable polar aprotic solvent (e.g. dichloromethane, chloroform, N,N-dimethylacetamide or N,N-dimethylformamide).Subsequent reduction of the nitro group yields the corresponding silyl-protected (3-aminophenyl)methylene]hydroxylamine (V). The reduction is carried out using a suitable reducing agent (e.g., hydrogen, palladium on carbon in a suitable polar protic solvent) or, as exemplified in Scheme 1, using tin(II) chloride in ethyl acetate or, alternatively, with iron powder in acetic acid. The synthesis of the 2-(dimethylamino)-4-(haloalkyl)-6H-1,3-oxazin-6-ones of type (VII) proceeds in a two-step synthesis sequence (as described in WO2000 / 049002 A1) starting from the corresponding aminoacrylic acid esters, e.g., B. Ethyl (2Z)-3-amino-4,4-difluoropent-2-enoate by reaction with dimethylcarbamoyl chloride in N,N-dimethylformamide (DMF) using a suitable base (e.g. sodium hydride or potassium tert-butoxide) and subsequent cyclization to oxazin-6-one (VII) using phosphorus pentachloride and phosphorus oxychloride.The synthesis of ethyl (2Z)-3-amino-4,4-difluoropent-2-enoate, presented here as an example but not as a limitation, as the starting material, takes place in a two-step synthesis sequence by converting the commercially available ethyl 2,2-difluoropropionate into the corresponding beta-keto ester by means of Claisen condensation and subsequent conversion into the (2Z)-3-amino-4,4-difluoropent-2-enoate in the presence of ammonium acetate in ethanol. The subsequent condensation reaction of the protected (3-aminophenyl)methylene]hydroxylamine (V) with the oxazin-6-one (VII) using acetic acid as the solvent at a suitable temperature yields the uracil (VIII), whereby under the acetic acid reaction conditions, the silyl protecting group is immediately cleaved as the reaction progresses.The subsequent O-alkylation of the hydroxylamine group occurs by reaction with a corresponding α-haloacetic acid ester, shown in Scheme I as exemplified but not limiting as ethyl α-chloroacetate 35, and thus allows the synthesis of the substituted oxyiminomethylphenyluracils (IX). The required underlying α-haloacetic acid esters are commercially available or known from the literature. The O-alkylation is carried out using a suitable base (e.g., sodium hydride, potassium tert-butoxide, or potassium carbonate) in a suitable polar aprotic solvent (e.g., dichloromethane, chloroform, N,N-dimethylacetamide, or N,N-dimethylformamide). The final conversion to N-amino-N'-uracil (Ia) proceeds from the previously described uracil (IX) by N-amination, as shown in Scheme 1. The N-amination is carried out using a suitable amination reagent (e.g.O-(mesitylsulfonyl)hydroxylamine, O-(tolylsulfonyl)hydroxylamine, O-(diphenylphosphoryl)hydroxylamine) using a suitable base (e.g., sodium hydride, potassium tert-butoxide, or potassium carbonate) in a suitable polar aprotic solvent (e.g., dichloromethane, chloroform, N,N-dimethylacetamide, or N,N-dimethylformamide). Ester cleavage of the terminal ester group of N-amino-N'-uracil (Ia) by ester cleavage processes known to those skilled in the art yields the carboxylic acid (Ib) corresponding to N-amino-N'-uracil (Ia). This can then be converted into various ester variants of N-amino-N'-uracil (Ic) by esterification with a suitable alcohol R-OH. The esterification can be carried out, as shown by way of example but not limitation in Scheme 2, using suitable coupling reagents (e.g.HOBt = 1-hydroxybenzotriazole, EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, HATU = O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, T3P = 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide) and suitable bases (e.g. diisopropylethylamine, triethylamine) in a suitable polar aprotic solvent (e.g. dichloromethane, chloroform). Alternatively, the esterification can be carried out via transformation into the acid chloride using thionyl chloride and subsequent reaction with the alcohol R-OH, using a suitable polar aprotic solvent (e.g., dichloromethane (DCM), chloroform, N,N-dimethylacetamide (DMA), or N,N-dimethylformamide (DMF)). The synthesis of the N-methyluracils of the general formula Id, Ie, or If proceeds as described below by way of example in Scheme 2, where R. 1 here, by way of example but not limitation, is fluorine, R 6by way of example, but not limitation, is methyl, R 7 by way of example, but not limitation, is hydrogen, R 3 by way of example, but not limitation, is hydrogen and R 4 by way of example, but not limitation, is methyl and R 5by way of example but not limitation, is methyl. Starting from the uracil (VIII) described in Scheme 1, the reaction to give the silyl-protected uracil (X) takes place with suitable trialkylsilyl chlorides, represented here by way of example but not limitation as tert-butyldimethylsilyl chloride. The silylation is carried out using a suitable base (e.g. triethylamine or Hünig's base) in a suitable polar aprotic solvent (e.g. dichloromethane, chloroform, N,N-dimethylacetamide or N,N-dimethylformamide). The silyl-protected uracil (X) is converted into the N-methyl-N'-phenyluracil (XI) by subsequent N-methylation. The methylation is carried out using a suitable base (e.g. sodium hydride, potassium tert-butoxide or potassium carbonate) in a suitable polar aprotic solvent (e.g. dichloromethane, chloroform, N,N-dimethylacetamide or N,N-dimethylformamide).Subsequent deprotection to the hydroxylamine group is carried out by stirring with 2N hydrochloric acid, thus allowing the synthesis of the free hydroximinomethylphenyluracils (XII). Scheme 2 The subsequent O-alkylation of the hydroxylamine group occurs by reaction with a corresponding α-haloacetic acid ester, shown in Scheme II as 2-bromopropionic acid ethyl ester by way of example but not limitation, and thus allows the synthesis of the substituted oxyiminomethylphenyluracils (Id). The required underlying α-haloacetic acid esters are commercially available or known from the literature. The O-alkylation is carried out using a suitable base (e.g., sodium hydride, potassium tert-butoxide, or potassium carbonate) in a suitable polar aprotic solvent (e.g., dichloromethane, chloroform, N,N-dimethylacetamide, or N,N-dimethylformamide). The corresponding carboxylic acid (Ie) is obtained by ester cleavage of the terminal ester group of N-methyl-N'-uracil (Id) according to ester cleavage processes known to those skilled in the art.This can then be converted into various ester variants of N-methyl-N'-uracil (If) by esterification with a suitable alcohol R-OH. The esterification can be carried out, as shown in Scheme 2 by way of example but not limitation, using suitable coupling reagents (e.g., HOBt = 1-hydroxybenzotriazole, EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, HATU = O-(7-.

[0010] Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, T3P = 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide) and suitable bases (e.g., diisopropylethylamine, triethylamine) in a suitable polar aprotic solvent (e.g., dichloromethane, chloroform). Alternatively, the esterification can be carried out via transformation into the acid chloride using thionyl chloride and subsequent reaction with the alcohol R-OH, using a suitable polar aprotic solvent (e.g., dichloromethane (DCM), chloroform, N,N-dimethylacetamide (DMA), or N,N-dimethylformamide (DMF)). Selected detailed synthesis examples for the compounds of the general formula (I) according to the invention are listed below. The example numbers given correspond to the numberings given in Tables I.1 to I.14 below. 1 H-NMR, 13 C-NMR and 19F- NMR spectroscopic data given for the chemical examples described in the following sections (400 MHz at 1 H-NMR and 150 MHz at 13 C-NMR and 375 MHz at 19F-NMR (CDCl3, CD3OD, or d6-DMSO solvent, internal standard: tetramethylsilane, δ = 0.00 ppm) was obtained using a Bruker instrument. The designated signals have the following meanings: br = broad; s = singlet, d = doublet, t = triplet, dd = double doublet, ddd = doublet of a double doublet, m = multiplet, q = quartet, quint = quintet, sext = sextet, sept = septet, dq = double quartet, dt = double triplet. For mixtures of diastereomers, either the significant signals of both diastereomers or the characteristic signal of the major diastereomer are given. The abbreviations used for chemical groups have the following meanings: Me = CH3, Et = CH2CH3, t-Hex = C(CH3)2CH(CH3)2, t-Bu = C(CH3)3, n-Bu = unbranched butyl, n-Pr = unbranched propyl, i-Pr = branched propyl, c-Pr = cyclopropyl, c-Hex = cyclohexyl. Synthesis examples: No. I.3-442: (Ethyl-{[(E)-{5-[3-amino-4-(1,1-difluorethyl)-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-2- chlor-4-fluorbenzyliden}amino]oxy}acetat . ... N-[(E)-(5-Nitro-2-chloro-4-fluorophenyl)methylene]hydroxylamine (4390 mg, 20.09 mmol; for preparation, see J. Agric. Food Chem. 2019, 67, 45, 12382–12392) was dissolved in 66 mL of dichloromethane, and triethylamine (5081 mg, 50.21 mmol) and tert-butylsilyl chloride (6055 mg, 40.17 mmol) were added at room temperature. The reaction solution was stirred for 1 h at room temperature. After monitoring by TLC, the mixture was quenched with water, and the aqueous phase was thoroughly extracted several times with dichloromethane. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. Final purification by column chromatography yielded N-[(E)-(5-nitro-2-chloro-4-fluorophenyl)methylene]-O-[tert-butyl(dimethyl)silyl]hydroxylamine (6070 mg, purity: 95%, 86% of theory), which was subsequently further reacted. The resulting N-[(E)-(5-nitro-2-chloro-4-fluorophenyl)methylene]-O-[tert-butyl(dimethyl)silyl]hydroxylamine (1227 mg, 3.69 mmol) was initially dissolved in 10 mL of ethyl acetate, and tin(II) chloride (2796 mg, 14.75 mmol) was added portionwise at 70 °C. The reaction mixture was then stirred at 60 °C for 2 hours. The reaction mixture was then poured into water and filtered through Celite. After separation of the phases, the aqueous phase was extracted several times with ethyl acetate, and the combined organic phases were subsequently dried over sodium sulfate, filtered, and concentrated under reduced pressure. Purification of the crude product by column chromatography gave N-[(E)-(5-amino-2-chloro-4-fluorophenyl)methylene]-O-[tert-butyl(dimethyl)silyl]hydroxylamine (750 mg, purity: 95%, 64% of theory), which was subsequently reacted further. N-[(E)-(5-Amino-2-chloro-4-fluorophenyl)methylene]-O-[tert-butyl(dimethyl)silyl]hydroxylamine (2861 mg, 9.44 mmol) was treated with 4-(1,1-difluoroethyl)-2-(dimethylamino)-6H-1,3-oxazin-6-one (2800 mg, 12.The resulting residue (7 mmol; prepared analogously to WO2000 / 049002) was dissolved in 50 mL of acetic acid and stirred for 2 h at 110 °C. After complete conversion, the reaction mixture was treated with water and then thoroughly extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered off, and concentrated under reduced pressure. Purification of the crude product by column chromatography afforded 3-{4-chloro-2-fluoro-5-[(E)-(hydroxyimino)methyl]phenyl}-6-(1,1-difluoroethyl)pyrimidine-2,4(1H,3H)-dione (1540 mg, purity: 95%, 44% of theory) as a colorless solid, which was further reacted in the same manner. The resulting 3-{4-chloro-2-fluoro-5-[(E)-(hydroxyimino)methyl]phenyl}-6-(1,1-difluoroethyl)pyrimidine-2,4(1H,3H)-dione (308 mg, 0.88 mmol) was dissolved in 5 mL of N,N-dimethylformamide, potassium carbonate (159 mg, 1.15 mmol) was added, and subsequently ethyl chloroacetate (141 mg, 1.15 mmol) was added.The reaction solution was then stirred for 2 hours at room temperature. After monitoring by TLC, the mixture was left to stand overnight and quenched with water the following day. After adding a few drops of 6N hydrochloric acid, the aqueous phase was thoroughly extracted several times with methylene chloride. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. Subsequent purification by column chromatography afforded ethyl {[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}acetate (261 mg, purity: 35 99%, 61% of theory) as a colorless oil, which was further reacted in this manner. The resulting ethyl {[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}acetate (210 mg, 0.48 mmol) was dissolved in 5 mL of abs. tetrahydrofuran, treated with sodium hydride (21 mg, 0.53 mmol), a 60% dispersion in mineral oil) was added and stirred at room temperature for 30 min. O-(diphenylphosphinoyl)hydroxylamine (147 mg, 0.62 mmol) was then added. The resulting reaction mixture was stirred under nitrogen for 2 h. After complete conversion, water was added, dichloromethane was added, and the mixture was separated using a phase separator, followed by evaporation under reduced pressure. Purification of the crude product by column chromatography gave ethyl {[(E)-{5-[3-amino-4-(1,1-difluoroethyl)-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-2-chloro-4-fluorobenzylidene}amino]oxy}acetate (120 mg, purity: 85%, 47% of theory) as a colorless solid. 1H NMR (CDCl3, ppm): 8.55 (s, 1H), 7.83 (d, 1H), 7.32 (d, 1H), 6.14 (s, 1H), 4.69 (s, 2H), 4.64 (s, 2H), 4.25 (q, 2H), 2.18 (t, 3H), 1.28 (t, 3H). Nr. I.2-442 (Racemat): Ethyl-(2RS)-2-{[(E)-{2-chlor-5-[4-(1,1-difluorethyl)-3-methyl-2,6-dioxo-3,6- dihydropyrimidin-1(2H)-yl]-4-fluorbenzyliden}amino]oxy}propanoat 3-{4-Chloro-2-fluoro-5-[(E)-(hydroxyimino)methyl]phenyl}-6-(1,1-difluoroethyl)pyrimidine-2,4(1H,3H)-dione (500 mg, 1.43 mmol) was dissolved in 7.5 mL of dichloromethane, and triethylamine (364 mg, 3.59 mmol) and tert-butylsilyl chloride (434 mg, 2.87 mmol) were added. The reaction solution was stirred for 1 h at room temperature. After TLC monitoring, the mixture was quenched with water, and the aqueous phase was thoroughly extracted several times with dichloromethane. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. Final column chromatographic purification yielded 3-{5-[(E)-({[tert-Butyl(dimethyl)silyl]oxy}imino)methyl]-4-chloro-2-fluorophenyl}-6-(1,1-difluoroethyl)pyrimidine-2,4(1H,3H)-dione (555 mg, purity: 95%, 79% of theory), which was subsequently further reacted.The resulting 3-{5-[(E)-({[tert-Butyl(dimethyl)silyl]oxy}imino)methyl]-4-chloro-2-fluorophenyl}-6-(1,1-difluoroethyl)pyrimidine-2,4(1H,3H)-dione (550 mg, 1.19 mmol) was dissolved in 8 mL of N,N-dimethylformamide, potassium carbonate (494 mg, 3.57 mmol) was added, and then iodomethane (363 mg, 2.38 mmol) was added. The reaction solution was stirred for 2 h at 110 °C. After monitoring by TLC, the mixture was quenched with water, and the aqueous phase was thoroughly extracted several times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. By final column chromatographic purification, 3-{5-[(E)-({[tert-Butyl(dimethyl)silyl]oxy}imino)methyl]-4-chloro-2-fluorophenyl}-6-(1,1-difluoroethyl)-1-methylpyrimidine-2,4(1H,3H)-dione (521 mg, purity: 97%, 89% of theory) was obtained in the form of a colorless semicrystalline oil.The 3-{5-[(E)-({[tert-Butyl(dimethyl)silyl]oxy}imino)methyl]-4-chloro-2-fluorophenyl}-6-(1,1-difluoroethyl)-1-methylpyrimidine-2,4(1H,3H)-dione (520 mg, 1.09 mmol) generated in the precursor was stirred in approximately 1.5 mL of 4N aqueous hydrochloric acid for 2 h at room temperature. Subsequently, 200 mL of water was added, and the aqueous phase was thoroughly extracted several times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. Final purification by column chromatography yielded 3-{4-chloro-2-fluoro-5-[(E)-(hydroxyimino)methyl]phenyl}-6-(1,1-difluoroethyl)-1-methylpyrimidine-2,4(1H,3H)-dione (320 mg, purity: 97%, 78% of theory) as a colorless oil, which was further reacted. The resulting 3-{4-chloro-2-fluoro-5-[(E)-(hydroxyimino)methyl]phenyl}-6-(1,1-difluoroethyl)-1-methylpyrimidine-2,4(1H,3H)-dione (1150 mg, 3.17 mmol) was dissolved in 20 mL of N,N-dimethylformamide, treated with potassium carbonate (571 mg, 4.13 mmol), and then ethyl (2RS)-bromopropionate (764 mg, 4.13 mmol) was added. The reaction solution was stirred for 2 h at room temperature. After monitoring by TLC, the mixture was quenched with water, and the aqueous phase was thoroughly extracted several times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. By final column chromatographic purification, ethyl (2RS)-2-{[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}propanoate (1517 mg, purity: 95%, 98% of theory) was obtained in the form of a colorless solid. 1H NMR (CDCl3, ppm): 8.51 (s, 1H), 7.81 (d, 1H), 7.30 (d, 1H), 6.17 (s, 1H), 4.78 (q, 1H), 4.23 (q, 2H), 3.58 (s, 3H), 2.05 (t, 3H), 1.53 (d, 3H), 1.28 (t, 3H). No. I.2-442 (Enantiomer 1) [(-)-rotating] and No. I.2-442 (Enantiomer 2) [(+)-rotating]: Ethyl (+)-2-{[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}propanoate and Ethyl (-)-2-{[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}propanoate (Enantiomers 1 and 2 shown below with an * at the chiral center)

[0011] The resulting racemic ethyl (2RS)-2-{[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}propanoate (875 mg) was then separated into the enantiomers by chiral supercritical fluid chromatography (SFC) on a CHIRALCEL OZ column. After 1.90 - 2.50 min, 414 mg (44% yield) of a colorless solid (enantiomer 1, II2-442 (enantiomer 1), (-)-rotating) was obtained. 1 H NMR (CDCl3, ppm): 8.51 (s, 1H), 7.81 (d, 1H), 7.30 (d, 1H), 6.17 (s, 1H), 4.78 (q, 1H), 4.23 (q, 2H), 3.58 (s, 3H), 2.05 (t, 3H), 1.53 (d, 3H), 1.28 (t, 3H). Optical rotation: 38.52 (MeOH, 2 mg / mL), and after 2.65–3.25 min, 409 mg (43% yield) of a colorless solid (enantiomer 2, II2-442 (enantiomer 2), (+)-rotating) was obtained. 1H NMR (CDCl3, ppm): 8.51 (s, 1H), 7.81 (d, 1H), 7.30 (d, 1H), 6.15 (s, 1H), 4.78 (q, 1H), 4.23 (q, 2H), 3.58 (s, 3H), 2.05 (t, 3H), 1.53 (d, 3H), 1.28 (t, 3H). Optical rotation + 41.70 (MeOH, 2 mg / mL). The absolute configuration of the individual enantiomers was not assigned, so differentiation was made solely based on the optical rotation without knowledge of the absolute configuration. No. I.1-481: {[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}acetic acid H Ethyl {[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}acetate (135 mg, 0.30 mmol) was initially dissolved in 3 mL of glacial acetic acid, and 0.5 mL of 6N aqueous hydrochloric acid was added. The reaction solution was stirred for 3 h at 30 °C. The mixture was left to stand overnight and, after monitoring by TLC, water was added the following day. The aqueous phase was then thoroughly extracted several times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. By final column chromatographic purification, {[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}acetic acid (14.5 mg, purity: 95%, 11% of theory) was obtained in the form of a colorless solid. 1H NMR (CDCl3, ppm): 8.55 (s, 1H), 7.83 (d, 1H), 7.31 (d, 1H), 6.17 (s, 1H), 4.74 (s, 2H), 3.58 (s, 3H), 2.05 (t, 3H). Nr. I.1-1: 2-Methoxyethyl-{[(E)-{2-chlor-5-[4-(1,1-difluorethyl)-3-methyl-2,6-dioxo-3,6- dihydropyrimidin-1(2H)-yl]-4-fluorbenzyliden}amino]oxy}acetat To a solution of 3-methoxy-1-propanol (44 mg, 0.57 mmol) in 5 mL of dichloromethane was added {[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}acetic acid (150 mg, 0.44 mmol), followed by 1-hydroxy-1H-benzotriazole hydrate (89 mg, 0.57 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (111 mg, 0.57 mmol), and 4-dimethylaminopyridine (10 mol%). The mixture was stirred at RT for 5 h. After standing overnight at RT, water was added, dichloromethane was added, and the mixture was separated using a phase separator, followed by evaporation under reduced pressure. Purification of the crude product by column chromatography yielded 2-methoxyethyl {[(E)-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorobenzylidene}amino]oxy}acetate (132 mg, purity: 97%, 71% of theory) as a colorless oil, which later crystallized. 1H NMR (CDCl3, ppm): 8.54 (s, 1H), 7.82 (d, 1H), 7.31 (d, 1H), 6.15 (s, 1H), 4.74 (s, 2H), 4.33 (m, 2H), 3.62 (m, 2H), 3.58 (s, 2H), 3.38 (s, 3H), 2.05 (t, 3H). Analogously to the preparation examples given above and cited at the appropriate point, and taking into account the general information for the preparation of substituted oxyiminomethylphenyluracils with 4-difluoroalkyl substitution on the uracil, the following compounds are obtained. If a structural element in Table 1 is defined by a structural formula containing a dashed line, this dashed line indicates that the group in question is bonded to the rest of the molecule at this position. If a structural element in Table 1 is defined by a structural formula containing an arrow, the arrow represents a bond between the respective group Q and the carbonyl group in the general formula (I). Table I.1: Preferred compounds of formula (I.1) are compounds I.1-1 to I.1-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.1-1 to I.1-500 of Table I.1 are thus defined by the meaning of the respective entries Nos. 1 to 500 for Q in Table 1. Table 1: ) Table I.2: Preferred compounds of formula (I.2) are compounds I.2-1 to I.2-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.2-1 to I.2-500 of Table I.2 are thus defined by the meaning of the respective entries No. 1 to 500 for Q in Table 1. Table I.3: Preferred compounds of formula (I.3) are compounds I.3-1 to I.3-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.3-1 to I.3-500 of Table I.3 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.4: Preferred compounds of formula (I.4) are compounds I.4-1 to I.4-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.4-1 to I.4-500 of Table I.4 are thus defined by the meaning of the respective entries No. 1 to 500 for Q in Table 1. Table I.5: Preferred compounds of formula (I.5) are compounds I.5-1 to I.5-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.5-1 to I.5-500 of Table I.5 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.6: Preferred compounds of formula (I.6) are compounds I.6-1 to I.6-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.6-1 to I.6-500 of Table I.6 are thus defined by the meaning of the respective entries No. 1 to 500 for Q in Table 1. Table I.7: Preferred compounds of formula (I.7) are compounds I.7-1 to I.7-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.7-1 to I.7-500 of Table I.7 are thus defined by the meaning of the respective entries No. 1 to 500 for Q in Table 1. Table I.8: Preferred compounds of formula (I.8) are compounds I.8-1 to I.8-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.8-1 to I.8-500 of Table I.8 are thus defined by the meaning of the respective entries No. 1 to 500 for Q in Table 1. Table I.9: Preferred compounds of formula (I.9) are compounds I.9-1 to I.9-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.9-1 to I.9-500 of Table I.9 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.10: Preferred compounds of formula (I.10) are compounds I.10-1 to I.10-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.10-1 to I.19-500 of Table I.10 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.11: Preferred compounds of formula (I.11) are compounds I.11-1 to I.11-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.11-1 to I.11-500 of Table I.11 are thus defined by the meaning of the respective entries No. 1 to 500 for Q in Table 1. Table I.12: Preferred compounds of formula (I.12) are compounds I.12-1 to I.12-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.12-1 to I.12-500 of Table I.12 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.13: Preferred compounds of formula (I.13) are compounds I.13-1 to I.13-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.13-1 to I.13-500 of Table I.13 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.14: Preferred compounds of formula (I.14) are the compounds I.14-1 to I.14-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.14-1 to I.14-500 of Table I.14 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. NMR data of selected examples: The 1 H-NMR data of selected examples of compounds of general formula (I) are presented in two different ways, namely (a) classical NMR evaluation and interpretation or (b) in the form of 1H-NMR peak lists according to the method described below. a) classical NMR interpretation b) NMR peak list method The 1 H-NMR data of selected examples are presented in the form of 1 H-NMR peak lists are recorded. For each signal peak, the δ value in ppm is listed first, followed by the signal intensity in parentheses. The δ value – signal intensity number pairs of different signal peaks are listed separated by semicolons. The peak list of an example therefore has the form: δ1 (Intensity1 ) ; δ2 (intensity2);……..; δi (intensityi );……; δn (Intensityn) The intensity of sharp signals correlates with the height of the signals in a printed example of an NMR spectrum in cm and shows the true ratios of the signal intensities. For broad signals, multiple peaks or the center of the signal and their relative intensity compared to the most intense signal in the spectrum can be shown. For calibration of the chemical shift of 1 H-NMR spectra use tetramethylsilane and / or the chemical shift of the solvent, especially in the case of spectra measured in DMSO. Therefore, the tetramethylsilane peak may or may not appear in NMR peak lists. 1 H-NMR peaks are similar to the classical 1 H-NMR printouts and thus usually contain all peaks that are found in a classical NMR interpretation. In addition, they can be interpreted like classical 1H-NMR printouts show solvent signals, signals of stereoisomers of the target compounds, which are also subject of the invention, and / or peaks of impurities. When reporting compound signals in the delta range of solvents and / or water, our lists of 1H NMR peaks show the usual solvent peaks, for example, peaks of DMSO in DMSO-D6 and the peak of water, which usually have a high average intensity. The peaks of stereoisomers of the target compounds and / or peaks of impurities usually have a lower average intensity than the peaks of the target compounds (e.g., with a purity of >90%). Such stereoisomers and / or impurities can be typical for the respective manufacturing process. Their peaks can thus help identify the reproduction of our manufacturing process based on "by-product fingerprints." An expert who calculates the peaks of the target compounds using known methods (MestreC, ACD simulation, but also empirically evaluated expected values) can isolate the peaks of the target compounds as needed, using additional intensity filters if necessary.This isolation would be similar to the peak picking involved in classical music. 1 H-NMR interpretation. Further details on 1 H-NMR peak lists can be found in the Research Disclosure Database Number 564025.

[0012] The present invention furthermore relates to the use of one or more compounds of the formula (I) according to the invention and / or salts thereof, as defined above, preferably in one of the embodiments identified as preferred or particularly preferred, in particular one or more compounds of the formulas (I.1-1) to (I.14-500) and / or salts thereof, each as defined above, as a herbicide and / or plant growth regulator, preferably in crops of useful and / or ornamental plants. The present invention furthermore relates to a method for controlling harmful plants and / or for regulating the growth of plants, characterized in that an effective amount of one or more compounds of the formula (I) according to the invention and / or salts thereof, as defined above, preferably in one of the embodiments identified as preferred or particularly preferred, in particular one or more compounds of the formulas (I.1-1) to (I.14-500) and / or salts thereof, each as defined above, or - an agent according to the invention, as defined below, is applied to the (pest) plants, (pest) plant seeds, the soil in or on which the (pest) plants grow, or the cultivated area. The present invention also provides a method for controlling undesirable plants, preferably in crops of useful plants, characterized in that an effective amount of - one or more compounds of the formula (I) and / or salts thereof, as defined above, preferably in one of the embodiments characterized as preferred or particularly preferred, in particular one or more compounds of the formulae (I.1-1) to (I.14-500) and / or salts thereof, each as defined above, or - an agent according to the invention, as defined below, is applied to undesirable plants (e.g.Harmful plants such as mono- or dicotyledonous weeds or unwanted crop plants), the seed of the unwanted plants (i.e. plant seeds, e.g. grains, seeds or vegetative propagating organs such as tubers or shoot parts with buds), the soil in or on which the unwanted plants grow (e.g. the soil of cultivated land or non-cultivated land) or the area under cultivation (i.e. area on which the unwanted plants will grow). The present invention furthermore also relates to methods for controlling and regulating the growth of plants, preferably useful plants, characterized in that an effective amount of one or more compounds of the formula (I) and / or salts thereof, as defined above, preferably in one of the embodiments characterized as preferred or particularly preferred, in particular one or more compounds of the formulae (I.1-1) to (I.14-500) and / or salts thereof, in each case as defined above, or - of a composition according to the invention, as defined below, the plant, the seed of the plant (i.e. plant seeds, e.g. grains, seeds or vegetative propagating organs such as tubers or shoot parts with buds), the soil in or on which the plants grow (e.g. the soil of cultivated land or non-cultivated land) or the area under cultivation (i.e. area on which the plants will grow) is applied. The compounds according to the invention or the compositions according to the invention can be applied, for example, by pre-sowing (optionally also by incorporation into the soil), pre-emergence and / or post-emergence methods. Some representatives of the mono- and dicotyledonous weed flora which can be controlled by the compounds according to the invention may be mentioned by way of example, without the mention of any restriction to specific species.Preferably, in a method according to the invention for controlling harmful plants or for regulating the growth of plants, one or more compounds of the formula (I) and / or salts thereof are used for controlling harmful plants or for regulating the growth in crops of useful plants or ornamental plants, the useful plants or ornamental plants being transgenic plants in a preferred embodiment.The compounds of formula (I) according to the invention and / or salts thereof are suitable for controlling the following genera of monocotyledonous and dicotyledonous weeds: Monocotyledonous weeds of the genera: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum.Dicotyledonous harmful plants of the genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium. If the compounds according to the invention are applied to the soil surface before the germination of the harmful plants (grass and / or weeds) (pre-emergence method), either the emergence of the grass or weed is prevented.Weed seedlings are completely prevented or they grow to the cotyledon stage, but then stop growing and finally die completely after three to four weeks. When the active ingredients are applied to the green parts of the plant by post-emergence, growth stops after treatment and the weeds remain in the growth stage present at the time of application or die completely after a certain time, so that in this way weed competition that is harmful to the crop plants is eliminated very early and sustainably. Although the compounds according to the invention have excellent herbicidal activity against monocotyledonous and dicotyledonous weeds, crop plants of economically important crops, e.g.Dicotyledonous crops of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Miscanthus, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or monocotyledonous crops of the genera Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum, Triticale, Triticum, Zea, are only slightly damaged or not damaged at all, depending on the structure of the respective compound according to the invention and its application rate. For these reasons, the present compounds are very suitable for the selective control of undesirable plant growth in plant crops such as agricultural crops or ornamental plantings. Furthermore, the compounds according to the invention (depending on their respective structure and the applied rate) exhibit excellent growth regulatory properties in crop plants.They regulate the plant's own metabolism and can thus be used to specifically influence plant components and facilitate harvesting, for example, by inducing desiccation and stunting. Furthermore, they are also suitable for the general control and inhibition of undesirable vegetative growth without killing the plants. Inhibition of vegetative growth plays a major role in many monocotyledonous and dicotyledonous crops, as it can, for example, reduce or completely prevent lodging. Due to their herbicidal and plant growth-regulating properties, the active ingredients can also be used to control weeds in crops of plants modified genetically or through conventional mutagenesis.The transgenic plants are generally characterized by particularly advantageous properties, for example, resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria or viruses. Other special properties relate, for example, to the harvested product in terms of quantity, quality, storability, composition and special ingredients. For example, transgenic plants with increased starch content or altered starch quality or those with a different fatty acid composition of the harvested product are known. With regard to transgenic crops, the use of the compounds according to the invention and / or their salts is preferred in economically important transgenic crops of useful and ornamental plants, e.g.of cereals such as wheat, barley, rye, oats, millet, rice, and maize, or also crops of sugar beet, cotton, soybeans, rapeseed, potatoes, tomatoes, peas, and other vegetables. The compounds according to the invention can preferably also be used as herbicides in crops that are resistant to the phytotoxic effects of the herbicides or have been genetically engineered to be resistant. Due to their herbicidal and plant growth-regulating properties, the active ingredients can also be used to control weeds in crops of known or yet-to-be-developed genetically modified plants.Transgenic plants are generally characterized by particularly advantageous traits, such as resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens such as certain insects or microorganisms such as fungi, bacteria, or viruses. Other special traits affect the harvested crop in terms of quantity, quality, storability, composition, and specific ingredients. Transgenic plants with increased starch content or altered starch quality, or those with a different fatty acid composition of the harvested crop, are known. Other special traits may include tolerance or resistance to abiotic stressors such as heat, cold, drought, salt, and ultraviolet radiation.Preference is given to using the compounds of formula (I) according to the invention or their salts in economically important transgenic crops of useful and ornamental plants, e.g. cereals such as wheat, barley, rye, oats, triticale, millet, rice, cassava and maize or also crops of sugar beet, cotton, soybeans, rapeseed, potatoes, tomatoes, peas and other vegetables. The compounds of formula (I) can preferably be used as herbicides in useful plant crops which are resistant to the phytotoxic effects of the herbicides or have been made resistant by genetic engineering. Conventional methods for producing new plants which have modified properties compared to previously existing plants include, for example, classical breeding methods and the generation of mutants. Alternatively, new plants with modified properties can be produced using genetic engineering methods.Numerous molecular biological techniques for producing new transgenic plants with modified traits are known to those skilled in the art. For such genetic manipulations, nucleic acid molecules can be introduced into plasmids, allowing mutagenesis or sequence modification through recombination of DNA sequences. Using standard methods, base substitutions can be performed, partial sequences can be removed, or natural or synthetic sequences can be added. Adapters or linkers can be attached to the DNA fragments to connect them to one another.The production of plant cells with reduced activity of a gene product can be achieved, for example, by expressing at least one corresponding antisense RNA, a sense RNA to achieve a cosuppression effect, or the expression of at least one appropriately constructed ribozyme that specifically cleaves transcripts of the aforementioned gene product. 35 For this purpose, DNA molecules can be used that comprise the entire coding sequence of a gene product, including any flanking sequences present, as well as DNA molecules that comprise only parts of the coding sequence, whereby these parts must be long enough to produce an antisense effect in the cells. It is also possible to use DNA sequences that exhibit a high degree of homology to the coding sequences of a gene product, but are not completely identical.When nucleic acid molecules are expressed in plants, the synthesized protein can be localized in any compartment of the plant cell. However, to achieve localization in a specific compartment, the coding region can, for example, be linked to DNA sequences that ensure localization in a specific compartment. Such sequences are known to the person skilled in the art (see, for example, Braun et al., EMBO J.11 (1992), 3219-3227). Expression of the nucleic acid molecules can also take place in the organelles of the plant cells. The transgenic plant cells can be regenerated into whole plants using known techniques. In principle, the transgenic plants can be plants of any plant species, i.e., both monocotyledonous and dicotyledonous plants.Thus, transgenic plants are obtainable that exhibit altered properties through the overexpression, suppression, or inhibition of homologous (= natural) genes or gene sequences, or the expression of heterologous (= foreign) genes or gene sequences. The compounds (I) according to the invention can preferably be used in transgenic crops that are resistant to growth promoters, such as dicamba, or to herbicides that inhibit essential plant enzymes, e.g., acetolactate synthases (ALS), EPSP synthases, glutamine synthases (GS), or hydroxyphenylpyruvate dioxygenases (HPPD), or to herbicides from the group of sulfonylureas, glyphosates, glufosinates, or benzoyl isoxazoles and analogous active ingredients.When the active compounds according to the invention are used in transgenic crops, in addition to the effects on weeds observed in other crops, effects often occur which are specific to the application in the respective transgenic crop, for example a modified or specifically expanded weed spectrum that can be controlled, modified application rates that can be used for application, preferably good combinability with the herbicides to which the transgenic crop is resistant, and influencing the growth and yield of the transgenic crops. 35 The invention therefore also relates to the use of the compounds of the formula (I) according to the invention and / or salts thereof as herbicides for controlling weeds in crops of useful or ornamental plants, optionally in transgenic crops.Preference is given to use in cereals, preferably maize, wheat, barley, rye, oats, millet, or rice, pre- or post-emergence. Preference is also given to use in soybeans pre- or post-emergence. The use according to the invention for controlling weeds or for regulating the growth of plants also includes the case in which the active ingredient of the formula (I) or its salt is only formed from a precursor substance ("prodrug") after application to the plant, in the plant, or in the soil. The invention also relates to the use of one or more compounds of the formula (I) or salts thereof or of an agent according to the invention (as defined below) (in a method) for controlling weeds or for regulating the growth of plants, characterized in that an effective amount of one or more compounds of the formula (I) or salts thereof is applied to the plants (weeds, optionallytogether with the crop plants) plant seeds, the soil in or on which the plants grow, or the cultivated area. The invention also relates to a herbicidal and / or plant growth regulating agent, characterized in that the agent (a) contains one or more compounds of the formula (I) and / or salts thereof as defined above, preferably in one of the embodiments characterized as preferred or particularly preferred, in particular one or more compounds of the formulas (I.1-1) to (I.14-500) and / or salts thereof, in each case as defined above, and (b) one or more further substances selected from groups (i) and / or (ii): (i) one or more further agrochemically active substances, preferably selected from the group consisting of insecticides, acaricides, nematicides, further herbicides (iethose which do not correspond to formula (I) defined above), fungicides, safeners, fertilizers 35 and / or other growth regulators, (ii) one or more formulation auxiliaries customary in plant protection. The other agrochemically active substances of component (i) of a composition according to the invention are preferably selected from the group of substances listed in "The Pesticide Manual", 19th edition. thedition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2021. A herbicidal or plant growth-regulating agent according to the invention preferably comprises one, two, three or more formulation auxiliaries (ii) customary in crop protection, selected from the group consisting of surfactants, emulsifiers, dispersants, film formers, thickeners, inorganic salts, dusts, carriers that are solid at 25°C and 1013 mbar, preferably adsorptive, granulated inert materials, wetting agents, antioxidants, stabilizers, buffer substances, antifoams, water, organic solvents, preferably organic solvents that are miscible with water in any ratio at 25°C and 1013 mbar. The compounds (I) according to the invention can be used in the form of wettable powders, emulsifiable concentrates, sprayable solutions, dusts or granules in the customary preparations.The invention therefore also relates to herbicidal and plant growth-regulating compositions containing compounds of formula (I) and / or salts thereof. The compounds of formula (I) and / or salts thereof can be formulated in various ways, depending on the biological and / or chemical-physical parameters required. Possible formulation options include: wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions, suspension concentrates (SC), oil- or water-based dispersions, oil-miscible solutions, capsule suspensions (CS), dusts (DP), seed dressings, granules for broadcast and soil application, granules (GR) in the form of micro-, spray-, lift- and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations, microcapsules and waxes.These individual formulation types and the formulation aids such as inert materials, surfactants, solvents and other additives are known to the person skilled in the art and are described, for example, in: Watkins, "Handbook of Insecticide Dust Diluents and Carriers", 2nd Ed., Darland Books, Caldwell NJ; Hv Olphen, "Introduction to Clay Colloid Chemistry"; 2nd Ed., J. Wiley & Sons, NY; C. Marsden, "Solvents Guide"; 2nd Ed., Interscience, NY1963; McCutcheon's "Detergents and 35 Emulsifiers Annual", MC Publ. Corp., Ridgewood NJ; Sisley and Wood, "Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., NY1964; Schönfeldt, "Grenzflächenaktive Äthylenoxidaddukte", Wiss. Verlagsgesellschaft, Stuttgart 1976; Winnacker-Küchler, "Chemical Technology", Volume 7, C. Hanser Verlag Munich, 4th edition, 1986.Wettable powders are preparations that are evenly dispersible in water and contain, in addition to the active ingredient and a diluent or inert substance, ionic and / or non-ionic surfactants (wetting agents, dispersants), e.g., polyoxyethylated alkylphenols, polyoxyethylated fatty alcohols, polyoxyethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates, sodium ligninsulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate, or sodium oleoylmethyltaurine. To produce the wettable powders, the herbicidal active ingredients are finely ground in conventional equipment such as hammer mills, fan mills, and air jet mills and mixed simultaneously or subsequently with the formulation auxiliaries. Emulsifiable concentrates are prepared by dissolving the active ingredient in an organic solvent, e.g.,Butanol, cyclohexanone, dimethylformamide, xylene, or higher-boiling aromatics or hydrocarbons or mixtures of organic solvents with the addition of one or more ionic and / or non-ionic surfactants (emulsifiers). Examples of emulsifiers that can be used are: alkylarylsulfonic acid calcium salts such as Ca-dodecylbenzenesulfonate or non-ionic emulsifiers such as fatty acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, sorbitan esters such as sorbitan fatty acid esters or polyoxyethylene sorbitan esters such as polyoxyethylene sorbitan fatty acid esters. Dusts are obtained by grinding the active ingredient with finely divided solid substances, e.g. talc, natural clays such as kaolin, bentonite, and pyrophyllite, or diatomaceous earth. Suspension concentrates can be water- or oil-based.They can be produced, for example, by wet grinding using commercially available bead mills and, if appropriate, with the addition of surfactants, as already listed above for the other formulation types. Emulsions, e.g. oil-in-water emulsions (EW), can be produced, for example, using stirrers, colloid mills and / or static mixers using aqueous organic solvents and, if appropriate, surfactants, as already listed above for the other formulation types. 35 Granules can be produced either by spraying the active ingredient onto adsorptive, granulated inert material or by applying active ingredient concentrates using adhesives, e.g. polyvinyl alcohol, sodium polyacrylate or mineral oils, to the surface of carrier materials such as sand, kaolinite or granulated inert material.Suitable active ingredients can also be granulated in the manner customary for the production of fertilizer granules—if desired, mixed with fertilizers. Water-dispersible granules are generally produced by conventional processes such as spray drying, fluidized-bed granulation, disc granulation, mixing with high-speed mixers, and extrusion without solid inert material. For the production of disc, fluidized-bed, extruder, and spray granules, see, for example, the processes in "Spray-Drying Handbook," 3rd ed. 1979, G. Goodwin Ltd., London; J.E. Browning, "Agglomeration," Chemical and Engineering 1967, pp. 147 ff.; "Perry's Chemical Engineer's Handbook," 5th ed., McGraw-Hill, New York 1973, pp. 8-57. For further details on the formulation of pesticides see, for example, GC Klingman, "Weed Control as a Science", John Wiley and Sons, Inc., New York, 1961, pages 81-96 and JD Freyer, SA Evans, "Weed Control Handbook", 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pages 101-103. The agrochemical preparations, preferably herbicidal or plant growth regulating agents of the present invention preferably contain a total amount of 0.1 to 99% by weight, preferably 0.5 to 95% by weight, more preferably 1 to 90% by weight, particularly preferably 2 to 80% by weight, of active ingredients of the formula (I) and salts thereof. In wettable powders, the active ingredient concentration is, for example, about 10 to 90% by weight, the remainder to 100% by weight consisting of customary formulation constituents. In emulsifiable concentrates, the active ingredient concentration can be about 1 to 90, preferably 5 to 80% by weight. Dust-like formulations contain 1 to 30% by weight of active ingredient, preferably mostly 5 to 20% by weight of active ingredient, sprayable solutions contain about 0.05 to 80, preferably 2 to 50% by weight of active ingredient.In water-dispersible granules, the active ingredient content depends partly on whether the active compound is liquid or solid and which granulation aids, fillers, etc. are used. For water-dispersible granules, the active ingredient content, for example, is between 1 and 95 wt.%, preferably between 10 and 80 wt.%. In addition, the active ingredient formulations mentioned may contain the usual adhesives, wetting agents, dispersants, emulsifiers, penetration agents, preservatives, antifreeze agents, solvents, fillers, carriers, dyes, defoamers, evaporation inhibitors, and agents that affect pH and viscosity. Examples of formulation aids are described, among others, in "Chemistry and Technology of Agrochemical Formulations," ed. DA Knowles, Kluwer Academic Publishers (1998).The compounds of formula (I) or their salts can be used as such or in the form of their preparations (formulations) in combination with other pesticidally active substances, such as insecticides, acaricides, nematicides, herbicides, fungicides, safeners, fertilizers, and / or growth regulators, e.g., as ready-to-use formulations or as tank mixes. The combination formulations can be prepared based on the above-mentioned formulations, taking into account the physical properties and stability of the active ingredients to be combined.As combination partners for the compounds of formula (I) according to the invention in mixture formulations or in the tank mix, known active ingredients which are based on an inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate 3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II, protoporphyrinogen oxidase can be used, as they are described, for example, in Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 19. thedition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2021 and the literature cited therein. Of particular interest is the selective control of weeds in crops of useful and ornamental plants. Although the compounds (I) according to the invention already exhibit very good to sufficient selectivity in many crops, phytotoxicity can in principle occur in some crops and especially in the case of mixtures with other herbicides that are less selective. In this regard, combinations of compounds (I) according to the invention which comprise the compounds (I) or their combinations with other herbicides or pesticides and safeners are of particular interest. The safeners, which are used in an antidote-effective concentration, reduce the phytotoxic side effects of the herbicides / pesticides used, e.g.in economically important crops such as cereals (wheat, barley, rye, maize, rice, millet), sugar beet, sugar cane, rapeseed, cotton and soybeans, preferably cereals. The weight ratios of herbicide (mixture) to safener generally depend on the application rate of herbicide and the efficacy of the particular safener and can vary within wide limits, for example in the range from 200:1 to 1:200, preferably 100:1 to 1:100, in particular 20:1 to 1:20. The safeners can be formulated analogously to the compounds (I) or mixtures thereof with other herbicides / pesticides and provided and applied as a ready-made formulation or tank mix with the herbicides. For use, the herbicide or herbicide-safener formulations available in commercially available form are diluted, if appropriate, in the customary manner, e.g., in the case of wettable powders, emulsifiable concentrates, dispersions and water-dispersible granules, using water.Dust-like preparations, soil or broadcast granules and sprayable solutions are not usually diluted with other inert substances before use. External conditions such as temperature, humidity, etc. influence to a certain extent the application rate of the compounds of formula (I) and / or their salts. The application rate can vary within wide limits. For use as a herbicide to control weeds, the total amount of compounds of formula (I) and their salts is preferably in the range from 0.001 to 10.0 kg / ha, more preferably in the range from 0.005 to 5 kg / ha, more preferably in the range from 0.01 to 1.5 kg / ha, particularly preferably in the range from 0.05 to 1 kg / ha. This applies to both pre-emergence and post-emergence application.When using compounds of formula (I) and / or salts thereof as plant growth regulators, for example as stem shorteners in crops as mentioned above, preferably in cereal plants such as wheat, barley, rye, triticale, millet, rice or maize, the total application rate is preferably in the range from 0.001 to 2 kg / ha, preferably in the range from 0.005 to 1 kg / ha, in particular in the range from 10 to 500 g / ha, very particularly preferably in the range from 20 to 250 g / ha. This applies to both pre-emergence and post-emergence applications. Application as a stem shortener can take place at various stages of plant growth. Preference is given, for example, to application after tillering at the onset of longitudinal growth. Alternatively, when used as a plant growth regulator, seed treatment is also possible, which includes various seed dressing and coating techniques.The application rate depends on the individual techniques and can be determined in preliminary tests. Combination partners for the compounds of formula (I) according to the invention in compositions according to the invention (e.g., mixture formulations or tank mixes) include, for example, known active ingredients based on the inhibition of, for example, acetolactate synthase, acetyl-CoA-35 carboxylase, cellulose synthase, enolpyruvylshikimate 3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II, or protoporphyrinogen oxidase, as described, for example, in Weed Research 26 (1986) 441-445 or "The Pesticide Manual," 19. thedition, The British Crop Protection Council and the Royal Society of Chemistry, 2021, and the literature cited therein. Examples of known herbicides or plant growth regulators that can be combined with the compounds according to the invention are listed below. These active ingredients are designated either by their common name in the English version according to the International Organization for Standardization (ISO) or by their chemical name or code number. This always includes all application forms, such as acids, salts, esters, as well as all isomeric forms such as stereoisomers and optical isomers, even if these are not explicitly mentioned. Examples of such herbicidal mixture partners: Known herbicides or plant growth regulators that can be combined with compounds of the general formula (I) include:For example, the following active ingredients are to be mentioned (the compounds are designated either by the "common name" according to the International Organization for Standardization (ISO) or by the chemical name or by the code number) and always include all application forms such as acids, salts, esters and isomers such as stereoisomers and optical isomers. Examples of Icaeine and, in some cases, several application forms are mentioned: Acetochlor, Acifluorfen, Acifluorfen-methyl, Acifluorfen-sodium, Aclonifen, Alachlor, Allidochlor, Alloxydim, Alloxydim-sodium, Ametryn, Amicarbazon, Amidochlor, Amidosulfuron, 4-Amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropyridine-2-carboxylic acid, Aminocyclopyrachlor, Aminocyclopyrachlor-potassium, Aminocyclopyrachlor-methyl, Aminopyralid, Aminopyralid-dimethylammonium, Aminopyralid-tripromine, Amitrol, Ammonium sulfamate, Anilofos, Asulam, Asulam-potassium, Asulam-sodium, Atrazine, Azafenidine, Azimsulfuron, Beflubutamid, (S)-(-)- Beflubutamide,Beflubutamid-M, Benazolin, Benazolin-ethyl, Benazolin-dimethylammonium, Benazolin-Klaium, Benfluralin, Benfuresate, Bensulfuron, Bensulfuron-methyl, Bensulide, Bentazone, Bentazone-Sodium, Benzobicyclon, Benzofenap, Bicyclopyrone, Bifenox, Bilanafos, Bilanafos-Sodium, Bipyrazone, Bispyribac, bispyribac sodium, bixlozone, bromacil, bromacil lithium, bromacil sodium, bromobutide, bromofenoxime, bromoxynil, bromoxynil butyrate, bromoxynil potassium, bromoxynil heptanoate and bromoxynil octanoate, busoxinone, butachlor, butafenacil, butamifos, Butenachlor, Butralin, Butroxydim, Butylate, Cafenstrol, Cambendichlor, Carbetamide, Carfentrazone, Carfentrazone-Ethyl, Chloramben, Chloramben-ammonium, Chloramben-diolamine, Chloramben-methyl, Chloramben-methylammonium, Chloramben-sodium, Chlorbromuron, Chlorfenac, Chlorfenac-ammonium, Chlorfenac-sodium, Chlorfenprop, Chlorfenprop-methyl, Chlorflurenol, Chlorflurenol-methyl, Chloridazon, Chlorimuron, Chlorimuron-ethyl, Chlorophthalim, Chlorotoluron,Chlorsulfuron, 35 Chlorthal, Chlorthal-dimethyl, Chlorthal-monomethyl, Cinidon, Cinidon-ethyl, Cinmethylin, exo-(+)- Cinmethylin, d.h. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methylbenzyl)oxy]-7-oxabicyclo[2.2.1]heptan, exo-(-)-Cinmethylin, d.h. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methylbenzyl)oxy]-7- oxabicyclo[2.2.1]heptan, Cinosulfuron, Clacyfos, Clethodim, Clodinafop, Clodinafop-ethyl, Clodinafop- propargyl, Clomazon, Clomeprop, Clopyralid, Clopyralid-methyl, Clopyralid-olamin, Clopyralid- Kalium, Clopyralid-tripomin, Cloransulam, Cloransulam-methyl, Cumyluron, Cyanamide, Cyanazine, Cycloat, Cyclopyranil, Cyclopyrimorat, Cyclosulfamuron, Cycloxydim, Cyhalofop, Cyhalofop-butyl, Cyprazin, 2,4-D (sowie die Ammonium, Butotyl, Butyl, Cholin, Diethylammonium, Dimethylammonium, Diolamin, Doboxyl, Dodecylammonium, Etexyl, Ethyl, 2-Ethylhexyl, Heptylammonium, Isobutyl, Isooctyl, Isopropyl, Isopropylammonium, Lithium, Meptyl, Methyl, Kalium, Tetradecylammonium, Triethylammonium,Triisopropanolammonium, Tripromin and Trolamin Salze davon), 2,4-DB, 2,4-DB-butyl, 2,4-DB-Dimethylammonium, 2,4-DB-isooctyl, 2,4-DB-Kalium und 2,4-DB-Natrium, Daimuron (Dymron), Dalapon, Dalapon-Calcium, Dalapon-Magnesium, Dalapon- Natium, Dazomet, Dazomet-Natrium, n-Decanol, 7-Deoxy-D-sedoheptulose, Desmedipham, Detosyl- pyrazolat (DTP), Dicamba und seine Salze (z.B. Dicamba-biproamin, Dicamba-N,N-Bis(3- aminopropyl)methylamin, Dicamba-butotyl, Dicamba-cholin, Dicamba-Diglycolamin, Dicamba- Dimethylammonium, Dicamba-Diethanolaminemmonium, Dicamba-Diethylammonium, Dicamba- isopropylammonium, Dicamba-methyl, Dicamba-monoethanolamin, Dicamba-olamin, Dicamba- Kalium, Dicamba-Natium, Dicamba-Triethanolamin), Dichlobenil, 2-(2,4-Dichlorbenzyl)-4,4-dimethyl- 1,2-oxazolidin-3-on, 2-(2,5-Dichlorbenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, Dichlorprop, Dichlorprop-butotyl, Dichlorprop-Dimethylammonium, Dichhlorprop-etexyl, Dichlorprop- ethylammonium, Dichlorprop-isoctyl, Dichlorprop-methyl,Dichlorprop-Kalium, Dichlorprop-Natrium, Dichlorprop-P, Dichlorprop-P-Dimethylammonium, Dichlorprop-P-etexyl, Dichlorprop-P-Kalium, Dichlorprop-Natrium, Diclofop, Diclofop-methyl, Diclofop-P, Diclofop-P-methyl, Diclosulam, Difenzoquat, Difenzoquat-metilsulfate, Diflufenican, Diflufenzopyr, Diflufenzopyr-Natrium, Dimefuron, Dimepiperate, Dimesulfazet, Dimethachlor, Dimethametryn, Dimethenamid, Dimethenamid-P, Dimetrasulfuron, Dinitramine, Dinoterb, Dinoterb-Acetate, Diphenamid, Diquat, Diquat-Dibromid, Diquat-Dichloride, Dithiopyr, Diuron, DNOC, DNOC-Ammonium, DNOC-Kalium, DNOC-Natrium, Endothal, Endothal-Diammonium, Endothal-Dikalium, Endothal-Dinatrium, Epyrifenacil (S-3100), EPTC, Esprocarb, Ethalfluralin, Ethametsulfuron, Ethametsulfuron-Methyl, Ethiozin, Ethofumesate, Ethoxyfen, Ethoxyfen-Ethyl, Ethoxysulfuron, Etobenzanid, F-5231, d.h. N-[2- Chlor-4-fluor-5-[4-(3-fluorpropyl)-4,5-dihydro-5-oxo-1H-tetrazol-1-yl]-phenyl]-ethansulfonamid, F- 7967,i.e.3-[7-Chlor-5-fluor-2-(trifluormethyl)-1H-benzimidazol-4-yl]-1-methyl-6- (trifluormethyl)pyrimidin-2,4(1H,3H)-dion, Fenoxaprop, Fenoxaprop-P, Fenoxaprop-Ethyl, Fenoxaprop-P-Ethyl, Fenoxasulfone, Fenpyrazone, Fenquinotrione, Fentrazamid, Flamprop, Flamprop- Isoproyl, Flamprop-Methyl, Flamprop-M-Isopropyl, Flamprop-M-Methyl, Flazasulfuron, Florasulam, Florpyrauxifen, Florpyrauxifen-benzyl, Fluazifop, Fluazifop-Butyl, Fluazifop-Methyl, Fluazifop-P, 35 Fluazifop-P-Butyl, Flucarbazone, Flucarbazone-Natrium, Flucetosulfuron, Fluchloralin, Flufenacet, Flufenpyr, Flufenpyr-Ethyl, Flumetsulam, Flumiclorac, Flumiclorac-Pentyl, Flumioxazin, Fluometuron, Flurenol, Flurenol-Butyl, -Dimethylammonium und -Methyl, Fluoroglycofen, Fluoroglycofen-Ethyl, Flupropanat, Flupropanat-Natrium, Flupyrsulfuron, Flupyrsulfuron-Methyl, Flupyrsulfuron-Methyl- Natrium, Fluridon, Flurochloridon, Fluroxypyr, Fluroxypyr-Butometyl, Fluroxypyr-Meptyl, Flurtamon, Fluthiacet, Fluthiacet-Methyl, Fomesafen,Fomesafen-Natrium, Foramsulfuron, Foramsulfuron-Natrium, Fosamine, Fosamine-Ammonium, Glufosinat, Glufosinat-Ammonium, Glufosinat-Natrium, L- Glufosinat-Ammonium, L-Glufosinat-Natrium, Glufosinat-P-Natrium, Glufosinat-P-Ammonium, Glyphosat, Glyphosat-Ammonium, Glyphosat-Isopropylammonium, Glyphosat-Diammonium, Glyphosat-Dimethylammonium, Glyphosat-Kalium, Glyphosat-Natrium, Glyphosat-Sesquinatrium und Glyphosat-Trimesium, H-9201, d.h. O-(2,4-Dimethyl-6-nitrophenyl)-O-ethyl- isopropylphosphoramidothioat, Halauxifen, Halauxifen-methyl, Halosafen, Halosulfuron, Halosulfuron- Methyl, Haloxyfop, Haloxyfop-P, Haloxyfop-Ethoxyethyl, Haloxyfop-P-Ethoxyethyl, Haloxyfop- Methyl, Haloxyfop-P-Methyl, Haloxifop-Natrium, Hexazinon, HNPC-A8169, i.e. Prop-2-yn-1-yl (2S)- 2-{3-[(5-tert-butylpyridin-2-yl)oxy]phenoxy}propanoat, HW-02, d.h.1-(Dimethoxyphosphoryl)-ethyl- (2,4-dichlorphenoxy)acetat, Hydantocidin, Icafolin, Icafolin-Methyl, Imazamethabenz, Imazamethabenz-Methyl, Imazamox, Imazamox-Ammonium,Imazapic, Imazapic-Ammonium, Imazapyr, Imazapyr-Isopropylammonium, Imazaquin, Imazaquin-Ammonium, Imazaquin-Methyl, Imazethapyr, Imazethapyr-Ammonium, Imazosulfuron, Indanofan, Indaziflam, Indolauxipyr, Iodosulfuron, Iodosulfuron-Methyl, Iodosulfuron-Methyl-Natrium, Ioxynil, Ioxynil-Lithium, -Octanoat, -Kalium und Natrium, Ipfencarbazon, Iptriazopyrid, i.e. 3-[(Isopropylsulfonyl)methyl]-N-(5-methyl- 1,3,4-oxadiazol-2-yl)-5-(trifluormethyl)[1,2,4]triazolo-[4,3-a]pyridin-8-carboxamid, Isoproturon, Isouron, Isoxaben, Isoxaflutole, Karbutilat, KUH-043, d.h.3-({[5-(Difluormethyl)-1-methyl-3- (trifluormethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazol, Ketospiradox, Ketospiradox-Kalium, Lactofen, Lenacil, Linuron, MCPA, MCPA-Butotyl, -Butyl, -Dimethyl- ammonium, -Diolamin, -2-Ethylhexyl, -Ethyl, -Isobutyl, Isoctyl, -Isopropyl, -Isopropylammonium, - Methyl, Olamin, -Kalium, –Natrium und -Trolamin, MCPB, MCPB-Methyl, -Ethyl und -Natrium, Mecoprop, Mecoprop-Butotyl,Mecoprop- dimethylammonium, Mecoprop-Diolamin, Mecoprop-Etexyl, Mecoprop-Ethadyl, Mecoprop-Isoctyl, Mecoprop-Methyl, Mecoprop-Kalium, Mecoprop-Natrium, und Mecoprop-Trolamin, Mecoprop-P, Mecoprop-P-Butotyl, -Dimethylammonium, -2-Ethylhexyl und - Kalium, Mefenacet, Mefluidid, Mefluidid-Diolamin, Mefluidid-Kalium, Mesosulfuron, Mesosulfuron- Methyl, Mesosulfuron-Natrium, Mesotrion, Methabenzthiazuron, Metam, Metamifop, Metamitron, Metazachlor, Metazosulfuron, Methabenzthiazuron, Methiopyrsulfuron, Methiozolin, Methyl isothiocyanat, Metobromuron, Metolachlor, S-Metolachlor, Metosulam, Metoxuron, Metproxybicyclon, Metribuzin, Metsulfuron, Metsulfuron-Methyl, Molinat, Monolinuron, Monosulfuron, Monosulfuron- Methyl, MT-5950, d.h. N-[3-Chlor-4-(1-methylethyl)-phenyl]-2-methylpentanamid, NGGC-011, Napropamid, NC-310, i.e.4-(2,4-Dichlorbenzoyl)-1-methyl-5-benzyloxypyrazol, Neburon, 35 Nicosulfuron, Nonansäure (Pelargonsäure), Norflurazon, Ölsäure (Fettsäuren), Orbencarb, Orthosulfamuron,Oryzalin, Oxadiargyl, Oxadiazon, Oxasulfuron, Oxaziclomefone, Oxyfluorfen, Paraquat, Paraquat-dichlorid, Paraquat-Dimethylsulfat, Pebulat, Pendimethalin, Penoxsulam, Pentachlorphenol, Pentoxazon, Pethoxamid, Petroleumöl, Phenmedipham, Phenmedipham-Ethyl, Picloram, Picloram-dimethylammonium, Picloram-Etexyl, Picloram-Isoctyl, Picloram-Methyl, Picloram-Olamin, Picloram-Kalium, Picloram-Triethylammonium, Picloram-Tripromin, Picloram- Trolamin, Picolinafen, Pinoxaden, Piperophos, Pretilachlor, Primisulfuron, Primisulfuron-Methyl, Prodiamine, Profoxydim, Prometon, Prometryn, Propachlor, Propanil, Propaquizafop, Propazine, Propham, Propisochlor, Propoxycarbazone, Propoxycarbazone-Natrium, Propyrisulfuron, Propyzamid, Prosulfocarb, Prosulfuron, Pyraclonil, Pyraflufen, Pyraflufen-Ethyl, Pyraquinat, Pyrasulfotol, Pyrazolynat (Pyrazolat), Pyrazosulfuron, Pyrazosulfuron-Ethyl, Pyrazoxyfen, Pyribambenz, Pyribambenz-Isopropyl, Pyribambenz-Propyl, Pyribenzoxim, Pyributicarb, Pyridafol, Pyridat,Pyriftalid, Pyriminobac, Pyriminobac-Methyl, Pyrimisulfan, Pyrithiobac, Pyrithiobac-Natrium, Pyroxasulfon, Pyroxsulam, Quinclorac, Quinclorac-Dimethylammonium, Quinclorac-Methyl, Quinmerac, Quinoclamin, Quizalofop, Quizalofop-Ethyl, Quizalofop-P, Quizalofop-P-Ethyl, Quizalofop-P-Tefuryl, QYM201, i.e.1-{2-Chlor-3-[(3-cyclopropyl-5-hydroxy-1-methyl-1H-pyrazol-4-yl)carbonyl]-6- (trifluormethyl)phe-nyl}piperidin-2-on, Rimisoxafen, Rimsulfuron, Saflufenacil, Sethoxydim, Siduron, Simazine, Simetryn, SL-261, Sulcotrione, Sulfentrazone, Sulfometuron, Sulfometuron-Methyl, Sulfosulfuron, , SYP-249, d.h.1-Ethoxy-3-methyl-1-oxobut-3-en-2-yl-5-[2-chlor-4- (trifluormethyl)phenoxy]-2-nitrobenzoat, SYP-300, i.e.1-[7-Fluor-3-oxo-4-(prop-2-in-1-yl)-3,4- dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidin-4,5-dion, 2,3,6-TBA, TCA (Trichloressigsäure) und seine Salze, z.B. TCA-ammonium, TCA-Calcium, TCA-Ethyl, TCA- Magnesium, TCA-Natrium, Tebuthiuron, Tefuryltrione, Tembotrion, Tepraloxydim,Terbacil, Terbucarb, Terbumeton, Terbuthylazine, Terbutryn, Tetflupyrolimet, Thaxtomin, Thenylchlor, Thiazopyr, Thiencarbazone, Thiencarbazon-Methyl, Thifensulfuron, Thifensulfuron-Methyl, Thiobencarb, Tiafenacil, Tolpyralat, Topramezon, Tralkoxydim, Triafamon, Tri-allat, Triasulfuron, Triaziflam, Tribenuron, Tribenuron-Methyl, Triclopyr, Triclopyr-Butotyl, Triclopyr-Cholin, Triclopyr- Ethyl, Triclopyr-Triethylammonium, Trietazine, Trifloxysulfuron, Trifloxysulfuron-Natrium, Trifludimoxazin, Trifluralin, Triflusulfuron, Triflusulfuron-Methyl, Tritosulfuron, Harnstoffsulfat, Vernolat, XDE-848, ZJ-0862, d.h.3,4-Dichlor-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}anilin, 3-(2-Chlor-4-fluor-5-(3-methyl-2,6-dioxo-4-trifluormethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5- methyl-4,5-dihydroisoxazol-5-carbonsäuremethylester, 3-(2-Chlor-4-fluor-5-(3-methyl-2,6-dioxo-4- trifluormethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazol-5- carbonsäureethylester,3-(2-Chlor-4-fluor-5-(3-methyl-2,6-dioxo-4-trifluormethyl-3,6-dihydropyrimidin- 1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazol-5-carbonsäure, Ethyl-[(3-{2-chlor-4-fluor-5-[3-methyl- 2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}pyridin-2-yl)oxy]acetat, 3-Chlor- 2-[3-(difluormethyl)isoxazolyl-5-yl]phenyl-5-chlorpyrimidin-2-ylether, 2-(3,4-Dimethoxyphenyl)-4-[(2-35 hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-6-methylpyridazin-3(2H)-on, 2-({2-[(2- Methoxyethoxy)methyl]-6-methylpyridin-3-yl}carbonyl)cyclohexane-1,3-dion, (5-Hydroxy-1-methyl- 1H-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothiophen-5-yl)methanon, 1-Methyl-4- [(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothiophen-5-yl)carbonyl]-1H-pyrazol-5-yl propan-1- sulfonat, 4-{2-Chlor-3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-(methylsulfonyl)benzoyl}-1-methyl- 1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazol-4-carboxylat; Cyanomethyl-4-amino-3-chlor-5-fluor-6-(7- fluor-1H-indol-6-yl)pyridin-2-carboxylat,Prop-2-yn-1-yl 4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol- 6-yl)pyridin-2-carboxylat, Methyl-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2- carboxylat, Benzyl-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2-carboxylat, Ethyl-4- amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2-carboxylat, Methyl-4-amino-3-chlor-5-fluor- 6-(7-fluor-1-isobutyryl-1H-indol-6-yl)pyridin-2-carboxylat, Methyl 6-(1-acetyl-7-fluor-1H-indol-6-yl)- 4-amino-3-chlor-5-fluorpyridin-2-carboxylat, Methyl-4-amino-3-chlor-6-[1-(2,2-dimethylpropanoyl)-7- fluor-1H-indol-6-yl]-5-fluorpyridin-2-carboxylat, Methyl-4-amino-3-chlor-5-fluor-6-[7-fluor-1- (methoxyacetyl)-1H-indol-6-yl]pyridin-2-carboxylat, Kalium 4-amino-3-chlor-5-fluor-6-(7-fluor-1H- indol-6-yl)pyridin-2-carboxylat, Natrium-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2- carboxylat, Butyl-4-amino-3-chlor-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridin-2-carboxylat,4-Hydroxy-1-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 3-(5-tert-butyl-1,2-oxazol-3-yl)-4-hydroxy-1-methylimidazolidin-2-one, 3-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-4-hydroxy-1- methylimidazolidin-2-one, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1,5-dimethyl-3-(2- methylphenyl)quinazoline-2,4(1H,3H)-dione, 3-(2,6-Dimethylphenyl)-6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1-methylquinazolin-2,4(1H,3H)-dione, 2-[2-chloro-4-(methylsulfonyl)-3-(morpholin-4-ylmethyl)benzoyl]-3-hydroxycyclohex-2-en-1-one, 1-(2-carboxyethyl)-4-(pyrimidin-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(pyridazin-3-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 4-(Pyrimidin-2-yl)-1-(2-sulfoethyl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate),4-(Pyridazin-3-yl)-1-(2-sulfoethyl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(1,3-thiazol-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(1,3,4-thiadiazol-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), methyl (2R)-2-{[(E)-({2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methylidene)amino]oxy}propanoate, methyl (2S)- 2-{[(E)({2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methylidene)amino]oxy}propanoate, methyl (2R / S)-2-{[(E)({2-chloro-4-fluoro-5-[3-methyl-2,6- dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methylidene)amino]oxy}propanoate, (E)- 2-(trifluoromethyl)benzaldehyde-O-{2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoyl}oxime, 2-fluoro- N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-[(R)-propylsulfinyl]-4-(trifluormethyl)benzamid, (2R)-2-[(4-35 Amino-3,5-dichlor-6-fluor-2-pyridyl)oxy]propancarbonsäure, 2-Ethoxy-2-oxoethyl-1-{2-chlor-4-fluor- 5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenoxy}cyclopropancarboxylat, 2-Methoxy-2-oxoethyl-1-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4- (trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}cyclopropancarboxylat, {[(1-{2-Chlor-4- fluor-5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenoxy}cyclopropyl)carbonyl]oxy}essigsäure, 2-(2-Brom-4-chlorbenzyl)-4,4-dimethyl-1,2- oxazolidin-3-on, Methyl 3-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6- dihydropyrimidin-1(2H)-yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazol-6a-carboxylat, Ethyl 3-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazol-6a-carboxylat,Methyl-3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}-6-methyl-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazole-6a-carboxylate, 3-{2-Chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}-6-methyl-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazole-6a-carboxylic acid, 3-{2-Chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)- 3,6-dihydropyrimidin-1(2H)-yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazole-6a-carboxylic acid. Examples of growth regulators and plant stimulants as mixing partners are: Abscisic acid and related analogues [e.g. (2Z,4E)-5-[6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid, methyl-(2Z,4E)-5-[6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoate, (2Z,4E)-3-ethyl-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)penta-2,4-dienoic acid, (2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2,4-dienoic acid, methyl (2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2,4-dienoate, (2Z,4E)-5-(2-hydroxy-1,3-dimethyl-5-oxobicyclo[4.1.0]hept-3-en-2-yl)-3-methylpenta-2,4-dienoic acid], Acibenzolar, Acibenzolar- S-methyl, S-adenosylhomocysteine, Allantoin, 2-Aminoethoxyvinylglycine (AVG), Aminooxyacetic acid and related esters [e.g (Isopropylidene)-aminooxyacetic acid 2-(methoxy)-2-oxoethyl ester, (Isopropylidene)-aminooxyacetic acid 2-(hexyloxy)-2-oxoethyl ester, (Cyclohexylidene)-aminooxyacetic acid 2-(isopropyloxy)-2-oxoethyl ester], 1-Aminocycloprop-1-ylcarboxylic acid N-Methyl-1-aminocyclopropyl-1-carboxylic acid, 1-Aminocyclopropyl-1-carboxylic acid amide, substituted 1-Aminocyclopropyl-1-carboxylic acid derivatives as described in DE3335514, EP30287, DE2906507 or US5123951, 1-Aminocyclopropyl-1-hydroxamic acid, 5-Aminolevulinic acid, Ancymidol, 6-Benzylaminopurine, Bikinin, Brassinolide,Brassinolide-ethyl, L-canalin, catechin and catechins (e.g. (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol), chitooligosaccharides (CO; COs differ from LCOs in that they lack the fatty acid side chain characteristic of LCOs. COs, sometimes referred to as N-acetylchitooligosaccharides 35, are also composed of GlcNAc units, but have side chains that distinguish them from chitin molecules [(C8H13NO5)n, CAS No.1398-61-4] and chitosan molecules [(C5H11NO4)n, CAS No.9012-76-4]), chitin-like compounds, chlormequat chloride, cloprop, cyclanilides, 3-(Cycloprop-1-enyl)propionic acid, 1-[2-(4-cyano-3,5-dicyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-[2-(4-cyano-3-cyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-Cyclopropenylmethanol, Daminozide, Dazomet, Dazomet sodium, n-Decanol, Dikegulac, Dikegulac sodium, Endothal, Endothal di-potassium, di-sodium, and mono(N,N-dimethylalkylammonium), Ethephon,1-Ethylcyclopropene, flumetralin, flurenol, flurenol-butyl, flurenol-methyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfid, indole-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, jasmonic acid esters or other derivatives (e.g. jasmonic acid methyl ester, jasmonic acid ethyl ester), lipochitooligosaccharides (LCO, sometimes also referred to as symbiotic nodulation signals (Nod or Nod factors) or Myc factors), consist of an oligosaccharide backbone of β-l,4-linked N-acetyl-D-glucosamine residues (“GlcNAc”) with an N-linked fatty acid side chain fused to the non-reducing end. As can be seen from the literature, LCOs differ in the number of GlcNAc units in the backbone structure, in the length and saturation of the fatty acid chain as well as in the substitution of the reducing and non-reducing sugar units), linoleic acid or its derivatives, linolenic acid or its derivatives,Maleic hydrazide, mepiquat chloride, mepiquat pentaborate, 1-methylcyclopropene, 3-methylcyclopropene, methoxyvinylglycine (MVG), 3'-methylabscisic acid, 1-(4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide and related substituted (tetrahydroquinolin-6-yl)methanesulfonamides, (3E,3αR,8βS)-3-({[(2R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yl]oxy}methylene)-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one and related lactones as described in EP2248421, 2-(1-naphthyl)acetamide, 1-Naphthylacetic acid, 2-Naphthyloxyacetic acid, nitrophenolate mixture, 4-oxo-4[(2-phenylethyl)amino]butyric acid, paclobutrazol, 4-phenylbutyric acid and its salts (e.g. sodium 4-phenylbutanoate, potassium 4-phenylbutanoate), phenylalanine, N-phenylphthalamic acid, prohexadione, prohexadione calcium, 1-n-propylcyclopropene, putrescine, prohydrojasmone, rhizobitoxin, salicylic acid and salicyclic acid methyl ester, sarcosine, sodium cycloprop-1-en-1-yl acetate, sodium cycloprop-2-en-1-yl acetate,Sodium 3-(cycloprop-2-en-1-yl)propanoate, sodium 3-(cycloprop-1-en-1-yl)propanoate, sidefungin, spermidine, spermine, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tryptophan, tsitodef, uniconazole, uniconazole-P, 2-fluoro-N-(3-methoxyphenyl)-9H-purin-6-amine, 2-chloro-N-(3-methoxyphenyl)-9H-purin-6-amine. Also suitable as combination partners for the compounds of formula (I) according to the invention are, for example, the following safeners: S1) Compounds of formula (S1), ), where the symbols and indices have the following meanings: n A is a natural number from 0 to 5, preferably 0 to 3; RA 1 is halogen, (C1-C4)alkyl, (C1-C4)alkoxy, nitro or (C1-C4)haloalkyl; WA is an unsubstituted or substituted divalent heterocyclic radical from the group of saturated or aromatic five-membered ring heterocycles with 1 to 3 hetero ring atoms from the group N and O, wherein at least one N atom and at most one O atom is contained in the ring, preferably a radical from the group (WA 1 ) to (WA 5 ), mA is 0 or 1; R A 2 is OR A 3 , SR A 3 or NR A 3 R A 4 or a saturated or unsaturated 3- to 7-membered heterocycle having at least one N atom and up to 3 heteroatoms, preferably from the group O and S, which is bonded via the N atom to the carbonyl group in (S1) and is unsubstituted or substituted by radicals from the group (C1-C4)-alkyl, (C1-C4)-alkoxy or optionally substituted phenyl, preferably a radical of the formula OR A 3 , NHR A 4or N(CH3)2, in particular of the formula OR A 3 ; R A 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably having a total of 1 to 18 C atoms; R A 4 is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkoxy or substituted or unsubstituted phenyl; RA 5 is H, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C4)alkoxy(C1-C8)alkyl, cyano or COORA 9 , where RA 9 is hydrogen, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C1-C6)hydroxyalkyl, (C3-C12)cycloalkyl or tri-(C1-C4)alkylsilyl; R.A 6 , Attorney 7 , Attorney 8 are identical or different and are hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C3-C12)-cycloalkyl or substituted or unsubstituted phenyl; R A 10 is hydrogen, (C3-C 12)-cycloalkyl, substituted or unsubstituted phenyl or substituted or unsubstituted heteroaryl; preferably: a) compounds of the dichlorophenylpyrazolin-3-carboxylic acid type (S1 a ), preferably compounds such as 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazole-3-carboxylic acid, 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazole-3-carboxylic acid ethyl ester (S1-1) ("Mefenpyr-diethyl"), and related compounds as described in WO-A-91 / 07874; b) derivatives of dichlorophenylpyrazolecarboxylic acid (S1 b ), preferably compounds such as ethyl 1-(2,4-dichlorophenyl)-5-methyl-pyrazole-3-carboxylate (S1-2), ethyl 1-(2,4-dichlorophenyl)-5-isopropyl-pyrazole-3-carboxylate (S1-3), ethyl 1-(2,4-dichlorophenyl)-5-(1,1-dimethyl-ethyl)pyrazole-3-carboxylate (S1-4) and related compounds as described in EP-A-333131 and EP-A-269806; c) derivatives of 1,5-diphenylpyrazole-3-carboxylic acid (S1 c), preferably compounds such as ethyl 1-(2,4-dichlorophenyl)-5-phenylpyrazole-3-carboxylate (S1-5), methyl 1-(2-chlorophenyl)-5-phenylpyrazole-3-carboxylate (S1-6) and related compounds as described, for example, in EP-A-268554; d) compounds of the triazolecarboxylic acid type (S1 d ), preferably compounds such as fenchlorazole (ethyl ester), ie 1-(2,4-dichlorophenyl)-5-trichloromethyl-(1H)-1,2,4-triazole-3-carboxylic acid ethyl ester (S1-7), and related compounds as described in EP-A-174562 and EP-A-346620; e) compounds of the type 5-benzyl- or 5-phenyl-2-isoxazoline-3-carboxylic acid or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (S1 e), preferably compounds such as ethyl 5-(2,4-dichlorobenzyl)-2-isoxazoline-3-carboxylate (S1-8) or ethyl 5-phenyl-2-isoxazoline-3-carboxylate (S1-9) and related compounds as described in WO-A-91 / 0820230, or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1-10) or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1-11) ("Isoxadifen-ethyl") or -n-propyl ester (S1-12) or ethyl 5-(4-fluorophenyl)-5-phenyl-2-isoxazoline-3-carboxylate (S1-13) as described in patent application WO-A-95 / 07897.f) Compounds of the triazolyloxyacetic acid derivative type (S1f), preferably compounds such as methyl {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-14) or {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-15) or methyl {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-16) or {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-17) or Methyl {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-18) or {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-19), as described in patent application WO2021105101. S2) Quinoline derivatives of the formula (S2), ). where the symbols and indices have the following meanings: RB 1 is halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, nitro or (C1-C4)-haloalkyl; nB is a natural number from 0 to 5, preferably 0 to 3; RB 2 is OR B 3 , SR B 3 or NR B 3 R B 4 or a saturated or unsaturated 3- to 7-membered heterocycle having at least one N atom and up to 3 heteroatoms, preferably from the group O and S, which is linked via the N atom to the carbonyl group in (S2) and is unsubstituted or substituted by radicals from the group (C1-C4)-alkyl, (C1-C4)-alkoxy or optionally substituted phenyl, preferably a radical of the formula OR B 3 , NHR B 4 or N(CH3)2, in particular of the formula OR B 3 ; R B 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably with a total of 1 to 18 C atoms; 25 R B 4is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkoxy or substituted or unsubstituted phenyl; TB is a (C1 or C2)-alkanediyl chain which is unsubstituted or substituted by one or two (C1-C4)-alkyl radicals or by [(C1-C3)-alkoxy]-carbonyl; preferably: a) compounds of the 8-quinolinoxyacetic acid type (S2 a), preferably (5-chloro-8-quinolinoxy)acetic acid (1-methylhexyl) ester ("Cloquintocet-mexyl") (S2-1), (5-chloro-8-quinolinoxy)acetic acid (1,3-dimethyl-but-1-yl) ester (S2-2), (5-chloro-8-quinolinoxy)acetic acid 4-allyloxy-butyl ester (S2-3), (5-chloro-8-quinolinoxy)acetic acid 1-allyloxy-prop-2-yl ester (S2-4), (5-chloro-8-quinolinoxy)acetic acid ethyl ester (S2-5), (5-chloro-8-quinolinoxy)acetic acid methyl ester (S2-6), (5-chloro-8-quinolinoxy)acetic acid allyl ester (S2-7), (5-chloro-8-quinolinoxy)acetic acid 2-(2-propylidene- iminoxy)-1-ethyl ester (S2-8), (5-chloro-8-quinolinoxy)acetate 2-oxo-prop-1-yl ester (S2-9) and related compounds as described in EP-A-86750, EP-A-94349 and EP-A-191736 or EP-A-0492 366, and (5-chloro-8-quinolinoxy)acetic acid (S2-10), their hydrates and salts, for example their lithium, sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium,or phosphonium salts as described in WO-A-2002 / 34048; b) compounds of the type (5-chloro-8-quinolinoxy)malonic acid (S2, b ), preferably compounds such as (5-chloro-8-quinolinoxy)malonic acid diethyl ester, (5-chloro-8-quinolinoxy)malonic acid diallyl ester, (5-chloro-8-quinolinoxy)malonic acid methyl ethyl ester and related compounds as described in EP-A-0582198. S3) Compounds of formula (S3) ) where the symbols and indices have the following meanings: RC 1 is (C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C3-C7)cycloalkyl, preferably dichloromethyl; RC 2 , RC 3sind gleich oder verschieden Wasserstoff, (C1-C4)-Alkyl, (C2-C4)-Alkenyl, (C2-C4)-Alkinyl, (C1-C4), Haloalkyl, (C2-C4)-Haloalkenyl, (C1-C4)-Alkylcarbamoyl-(C1-C4)-Alkyl, (C2-C4)- Alkenylcarbamoyl-(C1-C4)-alkyl, (C1-C4)-Alkoxy-(C1-C4)-alkyl, Dioxolanyl-(C1-C4)-alkyl, Thiazolyl, Furyl, Furylalkyl, Thienyl, Piperidyl, substituiertes oder unsubstituiertes Phenyl, oder RC 2 und RC 3together form a substituted or unsubstituted heterocyclic ring, preferably an oxazolidine, thiazolidine, piperidine, morpholine, hexahydropyrimidine or benzoxazine ring; preferably: active ingredients of the dichloroacetamide type, which are frequently used as pre-emergence safeners (soil-acting safeners), such as: B. "Dichlormid" (N,N-diallyl-2,2-dichloroacetamide) (S3-1), "R-29148" (3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidine) from Stauffer (S3-2), "R-28725" (3-dichloroacetyl-2,2,-dimethyl-1,3-oxazolidine) from Stauffer (S3-3), "Benoxacor" (4-dichloroacetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazine) (S3-4), "PPG-1292" (N-allyl-N-[(1,3-dioxolan-2-yl)-methyl]-dichloroacetamide) from PPG Industries (S3-5), "DKA-24" (N-allyl-N-[(allylaminocarbonyl)methyl]-dichloroacetamide) from Sagro-Chem (S3-6), "AD-67" or "MON 4660" (3-dichloroacetyl-1-oxa-3-aza-spiro[4,5]decane) from Nitrokemia orMonsanto (S3-7), "TI-35" (1-Dichloroacetyl-azepane) from TRI-Chemical RT (S3-8), "Diclonon" (Dicyclonone) or "BAS145138" or "LAB145138" (S3-9) ((RS)-1-Dichloroacetyl-3,3,8a-trimethylperhydropyrrolo[1,2-a]pyrimidin-6-one) from BASF, "Furilazole" or "MON 13900" ((RS)-3-Dichloroacetyl-5-(2-furyl)-2,2-dimethyloxazolidine) (S3-10); and its (R)-isomer (S3-11). S4) N-Acylsulfonamides of the formula (S4) and their salts, ). where the symbols and indices have the following meanings: XD is CH or N; R D 1 is CO-NR D 5 R D 6 or NHCO-R D 7 ; R D 2 is halogen, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, nitro, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl or (C1-C4)-alkylcarbonyl; R D 3 is hydrogen, (C1-C4)alkyl, (C2-C4)alkenyl or (C2-C4)alkynyl; RD 4is halogen, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, (C3-C6)-cycloalkyl, phenyl, (C1-C4)-alkoxy, cyano, (C1-C4)-alkylthio, (C1-C4)-alkylsulfinyl, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl or (C1-C4)-alkylcarbonyl; RD 5 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C5-C6)-cycloalkenyl, phenyl or 3- to 6-membered heterocyclyl containing vD heteroatoms from the group nitrogen, oxygen and sulfur, where the last seven radicals are replaced by v D Substituents from the group consisting of halogen, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C2)-alkylsulfinyl, (C1-C2)-alkylsulfonyl, (C3-C6)-cycloalkyl, (C1-C4)-alkoxycarbonyl, (C1-C4)-alkylcarbonyl and phenyl and, in the case of cyclic radicals, also (C1-C4)-alkyl and (C1-C4)-haloalkyl; R D 6 is hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where the last three radicals are represented by v Dradicals from the group halogen, hydroxy, (C1-C4)-alkyl, (C1-C4)-alkoxy and (C1-C4)-alkylthio, or R D 5 and R D 6 together with the nitrogen atom carrying them form a pyrrolidinyl or piperidinyl radical; R D 7 is hydrogen, (C1-C4)-alkylamino, di-(C1-C4)-alkylamino, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, where the last two radicals are replaced by v D Substituents from the group consisting of halogen, (C1-C4)-alkoxy, (C1-C6)-haloalkoxy and (C1-C4)-alkylthio and, in the case of cyclic radicals, also (C1-C4)-alkyl and (C1-C4)-haloalkyl; n D is 0, 1 or 2; m D is 1 or 2; v D is 0, 1, 2 or 3; of these, preference is given to compounds of the N-acylsulfonamide type, e.g. of the following formula (S4 a ), which are known, for example, from WO-A-97 / 45016 ) where RD 7(C1-C6)-alkyl, (C3-C6)-cycloalkyl, where the last two radicals are substituted by vD substituents from the group halogen, (C1-C4)-alkoxy, (C1-C6)-haloalkoxy and (C1-C4)-alkylthio and, in the case of cyclic radicals, also (C1-C4)-alkyl and (C1-C4)-haloalkyl; RD 4 Halogen, (C1-C4)alkyl, (C1-C4)alkoxy, CF3; mD 1 or 2; v D is 0, 1, 2 or 3; and acylsulfamoylbenzoic acid amides, e.g. of the following formula (S4 b ), which are known for example from WO-A-99 / 16744, ) e.g. those in which RD 5 = Cyclopropyl and (RD 4 ) = 2-OMe is ("Cyprosulfamide", S4-1), RD 5 = Cyclopropyl and (RD 4 ) = 5-Cl-2-OMe is (S4-2), RD 5 = Ethyl and (RD 4 ) = 2-OMe is (S4-3), RD 5 = Isopropyl and (RD 4 ) = 5-Cl-2-OMe is (S4-4) and RD 5 = Isopropyl and (RD 4 ) = 2-OMe (S4-5). as well as compounds of the N-acylsulfamoylphenylurea type of the formula (S4c ), which are known for example from EP-A-365484, ) where RD 8 and RD 9 independently of one another hydrogen, (C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C3-C6)-alkenyl, (C3-C6)-alkynyl, R D 4Halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, CF3 mD means 1 or 2; for example 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3-methylurea, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3,3-dimethylurea, 1-[4-(N-4,5-dimethylbenzoylsulfamoyl)phenyl]-3-methylurea. S5) Active ingredients from the class of hydroxyaromatics and aromatic-aliphatic carboxylic acid derivatives (S5), e.g. 3,4,5-triacetoxybenzoic acid ethyl ester, 3,5-dimethoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicyclic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid, as described in WO-A-2004 / 084631, WO-A-2005 / 015994, WO-A-2005 / 016001. S6) Active ingredients from the class of 1,2-dihydroquinoxalin-2-ones (S6), e.g.1-Methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, 1-Methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-thione, 1-(2-Aminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one hydrochloride, 1-(2-Methylsulfonylaminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, as described in WO-A-2005 / 112630. S7) Compounds of formula (S7) as described in WO-A-1998 / 38856). where the symbols and indices have the following meanings: R E 1 , R E 2 are independently halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkyl, (C1-C4)-alkylamino, di-(C1-C4)-alkylamino, nitro; 25 A E is COOR E 3 or COSR E 4 RE 3 , RE 4 are independently hydrogen, (C1-C4)-alkyl, (C2-C6)-alkenyl, (C2-C4)-alkynyl, cyanoalkyl, (C1-C4)-haloalkyl, phenyl, nitrophenyl, benzyl, halobenzyl, pyridinylalkyl and alkylammonium, nE 1 is 0 or 1 nE2 , nE 3 are independently 0, 1 or 2, preferably diphenylmethoxyacetic acid, diphenylmethoxyacetate ethyl ester, diphenylmethoxyacetate methyl ester (CAS Reg. No. 41858-19-9) (S7-1). S8) Compounds of formula (S8), as described in WO-A-98 / 27049) where X F CH or N, n F in case X F =N is an integer from 0 to 4 and in case X F =CH is an integer from 0 to 5, R F 1 Halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, nitro, (C1-C4)-alkylthio, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl, optionally substituted. Phenyl, optionally substituted phenoxy, R F 2 Hydrogen or (C1-C4)-alkyl RF 3hydrogen, (C1-C8)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, or aryl, where each of the aforementioned C-containing radicals is unsubstituted or substituted by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy; or salts thereof, preferably compounds wherein XF is CH, nF is an integer from 0 to 2, RF 1 Halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, RF 2 hydrogen or (C1-C4)-alkyl, RF 3Hydrogen, (C1-C8)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, or aryl, where each of the aforementioned C-containing radicals is unsubstituted or substituted by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy, or salts thereof. S9) Active ingredients from the class of 3-(5-tetrazolylcarbonyl)-2-quinolones (S9), e.g. 1,2-dihydro-4-hydroxy-1-ethyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No. 219479-18-2), 1,2-dihydro-4-hydroxy-1-methyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No. 95855-00-8), as described in WO-A-1999 / 000020. S10) Compounds of the formulas (S10 a ) or (S10 b ) as described in WO-A-2007 / 023719 and WO-A-2007 / 023764 2 where R G 1 Halogen, (C1-C4)-Alkyl, Methoxy, Nitro, Cyano, CF3, OCF3Y G , Z G independently of each other O or S, nG is an integer from 0 to 4, RG 2(C1-C16)-Alkyl, (C2-C6)-Alkenyl, (C3-C6)-Cycloalkyl, Aryl; Benzyl, Halogenbenzyl, RG 3hydrogen or (C1-C6)-alkyl. S11) Active ingredients of the oxyimino compound type (S11), which are known as seed dressings, such as E.g., "Oxabetrinil" ((Z)-1,3-dioxolan-2-ylmethoxyimino(phenyl)acetonitrile) (S11-1), known as a seed dressing safener for millet against metolachlor damage, "Fluxofenim" (1-(4-chlorophenyl)-2,2,2-trifluoro-1-ethanone-O-(1,3-dioxolan-2-ylmethyl)-oxime) (S11-2), known as a seed dressing safener for millet against metolachlor damage, and "Cyometrinil" or "CGA-43089" ((Z)-cyanomethoxyimino(phenyl)acetonitrile) (S11-3), known as a seed dressing safener for millet against metolachlor damage. S12) Active ingredients from the class of isothiochromanones (S12), such as methyl [(3-oxo-1H-2-benzothiopyran-4(3H)-ylidene)methoxy]acetate (CAS Reg. No. 205121-04-6) (S12-1) and related compounds from WO-A-1998 / 13361.S13) One or more compounds from group (S13): "Naphthalic anhydride" (1,8-naphthalenedicarboxylic anhydride) (S13-1), known as a seed dressing safener for maize against damage from thiocarbamate herbicides, "Fenclorim" (4,6-dichloro-2-phenylpyrimidine) (S13-2), known as a safener for pretilachlor in sown rice, "Flurazole" (benzyl 2-chloro-4-trifluoromethyl-1,3-thiazole-5-carboxylate) (S13-3), known as a seed dressing safener for millet against damage from alachlor and metolachlor, "CL 304415" (CAS Reg. No. 31541-57-8) (4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid) (S13-4) from American Cyanamid, which is known as a safener for corn against damage from imidazolinones, "MG 191" (CAS Reg. No. 96420-72-3) (2-Dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) from Nitrokemia, which is known as a safener for corn, "MG-838" (CAS Reg. No. 133993-74-5) (2-propenyl 1-oxa-4-azaspiro[4.5]decane-4-carbodithioate) (S13-6) from Nitrokemia, "Disulfoton" (O,O-diethyl S-2-ethylthioethyl phosphodithioate) (S13-7), "Dietholate" (O,O-diethyl-O-phenylphosphorothioate) (S13-8), "Mephenate" (4-chlorophenyl methylcarbamate) (S13-9). S14) Active ingredients that, in addition to herbicidal activity against harmful plants, also have safener effects on crops such as rice, such as"Dimepiperate" or "MY-93" (S-1-methyl-1-phenylethyl-piperidine-1-carbothioate), known as a safener for rice against damage from the herbicide molinate, "Daimuron" or "SK 23" (1-(1-methyl-1-phenylethyl)-3-p-tolylurea), known as a safener for rice against damage from the herbicide imazosulfuron, "Cumyluron" = "JC-940" (3-(2-chlorophenylmethyl)-1-(1-methyl-1-phenylethyl)urea, see JP-A-60087254), known as a safener for rice against damage from some herbicides, "Methoxyphenone" or "NK 049" (3,3'-dimethyl-4-methoxybenzophenone), known as a safener for rice against damage from some herbicides, "CSB" (1-Bromo-4-(chloromethylsulfonyl)benzene) from Kumiai (CAS Reg. No. 54091-06-4), which is known as a safener against the damage of some herbicides in rice. S15) Compounds of formula (S15) or their tautomers as described in WO-A-2008 / 131861 and WO-A-2008 / 131860. where R H 1 a (C1-C6)-haloalkyl radical and RH 2 hydrogen or halogen and R H 3 , R H 4 independently of each other hydrogen, (C1-C 16 )-alkyl, (C2-C 16 )-alkenyl or (C2-C 16)-Alkynyl, where each of the last three radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, hydroxy, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted, or (C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed on one side of the ring with a 4 to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed on one side of the ring with a 4 to 6-membered saturated or unsaturated carbocyclic ring, wherein each of the latter 4 radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, hydroxy, cyano, (C1-C4)-alkyl,(C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted, or RH, 3 (C1-C4)-alkoxy, (C2-C4)-alkenyloxy, (C2-C6)-alkynyloxy or (C2-C4)-haloalkoxy and RH 4 hydrogen or (C1-C4)-alkyl, or RH 3 and RH 4together with the directly bonded N atom forms a four- to eight-membered heterocyclic ring which, in addition to the N atom, may also contain further hetero ring atoms, preferably up to two further hetero ring atoms from the group N, O and S and which is unsubstituted or substituted by one or more radicals from the group halogen, cyano, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio. S16) Active substances which are primarily used as herbicides but also have a safener effect on crops, e.g. (2,4-dichlorophenoxy)acetic acid (2,4-D), (4-chlorophenoxy)acetic acid, (R,S)-2-(4-chloro-o-tolyloxy)propionic acid (mecoprop), 4-(2,4-dichlorophenoxy)butyric acid (2,4-DB), (4-chloro-o-tolyloxy)acetic acid (MCPA), 4-(4-chloro-o-tolyloxy)butyric acid, 4-(4-chlorophenoxy)butyric acid, 3,6-dichloro-2-methoxybenzoic acid (dicamba), 1-(ethoxycarbonyl)ethyl 3,6-dichloro-2-methoxybenzoate (lactidichloroethyl).Preferred safeners in combination with the compounds of the formula (I) according to the invention and / or their salts, in particular with the compounds of the formulas (I.1-1) to (I.14-500) and / or their salts are: cloquintocet-mexyl, cyprosulfamide, fenchlorazole ethyl ester, isoxadifen ethyl, mefenpyr diethyl, fenclorim, cumyluron, S1-14, S1-15, S1-16, S1-17, S1-18, S1-19, S4-1 and S4-5, and particularly preferred safeners are: cloquintocet-mexyl, cyprosulfamide, isoxadifen ethyl and mefenpyr diethyl.Biological examples: The following abbreviations are used for the crops and weeds listed in the following tables: ABUTH: Abutilon theophrasti ALOMY: Alopecurus myosuroides AMARE: Amaranthus retroflexus AVEFA: Avena fatua BRSNW: Brassica napus DIGSA: Digitaria sanguinalis ECHCG: Echinochloa crus-galli GLXMA: Glycine max KCHSC: Kochia scoparia LOLRI: Lolium rigidum MATIN: Matricaria inodora ORYZA: Oryza sativa PHPBU : Pharbitis purpurea POLCO: Polygonum convolvulus SETVI: Setaria viridis VERPE: Veronica persica VIOTR: Viola tricolor TRZAS : Triticum aestivum ZEAMX: Zea mays A. Post-emergence herbicidal action Seeds of monocotyledonous and dicotyledonous weeds were sown in plastic or Wood fiber pots were placed in sandy loam soil, covered with soil, and grown in a greenhouse under controlled growth conditions. Two to three weeks after sowing, the test plants were treated at the single-leaf stage.The compounds according to the invention, formulated in the form of wettable powders (WP) or emulsion concentrates (EC), were then sprayed onto the green parts of the plants as an aqueous suspension or emulsion with the addition of 0.5% additive at a water application rate equivalent to 600 l / ha. After approximately three weeks of the test plants standing in the greenhouse under optimal growth conditions, the effect of the preparations was visually assessed in comparison to untreated controls. For example, 100% effect means plants have died, 0% effect means the same as the control plants. Tables A1 to A13 below show the effects of selected compounds of general formula (I) according to Table 1 on various weeds and at an application rate corresponding to 20 g / ha and lower, obtained according to the aforementioned test procedure. Table A1a: Post-emergence effect at 1.25 g / ha against ABUTH in %. Table A1b: Post-emergence effect at 5g / ha against ABUTH in % Table A1c: Post-emergence effect at 20g / ha against ABUTH in % Table A2a: Post-emergence effect at 1.25g / ha against ALOMY in % Table A2b: Post-emergence effect at 5g / ha against ALOMY in %

[0013] Table A2c: Post-emergence effect at 20g / ha against ALOMY in % Table A3: Post-emergence effect at 20g / ha against AVEFA in % Table A4a: Post-emergence effect at 5g / ha against DIGSA in % Table A4b: Post-emergence effect at 20g / ha against DIGSA in % Table A5a: Post-emergence efficacy at 1.25g / ha against ECHCG in % 10 Table A5b: Post-emergence effect at 5g / ha against ECHCG in % Table A5c: Post-emergence effect at 20g / ha against ECHCG in % Table A6a: Post-emergence effect at 5g / ha against LOLRI in % Table A6b: Post-emergence effect at 20g / ha against LOLRI in %

[0014] Table A7a: Post-emergence effect at 1.25g / ha against MATIN in % Table A7b: Post-emergence effect at 5g / ha against MATIN in % Table A7c: Post-emergence effect at 20g / ha against MATIN in % Table A8a: Post-emergence effect at 1.25g / ha against PHBPU in % Table A8b: Post-emergence effect at 5g / ha against PHBPU in % Table A8c: Post-emergence effect at 20g / ha against PHBPU in % Table A9a: Post-emergence effect at 1.25g / ha against POLCO in % Table A9b: Post-emergence effect at 5g / ha against POLCO in % Table A9c: Post-emergence effect at 20g / ha against POLCO in % Table A10a: Post-emergence effect at 1.25g / ha against SETVI in % Table A10b: Post-emergence effect at 5g / ha against SETVI in % Table A10c: Post-emergence effect at 20g / ha against SETVI in % Table A11a: Post-emergence effect at 1.25g / ha against VERPE in % Table A11b: Post-emergence effect at 5g / ha against VERPE in % Table A11c: Post-emergence effect at 20g / ha against VERPE in % Table A12a: Post-emergence effect at 1.25g / ha against VIOTR in % Table A12b: Post-emergence effect at 5g / ha against VIOTR in %

[0015] Table A12c: Post-emergence effect at 20g / ha against VIOTR in % Table A13a: Post-emergence effect at 1.25g / ha against KCHSC in % Table A13b: Post-emergence effect at 5g / ha against KCHSC in % Table A13c: Post-emergence effect at 20g / ha against KCHSC in %

[0016] Table A14a: Post-emergence effect at 1.25g / ha against AMARE in % Table A14b: Post-emergence effect at 5g / ha against AMARE in % Table A14c: Post-emergence effect at 20g / ha against AMARE in % B. Post-emergence effect on crops. Seeds of monocotyledonous and dicotyledonous crops were sown in plastic or wood-fiber pots in sandy loam soil, covered with soil, and grown in a greenhouse under controlled growth conditions. Two to three weeks after sowing, the test plants were treated at the single-leaf stage. The compounds of the invention, formulated as wettable powders (WP) or emulsion concentrates (EC), were then sprayed onto the green parts of the plants as an aqueous suspension or emulsion with the addition of 0.5% additive at a water application rate equivalent to 600 l / ha. After the test plants had been in the greenhouse for approximately three weeks under optimal growth conditions, the effect of the preparations was visually assessed in comparison to untreated controls.For example, 100% activity means plants are dead, 0% activity means the same as the control plants. Tables B1 to B4 below show the effects of selected compounds of general formula (I) according to Table 1 on various crops and at application rates corresponding to 20 g / ha and lower, obtained according to the aforementioned test protocol. Table B1: Post-emergence activity at 1.25 g / ha against ZEAMX in %. Table B2a: Post-emergence effect at 1.25g / ha against TRZAS in % Table B2b: Post-emergence effect at 5g / ha against TRZAS in % Table B2c: Post-emergence effect at 20g / ha against TRZAS in % Table B4: Post-emergence effect at 1.25g / ha against BRSNW in % As the above-mentioned results show, compounds of the general formula (I) according to the invention, when applied post-emergence, have good herbicidal activity against weeds such as, for example, Abutilon theophrasti, Alopecurus myosuroides, Amaranthus retroflexus, Avena fatua, Digitaria sanguinalis, Echinochloa crus-galli, Lolium rigidum, Matricaria inodora, Pharbitis purpurea, Polygonum convolvulus, Setaria viridis, Veronica persica, Viola tricolor and Kochia scoparia at an application rate of 0.02 kg of active ingredient or less per hectare, and good crop plant tolerance by organisms such as, for example, Zea mays, Triticum aestivum, Glycine max and Brassica napus at an application rate of 20 g per hectare or less.

Claims

Patent claims:

1. Substituted oxyiminomethylphenyluracils of the general formula (I) or their salts I) where W stands for the group W-1 or W2 stands R 1 for hydrogen, halogen, (C 1 -C 4 )-alkoxy, R 2 for halogen, cyano, nitro, C(O)NH 2 , C(S)NH 2 , (C 1 -C 8 )-haloalkyl, (C 2 -C 8 )-alkynyl, R 3 and R 4 independently for hydrogen, (C 1 -C 8 )-alkyl, R 13 O-(C 1 -C 8 )-alkyl, (C 3 -C 8 )- cycloalkyl, (C 2 -C 8 )-alkenyl, aryl-(C 1 -C 8 )-alkyl, heteroaryl-(C 1 -C 8 )-alkyl, heterocyclyl- (C 1 -C 8 )-alkyl, or R 3 and R 4together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 10-membered carbocyclic ring, which optionally carries further substituents, R 5 represents hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, R 13 O-(C1-C8)-alkyl, (C2-C8)-alkenyl, aryl-(C1-C8)-alkyl, heteroaryl-(C1-C8)-alkyl, heterocyclyl-(C1-C8)-alkyl, (C3-C8)-cycloalkyl, aryl, heteroaryl, heterocyclyl, R 6 represents (C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C2-C8)-alkenyl, aryl-(C1-C8)-alkyl, (C3-C8)-cycloalkyl-(C1-C8)-alkyl, R 7 represents hydrogen, fluorine, chlorine, or methyl, Q represents hydroxy or a radical of the following formulas 0 5 stands, R 8 for hydrogen, (C 1 -C 8 )-alkyl, (C 1 -C 8 )-haloalkyl, aryl, aryl-(C 1 -C 8 )-alkyl, heteroaryl, (C 2 -C 8 )-alkynyl, (C 2 -C8 )-Alkenyl, C(O)R 13 , C(O)OR 13 , (C 1 -C 8 )-Alkoxy- (C 1 -C 8 )-alkyl steht, R 9 für Wasserstoff oder (C1-C8)-Alkyl steht, R 10 für Wasserstoff, Halogen, Cyano, NO2, (C1-C8)-Alkyl, (C1-C8)-Haloalkyl, (C3-C8)- Cycloalkyl, (C3-C8)-Cycloalkyl-(C1-C8)-alkyl, (C3-C8)-Halocycloalkyl, (C3-C8)- Halocycloalkyl-(C1-C8)-alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, Aryl, Aryl-(C1-C8)- alkyl, Heteroaryl, Heteroaryl-(C1-C8)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C8)-alkyl, R 11 R 12 N-(C1-C8)-alkyl, R 13 O-(C1-C8)-alkyl, Cyano-(C1-C8)-alkyl, (C1-C8)- Alkylcarbonyloxy-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl-carbonyloxy-(C1-C8)-alkyl, Arylcarbonyloxy-(C1-C8)-alkyl, Heteroarylcarbonyloxy-(C1-C8)-alkyl, Heterocyclylcarbonyloxy-(C1-C8)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S- (C1-C8)-alkyl, R 14(O)S-(C1-C8)-alkyl, R 14 O2S-(C1-C8)-alkyl, tris-[(C1-C8)-alkyl]silyl-(C1-C8)-alkyl, bis-[(C1-C8)-alkyl](aryl)silyl(C1-C8)-alkyl, [(C1-C8)-alkyl]-bis-(aryl)silyl-(C1-C8)-alkyl, Tris-[(C1-C8)-alkyl]silyl, bis-hydroxyboryl-(C1-C8)-alkyl, bis-[(C1-C8)-alkoxy]boryl-(C1-C8)-alkyl, tetramethyl-1,3,2-dioxaborolan-2-yl, Tetramethyl-1,3,2-dioxaborolan-2-yl-(C1-C8)-alkyl, nitro-(C1-C8)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C8)-alkyl, R 11 R 12 N(O)C-(C1-C8)-alkyl, bis-(C1-C8)-alkoxy-(C1-C8)-alkyl, or R 8 and R 10 form with the carbon atom to which they are attached a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12gleich oder verschieden sind und unabhängig voneinander für Wasserstoff, (C1-C8)- Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C1-C8)-Cyanoalkyl, (C1-C10)-Haloalkyl, (C2-C8)-Haloalkenyl, (C3-C8)-Haloalkinyl, (C3-C10)-Cycloalkyl, (C3-C10)- Halocycloalkyl, (C4-C10)-Cycloalkenyl, (C4-C10)-Halocycloalkenyl, (C1-C8)-Alkoxy- (C 1 -C 8 )-alkyl, (C 1 -C 8 )-Haloalkoxy-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkylthio-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Haloalkylthio-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkoxy-(C 1 -C 8 )-haloalkyl, Aryl, Aryl- (C 1 -C 8 )-alkyl, Heteroaryl, Heteroaryl-(C 1 -C 8 )-alkyl, (C 3 -C 8 )-Cycloalkyl-(C 1 -C 8 )-alkyl, (C 4 -C 10 )-Cycloalkenyl-(C 1 -C 8 )-alkyl, COR 13 , SO 2 R14 , heterocyclyl, (C 1 -C 8 )- alkoxycarbonyl, bis-[(C 1 -C 8 )-alkyl]aminocarbonyl-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkyl-amino-carbonyl-(C 1 -C 8 )-alkyl, aryl-(C 1 -C 8 )-alkyl-aminocarbonyl-(C 1 -C 8 )-alkyl, aryl-(C 1 -C 8 )-alkoxycarbonyl, heteroaryl-(C 1 -C 8 )-alkoxycarbonyl, (C 2 -C 8 )-Alkenyloxycarbonyl, (C 2 -C 8 )-alkynyloxycarbonyl, heterocyclyl-(C 1 -C 8 )-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13 for hydrogen, (C 1 -C 8)-Alkyl, (C 2 -C 8 )-Alkenyl, (C 2 -C 8 )-Alkinyl, (C 1 -C 8 )-Cyanoalkyl, (C 1 -C 10 )-Haloalkyl, (C 2 -C 8 )-Haloalkenyl, (C 3 -C 8 )-Haloalkinyl, (C 3 -C 10 )-Cycloalkyl, (C 3 -C 10 )-Halocycloalkyl, (C 4 -C 10 )-Cycloalkenyl, (C 4 -C 10 )-Halocycloalkenyl, (C 1 -C 8 )- Alkoxy-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Haloalkoxy-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkoxy-(C 1 -C 8)- haloalkyl, (C1-C8)-Alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)- alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkoxy- (C1-C8)-alkoxy-(C1-C8)-alkyl, Aryl, Aryl-(C1-C8)-alkyl, Aryl-(C1-C8)-alkoxy-(C1-C8)- alkyl, Heteroaryl, Heteroaryl-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl-(C1-C8)-alkyl, (C4-C10)- Cycloalkenyl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkyl]aminocarbonyl-(C1-C8)-alkyl, (C1-C8)- Alkyl-aminocarbonyl-(C1-C8)-alkyl, Aryl-(C1-C8)-alkyl-aminocarbonyl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkyl]amino-(C2-C6)-alkyl, (C1-C8)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1- C8)-alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C8)-alkyl, R 14 (O)S-(C1-C8)-alkyl, R 14O2S- (C1-C8)-alkyl, Hydroxycarbonyl-(C1-C8)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C8)- alkyl, Tris-[(C1-C8)-Alkyl]silyl-(C1-C8)-alkyl, Bis-[(C1-C8)-Alkyl](aryl)silyl(C1-C8)- alkyl, [(C1-C8)-Alkyl]-bis-(aryl)silyl-(C1-C8)-alkyl, (C1-C8)-Alkylcarbonyloxy-(C1-C8)- alkyl, (C3-C8)-Cycloalkylcarbonyloxy-(C1-C8)-alkyl, Arylcarbonyloxy-(C1-C8)-alkyl,35 Heteroarylcarbonyloxy-(C1-C8)-alkyl, Heterocyclylcarbonyloxy-(C1-C8)-alkyl, Aryloxy- (C1-C8)-alkyl, Heteroaryloxy-(C1-C8)-alkyl, (C1-C8)-Alkoxycarbonyl steht, R 14 für Wasserstoff, (C1-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C1-C8)-Cyanoalkyl, (C1-C10)-Haloalkyl, (C2-C8)-Haloalkenyl, (C3-C8)-Haloalkinyl, (C3-C10)-Cycloalkyl, (C3-C10)-Halocycloalkyl, (C4-C10)-Cycloalkenyl, (C4-C10)-Halocycloalkenyl, (C1-C8)- Alkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)-haloalkyl, Aryl, Aryl-(C1-C8)-alkyl, Heteroaryl, Heteroaryl-(C1-C8)-alkyl, Heterocyclyl-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl- (C 1 -C 8 )-alkyl, (C4 -C 10 )-Cycloalkenyl-(C 1 -C 8 )-alkyl, Bis-[(C 1 -C 8 )-alkyl]amino, (C 1 -C 8 )- Alkyl-amino, Aryl-(C 1 -C 8 )-amino, Aryl-(C 1 -C 6 )-alkyl-amino, Aryl-[(C 1 -C 8 )- alkyl]amino; (C 3 -C 8 )-Cycloalkyl-amino, (C 3 -C 8 )-Cycloalkyl-[(C 1 -C 8 )-alkyl]amino; N- Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, N-Morpholinyl steht und R 15 und R 16 unabhängig voneinander für (C 1 -C 8 )-Alkyl, (C 3 -C 8 )-Cycloalkyl, Aryl, Heteroaryl, Heterocyclyl stehen, oder R 15 und R 16with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 7-membered carbocycle.

2. Compounds of the general formula (I) according to claim 1 and / or a salt thereof, characterized in that W represents the group W -1 W-2 stands R 1 represents hydrogen, fluorine, chlorine, bromine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, trifluoromethyl, ethynyl, propyn-1-yl, R 3 and R 4 independently of each other represent hydrogen, (C1-C6)-alkyl, R 13 O-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, aryl-(C1-C6)-alkyl, heteroaryl-(C1-C6)-alkyl, or heterocyclyl-(C1-C6)-alkyl, or R 3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 10-membered carbocyclic ring, R 5 for hydrogen, (C 1 -C 6)-Alkyl, (C 1 -C 6 )-Haloalkyl, R 13 O-(C 1 -C 6 )-alkyl, Aryl-(C 1 -C 6 )- alkyl, Heteroaryl-(C 1 -C 6 )-alkyl, Heterocyclyl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-Cycloalkyl, Aryl, Heteroaryl, Heterocyclyl, steht, R 6 für (C 1 -C 6 )-Alkyl, (C 3 -C 6 )-Cycloalkyl, (C 2 -C 6 )-Alkenyl, Aryl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )- Cycloalkyl-(C 1 - C 6 )-alkyl steht, R 7 für Wasserstoff, Methyl steht, Q für Hydroxy oder einen Rest der nachfolgenden Formeln 0 R 5 steht, R 8 für Wasserstoff, (C1-C6)-Alkyl, (C1-C6)-Haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, (C2-C6)-Alkinyl, (C2-C6)-Alkenyl, C(O)R 13 , C(O)OR 13 , (C1-C6)-Alkoxy-(C1-C6)-alkyl steht, R 9für Wasserstoff oder (C1-C6)-Alkyl steht, R 10 für Wasserstoff, Halogen, Cyano, NO2, (C1-C7)-Alkyl, (C1-C7)-Haloalkyl, (C3-C7)- Cycloalkyl, (C3-C7)-Cycloalkyl-(C1-C7)-alkyl, (C3-C7)-Halocycloalkyl, (C3-C7)- Halocycloalkyl-(C1-C7)-alkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, Aryl, Aryl-(C1-C7)- alkyl, Heteroaryl, Heteroaryl-(C1-C7)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C7)-alkyl, R 11 R 12 N-(C1-C7)-alkyl, R 13 O-(C1-C7)-alkyl, Cyano-(C1-C7)-alkyl, (C1-C7)- Alkylcarbonyloxy-(C1-C7)-alkyl, (C3-C7)-Cycloalkylcarbonyloxy-(C1-C7)-alkyl, Arylcarbonyloxy-(C1-C7)-alkyl, Heteroarylcarbonyloxy-(C1-C7)-alkyl, Heterocyclylcarbonyloxy-(C1-C7)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S- (C1-C7)-alkyl, R 14 (O)S-(C1-C7)-alkyl, R 14O2S-(C1-C7)-alkyl, tris-[(C1-C7)-alkyl]silyl-(C1-C7)-alkyl, bis-[(C1-C7)-alkyl](aryl)silyl(C1-C7)-alkyl, [(C1-C7)-alkyl]-bis-(aryl)silyl-(C1-C7)-alkyl, Tris-[(C1-C7)-alkyl]silyl, bis-hydroxyboryl-(C1-C7)-alkyl, bis-[(C1-C7)-alkoxy]boryl-(C1-C7)-alkyl, tetramethyl-1,3,2-dioxaborolan-2-yl, Tetramethyl-1,3,2-dioxaborolan-2-yl-(C1-C7)-alkyl, nitro-(C1-C7)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C 1 -C 7 )-alkyl, R 11 R 12 N(O)C-(C 1 -C 7 )-alkyl, bis- (C 1 -C 7 )-alkoxy-(C 1 -C 7 )-alkyl, or R 8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12gleich oder verschieden sind und unabhängig voneinander für Wasserstoff, (C 1 -C 6 )- Alkyl, (C 2 -C 6 )-Alkenyl, (C 2 -C 6 )-Alkinyl, (C 1 -C 6 )-Cyanoalkyl, (C 1 -C 6 )-Haloalkyl, (C 2 -C 6 )-Haloalkenyl, (C 3 -C 6 )-Haloalkinyl, (C 3 -C 6 )-Cycloalkyl, (C 3 -C 6 )-Halocycloalkyl, (C 4 -C 6 )-Cycloalkenyl, (C 4 -C 6 )-Halocycloalkenyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Haloalkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkylthio-(C 1 -C 6 )-alkyl, (C 1 -C 6 )- Haloalkylthio-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-haloalkyl, Aryl, Aryl-(C 1 -C6 )- alkyl, Heteroaryl, Heteroaryl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-Cycloalkyl-(C 1 -C 6 )-alkyl, (C 4 -C 6 )- Cycloalkenyl-(C 1 -C 6 )-alkyl, C(O)R 13 , SO 2 R 14 , Heterocyclyl, (C 1 -C 6 )-Alkoxycarbonyl, Bis-[(C 1 -C 6 )-alkyl]aminocarbonyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkyl-aminocarbonyl-(C 1 -C 6 )- alkyl, Aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxycarbonyl, Heteroaryl-(C1-C6)-alkoxycarbonyl, (C2-C6)-Alkenyloxycarbonyl, (C2-C6)- Alkinyloxycarbonyl, Heterocyclyl-(C1-C6)-alkyl stehen, oder R 11 und R 12mit dem Stickstoffatom, an das sie gebunden sind, einen vollständig gesättigten oder teilgesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 10-gliedrigen monocyclischen oder bicyclischen Ring bilden, R 13 für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)-Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)-Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)- Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-35 haloalkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)- alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy- (C1-C6)-alkoxy-(C1-C6)-alkyl, Aryl, Aryl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxy-(C1-C6)- alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C4-C6)- Cycloalkenyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)-alkyl, (C1-C6)- Alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C7)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]amino-(C2-C6)-alkyl, (C1-C6)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1- C6)-alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C6)-alkyl, R 14 (O)S-(C1-C6)-alkyl, R 14 O2S- (C 1 -C 6 )-alkyl, Hydroxycarbonyl-(C 1 -C 6 )-alkyl, Heterocyclyl, Heterocyclyl-(C 1 -C 6 )- alkyl, Tris-[(C 1 -C 6 )-Alkyl]silyl-(C 1 -C 6 )-alkyl, Bis-[(C 1 -C 6 )-Alkyl](aryl)silyl(C 1 -C 6 )- alkyl, [(C 1 -C 6 )-Alkyl]-bis-(aryl)silyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkylcarbonyloxy-(C 1 -C 6 )- alkyl, (C 3 -C6 )-Cycloalkylcarbonyloxy-(C 1 -C 6 )-alkyl, Arylcarbonyloxy-(C 1 -C 6 )-alkyl, Heteroarylcarbonyloxy-(C 1 -C 6 )-alkyl, Heterocyclylcarbonyloxy-(C 1 -C 6 )-alkyl, Aryloxy- (C 1 -C 6 )-alkyl, Heteroaryloxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxycarbonyl steht, R 14 für Wasserstoff, (C 1 -C 6 )-Alkyl, (C 2 -C 6 )-Alkenyl, (C 2 -C 6 )-Alkinyl, (C 1 -C 6 )-Cyanoalkyl, (C 1 -C 6 )-Haloalkyl, (C 2 -C 6 )-Haloalkenyl, (C 3 -C 6 )-Haloalkinyl, (C 3 -C 6 )-Cycloalkyl, (C 3 -C 6 )-Halocycloalkyl, (C 4 -C 6 )-Cycloalkenyl, (C 4 -C 6 )-Halocycloalkenyl, (C 1 -C 6 )- Alkoxy-(C 1 -C 6)-alkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-haloalkyl, Aryl, Aryl-(C 1 -C 6 )-alkyl, Heteroaryl, Heteroaryl-(C 1 -C 6 )-alkyl, Heterocyclyl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-Cycloalkyl- (C 1 -C 6 )-alkyl, (C 4 -C 6 )-Cycloalkenyl-(C 1 -C 6 )-alkyl, Bis-[(C 1 -C 6 )-alkyl]amino, (C 1 -C 6 )- Alkyl-amino, Aryl-(C 1 -C 6 )-amino, Aryl-(C 1 -C 6 )-alkyl-amino, Aryl-[(C 1 -C 6 )- alkyl]amino; (C 3 -C 6 )-Cycloalkyl-amino, (C 3 -C 6 )-Cycloalkyl-[(C 1 -C 6 )-alkyl]amino; N- Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, N-Morpholinyl steht, und R 15 und R 16independently of one another represent (C1-C6)-alkyl, (C3-C6)-cycloalkyl, aryl, heteroaryl, heterocyclyl, or R 15 and R 16 with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 7-membered carbocycle.

3. Compounds of the general formula (I) according to claim 1 or 2 and / or a salt thereof, characterized in that W represents the group stands R 1 represents hydrogen, fluorine, chlorine, R 2 for fluorine, chlorine, bromine, cyano, nitro, C(O)NH 2 , C(S)NH 2 , trifluoromethyl, R 3 and R 4 independently of one another represent hydrogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, or R 3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 7-membered carbocyclic ring, R 5represents hydrogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, R 6 represents methyl, ethyl, prop-1-yl, R 7 represents hydrogen, Q represents hydroxy or a radical of the following formulas 0 R 5 stands, R 8 for hydrogen, (C 1 -C 5 )-alkyl, (C 1 -C 5 )-haloalkyl, aryl, aryl-(C 1 -C 5 )-alkyl, heteroaryl, (C 2 -C 5 )-alkynyl, (C 2 -C 5 )-alkenyl, C(O)R 13 , C(O)OR 13 , (C 1 -C 5 )-alkoxy-(C 1 -C 5 )-alkyl, R 9 for hydrogen or (C 1 -C 5 )-alkyl, R 10für Wasserstoff, Halogen, Cyano, NO2, (C1-C6)-Alkyl, (C1-C6)-Haloalkyl, (C3-C6)- Cycloalkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C3-C6)-Halocycloalkyl, (C3-C6)- Halocycloalkyl-(C1-C6)-alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, Aryl, Aryl-(C1-C6)- alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)-alkyl, R 11 R 12 N-(C1-C6)-alkyl, R 13 O-(C1-C6)-alkyl, Cyano-(C1-C6)-alkyl, (C1-C6)- Alkylcarbonyloxy-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-Cycloalkylcarbonyloxy-(C 1 -C 6 )-alkyl, Arylcarbonyloxy-(C 1 -C 6 )-alkyl, Heteroarylcarbonyloxy-(C 1 -C 6 )-alkyl, Heterocyclylcarbonyloxy-(C 1 -C 6 )-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO 2 R 14 , R 14 S- (C 1 -C 6 )-alkyl, R 14 (O)S-(C 1 -C 6 )-alkyl, R14 O 2 S-(C 1 -C 6 )-alkyl, Tris-[(C 1 -C 6 )-Alkyl]silyl- (C 1 -C 6 )-alkyl, Bis-[(C 1 -C 6 )-Alkyl](aryl)silyl(C 1 -C 6 )-alkyl, [(C 1 -C 6 )-Alkyl]-bis- (aryl)silyl-(C 1 -C 6 )-alkyl, Tris-[(C 1 -C 6 )-Alkyl]silyl, Bis-hydroxyboryl-(C 1 -C 6 )-alkyl, Bis- [(C 1 -C 6 )-alkoxy]boryl-(C 1 -C 6 )-alkyl, Tetramethyl-1,3,2-Dioxaborolan-2-yl, Tetramethyl-1,3,2-Dioxaborolan-2-yl-(C 1 -C 6 )-alkyl, Nitro-(C 1 -C 6 )-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C 1 -C 6 )-alkyl, R 11 R 12 N(O)C-(C 1 -C 6 )-alkyl, Bis- (C 1 -C 6 )-alkoxy-(C 1 -C 6)-alkyl, or R 8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12 are the same or different and independently represent hydrogen, (C 1 -C 6 )-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-cyanoalkyl, (C1-C6)-haloalkyl, (C2-C6)-haloalkenyl, (C3-C6)-haloalkynyl, (C3-C10)-cycloalkyl, (C3-C6)-halocycloalkyl, (C4-C6)-cycloalkenyl, (C4-C6)-halocycloalkenyl, (C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-haloalkoxy-(C1-C6)-alkyl, (C1-C6)-alkylthio-(C1-C6)-alkyl, (C1-C6)-haloalkylthio-(C1-C6)-alkyl, (C1-C6)-alkoxy-(C1-C6)-haloalkyl, aryl, aryl-(C1-C6)-alkyl, heteroaryl, heteroaryl-(C1-C6)-alkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, (C4-C10)-cycloalkenyl-(C1-C6)-alkyl, C(O)R 13 , SO2R14 , heterocyclyl, (C1-C6)-alkoxycarbonyl, bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)-alkyl, (C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxycarbonyl, heteroaryl-(C1-C6)-alkoxycarbonyl, (C2-C6)-alkenyloxycarbonyl, (C2-C6)-alkynyloxycarbonyl, heterocyclyl-(C1-C6)-alkyl, or 35 R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C10)-Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)-Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)- Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)- haloalkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-alkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )- alkoxy-(C 1 -C 6 )-alkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-alkoxy-(C 1 -C 6 )-alkoxy- (C 1 -C 6 )-alkoxy-(C 1 -C 6 )-alkyl, Aryl, Aryl-(C 1 -C 6 )-alkyl, Aryl-(C 1 -C 6 )-alkoxy-(C 1 -C 6 )- alkyl, Heteroaryl, Heteroaryl-(C 1 -C 6)-alkyl, (C 3 -C 6 )-Cycloalkyl-(C 1 -C 6 )-alkyl, (C 4 -C 6 )- Cycloalkenyl-(C 1 -C 6 )-alkyl, Bis-[(C 1 -C 6 )-alkyl]aminocarbonyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )- Alkyl-aminocarbonyl-(C 1 -C 6 )-alkyl, Aryl-(C 1 -C 6 )-alkyl-aminocarbonyl-(C 1 -C 6 )-alkyl, Bis-[(C 1 -C 6 )-alkyl]amino-(C 2 -C 6 )-alkyl, (C 1 -C 6 )-Alkyl-amino-(C 2 -C 6 )-alkyl, Aryl-(C 1 - C 6 )-alkyl-amino-(C 2 -C 6 )-alkyl, R 14 S-(C 1 -C 6 )-alkyl, R 14 (O)S-(C 1 -C 6 )-alkyl, R 14 O 2 S- (C 1 -C 6 )-alkyl, Hydroxycarbonyl-(C 1 -C 6 )-alkyl, Heterocyclyl, Heterocyclyl-(C 1-C 6 )- alkyl, Tris-[(C 1 -C 6 )-Alkyl]silyl-(C 1 -C 6 )-alkyl, Bis-[(C 1 -C 6 )-Alkyl](aryl)silyl(C 1 -C 6 )- alkyl, [(C 1 -C 6 )-Alkyl]-bis-(aryl)silyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkylcarbonyloxy-(C 1 -C 6 )- alkyl, (C 3 -C 6 )-Cycloalkylcarbonyloxy-(C 1 -C 6 )-alkyl, Arylcarbonyloxy-(C 1 -C 6 )-alkyl, Heteroarylcarbonyloxy-(C 1 -C 6 )-alkyl, Heterocyclylcarbonyloxy-(C 1 -C 6 )-alkyl, Aryloxy- (C 1 -C 6 )-alkyl, Heteroaryloxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxycarbonyl steht, R 14 für Wasserstoff, (C 1 -C 6 )-Alkyl, (C 2 -C 6 )-Alkenyl, (C 2 -C 6 )-Alkinyl, (C 1 -C 6)-Cyanoalkyl, (C 1 -C 6 )-Haloalkyl, (C 2 -C 6 )-Haloalkenyl, (C 3 -C 6 )-Haloalkinyl, (C 3 -C 10 )-Cycloalkyl, (C3-C6)-Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)- Alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, Heterocyclyl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl- (C1-C6)-alkyl, (C4-C6)-Cycloalkenyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]amino, (C1-C6)- Alkyl-amino, Aryl-(C1-C6)-amino, Aryl-(C1-C6)-alkyl-amino, Aryl-[(C1-C6)- alkyl]amino; (C3-C6)-Cycloalkyl-amino, (C3-C6)-Cycloalkyl-[(C1-C6)-alkyl]amino; N- Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, N-Morpholinyl steht und R 15 und R 16 unabhängig voneinander für (C1-C6)-Alkyl, (C3-C6)-Cycloalkyl, Aryl, Heteroaryl, Heterocyclyl stehen, oder 35 R 15 und R 16form a fully saturated monocyclic 3- to 6-membered carbocycle with the carbon atom to which they are attached.

4. Compounds of general formula (I) and / or salts thereof according to any one of claims 1 to 3, characterized in that W represents the group W -1 W-2 stands R 1 represents hydrogen, fluorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, R 3 and R 4 independently of one another represent hydrogen, methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methyl-prop-1-yl, 1,1-dimethyleth-1-yl, trifluoromethyl, or R 3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 7-membered carbocyclic ring, R 5represents hydrogen, methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methyl-prop-1-yl, 1,1-dimethyleth-1-yl, trifluoromethyl, R 6 stands for methyl, ethyl, R 7 stands for hydrogen, and Q stands for one of the following specifically named groups Q-1 to Q-500: ooo , -) o . C .-\ SV NV.\ / S\ --. ov / , s> .. / o 0 „.

0. _ , o . / ' / ' ..7 0 * / \ ., o - o with ( cc ".0„......,.....„....,.S ".0„......,.....„....,.SN ,7 ,. / ON,VsN7 N., N , Nr S i, zz O , r O F F O C C O C Î C C C3 7CI C C C / C / 10 5. Compounds of general formula (I) and / or salt thereof according to any one of claims 1 to 4, characterized in that W represents the group W -1 W-2 stands R 1 stands for hydrogen, fluorine, 15 R 2 represents fluorine, chlorine, bromine, cyano, nitro, R 3 and R 4 independently of one another represent hydrogen, methyl, ethyl, prop-1-yl, or R 3 and R 4 together with the carbon atom to which they are attached, form a fully saturated or partially saturated, 3 to 6-membered carbocyclic ring, R 5 represents hydrogen, methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methyl-prop-1-yl, 1,1-dimethyleth-1-yl, trifluoromethyl, R 6 stands for methyl, ethyl, R 7represents hydrogen, and Q represents one of the groups Q-1 to Q-500 specifically mentioned in claim 4.

6. Compounds of the general formula (I) and / or their salt according to one of claims 1 to 5, characterized in that W represents the group W -1 W-2 stands R 1 represents hydrogen, fluorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, R 3 and R 4 independently represent hydrogen, methyl, ethyl R 5 represents hydrogen, methyl, ethyl, prop-1-yl, trifluoromethyl, R 6 stands for methyl, ethyl, R 7 represents hydrogen, and Q represents one of the groups Q-1 to Q-500 specifically mentioned in claim 4.

7. Compounds of the general formula (I) and / or their salt according to one of claims 1 to 6, characterized in that W represents the group W -1 W-2 stands R 1 stands for fluorine, R 2 stands for chlorine, R3 and R 4 independently of each other represent hydrogen, methyl, R 5 stands for hydrogen, R 6 stands for methyl, R 7 represents hydrogen, and Q represents one of the groups Q-1, Q-286, Q-371, Q-441, Q-442, or Q-481 specifically mentioned in claim 4.

8. Use of one or more compounds of general formula (I) as defined in any one of claims 1 to 7 and / or salts thereof as a herbicide and / or plant growth regulator, preferably in crops of useful and / or ornamental plants.

9. A herbicidal and / or plant growth-regulating agent, characterized in that the agent contains one or more compounds of general formula (I) as defined in any one of claims 1 to 7 and / or salts thereof, and further one or more substances selected from groups (i) and / or (ii), with (i) one or more further agrochemically active substances, preferably selected from the group consisting of insecticides, acaricides, nematicides, further herbicides, fungicides, safeners, fertilizers, and / or further growth regulators, (ii) one or more formulation auxiliaries customary in crop protection. 10.A method for controlling harmful plants or for regulating the growth of plants, characterized in that an effective amount of - one or more compounds of the general formula (I) as defined in any one of claims 1 to 7 and / or salts thereof, or - an agent according to claim 9 is applied to the plants, plant seeds, the soil in or on which the plants grow, or the area under cultivation.

Images